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English abstract. 
Herpesvirales is an ancient group of DNA viruses that infect different animal species, includ-
ing reptiles. The Alphaherpesvirus is the major subfamily of Herpesvirales involved in reptile 
infections, and responsible for the onset of variably severe necrotizing lesions, affecting dif-
ferent body parts, and frequently associated with the animal’s death. The death of the animal 
can be caused directly by the effect of the virus, or more frequently by the onset of secondary 
bacterial infections. Today, the reptile species most commonly kept as household pets are tor-
toises, lizards, and snakes. Compared to the owners of the other two groups of reptiles, at least 
in Europe, pet tortoise owners frequently buy animals that are collected from the wild (espe-
cially exotic species) and are also prone to abandon these animals into the wild. Moreover, 
good breeding practices are frequently not applied to reptile breeding centers, which com-
monly introduce new animals in their enclosure without testing and/or quarantining the ani-
mals. These habits have different consequences, including spreading both exotic and non-ex-
otic diseases on Italian soil. Among all viruses infecting chelonians, herpesviruses are the 
group with the highest number of members, with more than five groups affecting turtles and 
tortoises. International literature reports herpesviruses as one of the most relevant causes of 
death in chelonians. Despite the relevance of the disease from both a conservational and eco-
nomical point of view, no information is available on the presence of these viruses in Italy, 
and very little is known about the genetic characteristics and the host-pathogen interaction 
mechanisms. This work aims to identify the presence of Testudinid herpesviruses (TeHVs) in 
Italy, characterize the genome of the virus, and start to understand the host-pathogen interac-
tion mechanisms between TeHV3 and Testudo graeca. To evaluate the presence of TeHVs in 
Italy, we carried out a prospective study, performing the ELISA test on live animals in the 
WWF Vanzago's Oasis, combined with PCR on both prospective and retrospective samples 
collected from the archive of the anatomical pathology section of the University of Milan. 
Complete necropsy and histological evaluation were performed on all prospective samples af-
ter their natural death. Furthermore, viral isolation was successfully carried out on one of the 
Vanzago cases. Using both TeHV3 strains collected in Italy, USA, and Switzerland, complete 
genome sequencing was performed. Evaluation of T. graeca immune response against TeHV3 
was evaluated by creating a bacteriophage expression library screened with hyperimmune tor-
toise sera, obtained from a previous transmission study.  
Our study demonstrates that from both the prospective and retrospective samples, all that were 
positive were TeHV3, but one retrospective sample was TeHV1 positive.  
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TeHV3 genome sequencing demonstrated that the viral genome is at least 150,080 nucleotides 
long, arranged in a D-type configuration, and extensively co-linear with the human herpesvi-
rus 1 genome. From an immunological point of view, we were able to identify three relevant 
TeHV3 candidate antigenic proteins, TE-17, UL-15, and gB. Although we initially supposed 
the gB was the most relevant antigenic protein in T. graeca immune response against TeHV3, 
further investigation showed that the gB sequence in the evaluated phagemid was antisense 
compared to the origin of replication, and could not be transcribed. To assess the possible im-
munological relevance of TeHV3 gB protein in boosting host immune response, we per-
formed enzymatic restriction, PCR cloning and PCR direct site mutagenesis on the original 
phagemid, to obtain new structures containing only one of the three possible immunogenic 
proteins previously identified.  
Despite the numerous attempts and techniques used, we are currently not able to obtain viable 
bacteria to confirm our hypothesis.   
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Abstract in Italiano. 
Gli Herpesvirales sono un gruppo di virus a DNA ontogeneticamente antico, in grado di infet-
tare diverse specie animali inclusi i rettili. Tra le diverse famiglie di herpesvirus gli Alphaher-
pesvirus sono la sottofamiglia di Herpesvirales maggiormente coinvolta nelle infezioni di ret-
tili e sono responsabili di lesioni necrotizzanti di gravità variabile a carico di diversi organi; 
spesso le lesioni portano a morte il soggetto sia a causa dei danni indotti direttamente dal virus 
che per l’insorgenza di infezioni batteriche secondarie. Tra tutte le specie di rettili le tartaru-
ghe, le lucertole e i serpenti sono gli animali domestici più comuni. I proprietari di tartarughe 
sono, tra le tipologie di proprietari di rettili, quelli più proni ad acquistare animali prelevati in 
natura e ad abbandonare specie alloctone sul territorio. Inoltre, sono presenti numerosi alleva-
menti amatoriali di queste specie che non rispettano le buone norme di allevamento e introdu-
cono animali senza effettuare regolare quarantena. La somma di questi comportamenti ha 
avuto molteplici conseguenze, tra le quali la diffusione di malattie esotiche e non esotiche 
nelle popolazioni autoctone di cheloni.  
Tra tutti i virus che possono causare infezioni nelle tartarughe, gli Herpesvirus sono i mag-
giormente rappresentati, con 5 gruppi in grado di infettare testuggini terrestri e acquatiche.  
Inoltre, sulla base di quanto riportato in letteratura, gli herpesvirus sono una delle principali 
cause di morte tra i cheloni. Sebbene questi agenti eziologici abbiano un ruolo di rilievo sia da 
un punto di vista della bioconservazione che economico, non sono presenti informazioni sulla 
presenza del virus in Italia e, in linea generale, pochissime informazioni sono disponibili sulle 
caratteristiche genetiche e sui meccanismi di interazione ospite-patogeno.  
Questo lavoro ha lo scopo di identificare la presenza di Testudinid herpesvirus (TeHVs) in 
Italia, caratterizzare il genoma del virus ed iniziare ad investigare i meccanismi di interazione 
ospite-patogeno tra TeHV3 e Testudo graeca.  
Per valutare la presenza dei TeHVs in Italia, abbiamo effettuato uno studio prospettico effet-
tuando test ELISA e PCR su tutte le tartarughe presenti nell’Oasi WWF di Vanzago ed ab-
biamo fatto, inoltre, uno studio retrospettivo effettuando la PCR sui campioni d’archivio 
dell’Istituto di Anatomia Patologica Veterinaria dell’Università di Milano. Esame necrosco-
pico ed istopatologico completo sono stati effettuati su tutti i soggetti deceduti spontanea-
mente provenienti dall’Oasi di Vanzago. Inoltre, da uno dei soggetti provenienti dall’Oasi è 
stato possibile effettuare l’isolamento virale. Utilizzando ceppi di TeHV3 provenienti da Ita-
lia, USA e Svizzera, è stato possibile sequenziare il genoma di TeHV3. La valutazione dell’in-
terazione ospite-patogeno è stata fatta utilizzando una libreria fagica screenata con siero ipe-
rimmune di T. graeca, ottenuto da uno studio di trasmissione precedente.  
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Il nostro studio ha dimostrato che tutti i campioni positivi, sia prospettici che retrospettivi, 
erano positivi per TeHV3, tranne un caso retrospettivo positivo per TeHV1. 
Il genoma di TeHV3 è risultato essere lungo, circa, 150.080 nucleotidi, con una configura-
zione genomica di tipo D ed è risultato altamente co-lineare con il genoma dell’Human herpe-
svirus 1.  
Da un punto di vista immunologico, abbiamo individuato tre potenziali proteine responsabili 
della risposta immunitaria dell’ospite, TE-17, UL-15 e la gB. Sebbene si fosse inizialmente 
ritenuto che la gB fosse la principale proteina responsabile della risposta immunitaria, valuta-
zioni successive hanno dimostrato che l’orientamento della sequenza che codifica per la gB 
nel fagemide fosse antisenso e che, quindi, non potesse essere trascritta. Per valutare il possi-
bile ruolo antigenico di gB, il fagemide originale è stato modificato in modo tale da contenere 
un solo frammento codificante. Le tecniche utilizzate per modificare il fagemide sono state: 
restrizione enzimatica, clonaggio con PCR e Site-direct mutagenesis con PCR.  
Sebbene siano stati fatti numerosi tentativi e utilizzate metodologie differenti, a tutt’oggi, non 
è stato possibile ottenere colonie batteriche contenti il fagemide modificato e, quindi, non è 
stato possibile confermare l’ipotesi originale.  
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Summary of the work. 
Numerous infectious diseases have been documented in reptiles, however there is very little 
information about their immunological response. One of the most diffuse and lethal reptile 
pathogens is Testudinid herpesvirus 3 (TeHV3), an Alphaherpesvirinae. All species of tor-
toises (Testudinidea) are considered susceptible to TeHV3, however the virus is over repre-
sented in the genus Testudo, which includes, among others, T. graeca, T. hermanni, T. mar-
ginata, and T. horsfieldii, which are popular pets in Europe. The incidence of TeHV3-associ-
ated disease is highest right after hibernation. 
The aim of this work is to partially characterize the immunological response of T. graeca to 
TeHV3. A bacteriophage library composed of about 5,000 clones containing genomic DNA 
fragments of TeHV3 was produced. Bacteriophages were amplified in a specific strain of E. 
coli and screened with TeHV3-seropositive sera from T. graeca. Phagemids were excised 
from the positive bacteriophages, sequenced, and compared with the TeHV3 genome to iden-
tify the encoding genes. Six different structural and non-structural proteins were identified as 
immune relevant. Vero cells were transfected with phagemids of the positive clones to con-
firm the previous results. TeHV3’s protein expression was assessed by F.A.C.S using T. 
graeca seropositive sera. Out of all six selected clones, only that expressing the partial se-
quence of the glycoprotein B (gB) showed a positive signal in the F.A.C.S. analysis. This re-
sult is consistent with the well-known immunogenicity of gB of other herpesviruses, including 
those infecting humans, and with the highly conserved role that gB plays in host-pathogen in-
teraction across species and evolution. 
 
Scientific background and working hypothesis: 
Italy is one of the European countries with the highest population of pet and wild tortoises. 
From the early 90s reptiles, that were once mostly considered as wild animals, have been inte-
grated in households, gaining the status of “non-conventional pets.” Despite this interest, Italian 
Testudo sp. population has steadily and rapidly declined in the last 20 years. Not only free 
ranging tortoises are in danger, but also pet and breeding animals have shown a progressive 
reduction in survival time, and the annual birth rate has been dramatically reduced, with severe 
economic losses. The causes of these losses have been hypothesized but not consistently eval-
uated, and have been ascribed to the emergence of infectious diseases and a severe increase of 
environmental pollution. The percentage of endangered reptile species increased from 9.94% 
in 2008 to 22.2% in 2014, of these 168 are critically endangered, 349 are endangered and 395 
are vulnerable according to the World Conservation Union (IUNC) Red List. More specifically, 
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the IUCN Red List reports 6 species as extinct, 31 as critically endangered, 44 as endangered 
and 59 as vulnerable on a global scale. Most of these species are imperilled by excessive har-
vesting and loss of suitable habitats [44], but recent work on environmental toxicology of 
aquatic species has shown that toxicants and pollution can seriously influence the reproduction 
activity and embryonic development of reptiles [35, 37]. In Italy the IUNC Red List reports four 
species of reptile in danger, among which are Testudo hermanni [“near threatened” class] and 
Testudo graeca (“vulnerable” class). These species, with the addition of the T. marginata, are 
the most represented in Italy and they are also included in the CITES (Convention on Interna-
tional Trade in Endangered Species of Wild Fauna and Flora) appendices II (species that are 
not necessarily now threatened by extinction but that may become so unless trade is closely 
controlled). Regarding the specific reason for the progressive decline of these species, espe-
cially during the last 30 years, there are seven most frequently mentioned causes: habitat loss 
[7, 11, 35, 36, 38, 39], removal from original habitat [6, 39], environmental contamination [11, 
35], climate change [11], invasive exotic species [11], disease and parasitism [11], cascading 
decline consequent to the numerical reduction of other related species [11].  
One of the most relevant infectious diseases that threaten the global survival of the Testudo spp. 
is the progressive diffusion of the Testudinid herpesvirus [18]. Many effects of a chronic infec-
tion with the T. herpesvirus may mimic pollutant effects; this contributes to the confusion on 
the various causes of the population decline. Tortoises’ and turtles’ herpesviruses have been 
characterized recently and, as reported by ICTV (International Committee on Taxonomy of 
Viruses), have been temporarily classified in the α- Herpesvirus, proposed genera Chelonivirus. 
Included in this genus are two proposed species: Testudinid herpesvirus (TeHVs), usually in-
fecting tortoise, and Chelonid herpesvirus [ChHV], usually infecting turtles [30, 47]. TeHVs 
are temporarily, divided into four genotypes. The origin of the four genotypes of TeHVs is not 
clear [30], but due to commercial trading they have a worldwide distribution. TeHV1 and 
TeHV3 [Eurasia] are both present in Europe [32, 45, 55] while TeHV2 has been identified in 
the USA and TeHV4 has been detected in Africa. TeHV3 is the best characterized genotype of 
Testudinid herpesvirus in Europe [19, 30]. All Testudo sp. species seem to be susceptible to the 
infection, but different levels of susceptibility have been hypothesized [18, 42]. TeHV3 infec-
tions are commonly defined by clinicians as “running nose” or “rhinitis- stomatitis complex” 
[30] but the clinical picture is more complex than the name would suggest. According to liter-
ature, the pathology starts as an upper respiratory-digestive tract disease with the involvement 
of nares [usually bilateral], eyes, gums and tongue [12, 30, 45, 55]. Macroscopically, the animal 
presents with a muco-purulent bilateral nasal discharge associated with a diphtheronecrotic sto-
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matitis-glossitis whit mono-lateral or bilateral conjunctivitis [15, 30, 42, 45, 52, 55]. Micro-
scopically, pneumonia has been observed, but the role of TeHV3 in the latter is not clear [30, 
55]. Microscopic lesions related to the TeHV3 infection are mainly necrotizing with occasional 
syncytia [30, 31, 42] in the mucosal epithelium, lung and central nervous system. The single 
specific diagnostic finding for TeHV3 infection is the presence of the typical, intranuclear, am-
phophilic inclusion bodies [13, 55]. Diagnosis of TeHV3 is performed with the following tests:  
1) Serology: It is an ELISA test, based on a colorimetric reaction. The test is now being vali-
dated for Geek’s (Testudo graeca) and Hermann’s (Testudo hermanni) tortoise with a sensitiv-
ity and a specificity of 97% and 98% respectively. The major limitation of this test is that it has 
not been validated on other tortoise species, moreover animals infected with the clinical disease 
have usually not yet seroconverted [19, 30, 31, 32, 55]  
2) Serum-neutralization: This test has the same pros and cons as the ELISA [30, 31, 32].  
3) Histology: This technique has low sensitivity but high specificity. Necrotic lesions in typical 
anatomical areas can be suggestive of TeHV3 infection, while the identification of typical in-
clusion bodies is diagnostic [30, 31, 32, 33, 55]. Unfortunately, it is mostly applied postmortem.  
4) PCR: identifies viral DNA, but positivity is not directly related to disease due to the charac-
teristic behavior of Herpesviruses to develop latency [30, 31, 48].  
5) Viral isolation: tortoise heart cells (Terrapente heart cells, TH-1) are generally infected 
through direct contact with a purified and homogenized sample of a suspected animal tissue 
[30]. Viral pathogenicity can be affected by conservation procedures, because of this viral iso-
lation requires long observation times. Despite time requirements, virial isolation should always 
be included in the “heard health” cases, to better complement viral characteristics and possibly 
develop a “in-house” vaccine based on the strain of the virus involved in the outbreak [30, 55].  
 
Despite the awareness of the presence and the spread of the virus in the Testudo spp. population, 
the long latency period associated with the time needed to produce an effective antibody con-
centration is considered the most accredited cause of the spread of the virus and the severe loss 
of tortoises. 
 
Aims: 
1) Evaluate for TeHV3 presence in Italy. Little is known regarding the prevalence and the dis-
tribution of TeHV3 in Europe, especially in Italy. What we expect is to find a prevalence similar 
to those identified in Spain, the UK, and the USA.  
We will also try to investigate the presence of TeHVs genotypes other than TeHV3.  
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2) Evaluate gross and microscopic lesions induced by TeHV3. Basing on the observation made 
in different countries about the pathological findings correlated to TeHV3 infections, we will 
try to confirm if the lesions reported in literature are also present in Italian tortoises, understand 
if TeHV3 induces different lesion profiles in different tortoise species, and if different strains 
of TeHV3 are present. 
 
3) Start investigating the immunological response of tortoises against viruses. With a bacterio-
phage expression library, we would like to try to identify the most relevant immunogenic pro-
teins of TeHV3 recognized by the host immune system. The purpose of this work is to better 
complement the host pathogen interaction, and try to develop new preventive approaches in-
cluding vaccines and more specific diagnostic tests. 
 
Sample collection: 
Samples were sent to us from the Oasis of Vanzago, a WWF oasis located near Milan, and by 
veterinarians as routine diagnostic cases for the anatomical pathology service of the Faculty of 
Veterinary medicine of the University of Milan. A total of 18 tortoises were collected. Addi-
tional 10 cases, originating from the same geographical area, were obtained as routine diag-
nostic animals. 
PCR and histopathology were performed on both groups, while necropsy and virological anal-
yses (such as viral isolation) were only carried out on the samples. 
 
Necropsy and prospective sample collections: 
All the twenty-eight dead animals were submitted to the veterinary pathology section of 
DIVET for necropsy evaluation, where oral swabs were performed on each of them. The ter-
minal part of the swab was cut and put into 2ml cryovials containing 0.5ml of Dulbecco’s 
Modified Eagle Medium (DMEM) containing 1% of penicillin 10,000,000 U/l. The swabs 
were frozen and stored at -80°C. 
The post-mortem examination was performed according to standard procedures [32]. Macro-
scopic findings and the collected samples were summarized on a specific worksheet (Annex I, 
see page 101).  
Samples collected from each animal for PCR and histopathology were brain, liver, kidneys, 
tongue, pharynx, trachea, esophagus, lungs, stomach, gut, heart, genital tract, spleen, and 
shell. Eyes and gums were included in the sampling list if lesions were macroscopically de-
tected. Two samples of each organ were collected for PCR. Of these, one was stored in an 
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empty cryovials, the other one in a cryovials with 0.5ml of Dulbecco's medium (MEM) added 
with 1% penicillin solution. 
Samples for PCR were frozen and stored at -80°C. Samples for histopathology were fixed in 
10% buffered formalin for ten days and then processed for the paraffin inclusion.  
 
PCR: 
Tissues were homogenized using TissueRuptor (Quiagen) and submitted for DNA extraction. 
DNA was extracted using the same extraction kit (QIAamp DNA FFPE Tissue Kit).  
DNA concentration and quality were evaluated with a spectrophotometer (Nanodrop, Thermo 
Fisher Scientific Inc.). 
Two different PCR protocols were applied to the study. The first protocol is termed "Pan-
Herpes" and was designed as screening PCR to identify the presence of Herpesvirales DNA in 
the sample. The “PanHerpes” is a nested-PCR using a preserved sequence of the DNA-poly-
merase as primer (see chapter 5, material and methods). 
“PanHerpes” positive samples were then re-evaluated using a TeHV3 and/or a TeHV2 spe-
cific PCR (see chapter 5, material and methods). 
The same cycling settings were used for both TeHV3 and TeHV2 specific PCR. 
Primes for TeHV3 (see chapter 5, material and methods). 
 
Host pathogen interaction immunological study: 
The procedure included three main steps: setup of a bacteriophage library, first immunoblot 
screening using Testudo graeca hyper-immune sera coming from a transmission study, and a 
second screening based on the FACS evaluation of the selected proteins in transformed eukar-
yotic cells. 
Virus and genomic DNA: The TeHV3 strain US1978/98 [1] was grown on Terrapene heart 
cells (TH-1; ATCC-CCL 50 Sub-line B1; American Type Culture Collection, Rockville, MD, 
USA) according to an established protocol [2–4]. The TeHV3 genomic DNA was obtained 
from the same strain similarly to what was previously described [2,4].  
Phage Library and DNA sequencing: 
Library preparation: the DNA fragments to insert into the bacteriophage were obtained ac-
cording to the manufacturer’s instructions. Distinct batches of US1978/98 genomic DNA 
were briefly fragmented by restriction digestion with Sao3AI for different lengths of time. 
The digested DNA batches were then resolved in a 1% DNA agarose gel. The digested batch, 
whose TeHV3 genomic DNA fragments ranged between 0.2 to 2 Kb, was selected and the 
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fragments were ligated into the bacteriophages genome using an auto-assembly bacterio-
phages kit (ZAP Express EcoR I/Xho I Library, Agilent Technologie, US).  
Phage amplification: The library was amplified according to the manufacturer’s instructions 
(ZAP Express EcoR I/Xho I Library, Agilent Technologie, US). Lambda bacteriophages con-
taining TeHV3 genomic fragments were initially briefly expanded, infecting the E. coli bacte-
rial strain XL1- MRF (ZAP Express EcoR I/Xho I Library, Agilent Technologie, US). Bacte-
ria were incubated with the bacteriophage suspension for six hours at 37°C while shaking. 
Following this the suspension contained both bacteria; bacteriophages were mixed with LB-
top-agar and overlaid on LB-agar in Petri dishes and incubated overnight at 37°C. The plates 
showing plaques of lysis were then overlaid with 8ml of SM buffer to harvest the bacterio-
phages. The buffer was then recovered and stored at +4C. The bacteriophage suspension was 
subsequently titrated by ten-fold dilutions, using the procedure described above, to determine 
the optimal concentration of the phage necessary to infect the bacterial cells.  
Sera collection: TeHV3 seropositive and seronegative sera samples were obtained from Greek 
tortoises [Testudo graeca] that were experimentally infected with either one of two strains of 
TeHV3 (US1978/98 and D4295/75) [3] or from spontaneously infected T. graeca.  
Library screening: Two consecutive screenings were performed on the bacteriophage library. 
In both XL1-MRF E.coli were infected with the selected suspension of bacteriophage as de-
scribed above and incubated at 37°C over night. The number of clones carrying a fragment of 
the TeHV3 genome was assessed by white/blue selection carried out according to standard 
protocol [3]. Plates were then cooled for 1hr at +4°C and then overlaid with a nitrocellulose 
membrane (0.5 µm, Ø82 mm, PROTRAN BA 85, REF. 10401116, CONV.-NO EW0051-1) 
that was left in place for 15 min. On each membrane and dish, reference markers were drawn 
to properly orientate the membrane for the selection of the positive clones. Membranes were 
then immersed in blocking solution (TBS-T with 5% skimmed milk powder-Brand) for 1hr at 
room temperature on a rocker. Membranes were then washed twice with blocking solution for 
5 min each, and twice with PBS for 30 seconds each. In the first screening the membranes 
were incubated with hyperimmune tortoise sera coming from the first transmission study per-
formed on TeHV3 by Origgi et al. [3]. During the second screening, membranes were incu-
bated in a mix of tortoise sera, composed of half hyperimmune serum from the transmission 
study and half from ELISA positive, spontaneously infected tortoises. Sera were diluted 1:20 
in blocking solution for 1hr and washed as described above. A biotinylated mouse monoclonal 
antibody (HL154) was directed against the heavy chain of Testudo spp. IgY was used as sec-
ondary antibody [2] at a concentration of 1µg/ml in PBS. The membrane was incubated with 
the primary antibody for 1hr on a rocker at room temperature and then washed as described 
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above. A mixture of 2 µl AP-Streptavidin (Zymed, 43-4322) and 2 µl of polyclonal antibody 
rabbit anti-mouse (Jackson ImmunoResearch, 315-005-003) diluted in 1ml of PBS was then 
applied to the membrane for 1 hour at room temperature. Following five washes of 10 seconds 
each with distilled water, the membrane was finally stained with the chromogen substrate 
composed of 45 µl NBT (18.5 mg/ml nitro blue tetrazolium chloride) with 35 µl BCIP (9.4 
mg/ml 5-bromo-4-chloro-3-indolyl-phosphate) diluted in 10ml of SM-Buffer (10ml 1M car-
bonate buffer + 10 ml 100mM MgCl2 + 980ml H2O). The chromogenic reaction was closely 
monitored for three minutes; then the membrane was rinsed 4-5 times with distilled water and 
immediately dried with Whatman 3M paper (Sigma-Aldrich, US).  
Positive bacteriophages were punched out from the plate using a 20µl tip. These phages were 
amplified and stored at 4°C according to the manufacturer’s instructions (ZAP Express Predi-
gested Vector Kit and ZAP Express Gigapack Cloning Kits, Agilent Technologies). 
The positive clones from the primary screening were then expanded and tested again with hy-
perimmune tortoise sera similarly to what is described above. After this, the selected clones 
were amplified in E. coli strain XLOLR to obtain the phagemids as described by the manufac-
turer (ZAP Express Predigested Vector Kit and ZAP Express Gigapack Cloning Kits, Agilent 
Technologies). Phagemids were then digested with SAO3AI to obtain the correspondent 
TeHV3 genomic inserts and resolved in a 2% agarose gel. 
Sequencing: Each of the positive clones was then partially sequenced in order to determine 
the identity of the genomic insert. A mastermix was used composed of 3µl of 10x PCR Buffer 
(Qiagen, Silicon Valley, USA), 0.4µl of dMTs, 2µl each of FW and RW Turboprimers (Tri-
Link, San Diego, USA), 0.1µl of Taq (Qiagen, Silicon Valley, USA), and 21.5µl of DNA-
RAN free water. Samples were then placed in a thermocycler (Thermofisher Inc., US) and 
amplified for the first time. The amplification program consisted of 3 minutes’ denaturation at 
94°C, then 35x amplification cycles subdivided in 30 sec. at 94°C denaturation, 30 sec. at 
65°C annealing and 2 minutes at 72°C elongation, with a final extension of 10 minutes 72°C 
to exhaust the polymerase. Each PCR amplicons was submitted for automated Sanger se-
quencing [ABI Prism 3700, Applied Biosystems] using the Big-dye terminator technology. 
Briefly, a master-mix containing 2l of Sequencing Buffer 5x (Thermofisher Inc., US), 0.5μl 
of either FW or RV Primer (10μM), 2μl of BigDye (Thermofisher Inc., US), 2 μl of DNA and 
ddH2O up to 10 μl was prepared. Sequencing was carried out using the same primers used for 
PCR amplification as described above. 
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Fluorescence Activated Cells Sorting [FACS] Validation in VERO cells: 
Eukaryotic cell transformation: extracted phagemid clones were used to transfect VERO cells. 
Briefly, 105 Vero cells were seeded in each well of a 6-well plate (TPP, Trasadingen, Switzer-
land) one day prior to transfection. On the following day, one microgram of phagemid was 
mixed with 135μl of OptiMEM (Thermoscientifc, US) and 3μl of TransIT-LT1 (Mirus Bio 
LLC, Medison WI, US) in Eppendorf tubes. A single well was used for each of the tested 
phagemids. Tubes were incubated for 15 minutes at room temperature. The suspension was 
then added to each well. Plates were gently mixed and incubated overnight at 37°C. Each 
phagemid was transfected in duplicate. 
Cell membrane fixation and permeabilization: one of the duplicates underwent permeabiliza-
tion, while the other did not. Initially, the cell monolayers of each well were fixed with cold 
(4°C) 10% buffered formalin directly into the well for 5 minutes. Later, cells were chemically 
and mechanically detached by using PBS 0.5 mM EDTA incubated for 30 minutes at 37°C and 
sterile cells scrapers (TPP, Switzerland), respectively. Detached cells were collected in 10 ml 
Falcon tubes (TPP, Switzerland) and centrifuged at 300g for 15 minutes. After two PBS washes, 
cells were resuspended in 10ml PBS. The cells that underwent permeabilization were instead 
resuspended into a 0.2% Tween 20 PBS solution, and incubated at 37°C for 15 minutes. After 
permeabilization cells were pelleted at 300g for 5 minutes, and finally resuspended in PBS. 
Cellular staining: The same staining procedure was performed for both permeabilized and not 
permeabilized cells to evaluate the expression of intracellular and superficial proteins. Cell 
tubes were centrifuged at 300g for 15 minutes and resuspended in to 300l of DPBS with 15l 
of seropositive T. graeca serum (1/20). Tubes were incubated at 4C° for one and a half hours. 
After incubation, cells were centrifuged (300g x 15min), washed two times with DPBS, and 
then resuspended in 1ml DPBS with 0.1μl of primary antibody (HL1546 mouse anti turtle-IgY), 
and incubated for 1 hour at room temperature. Primary antibody was washed away as described 
above. Later, a solution of 1ml DPBS with 0.5μl of secondary antibody (rabbit anti mouse, 
Jackson ImmunoResearch, 315-005-003) were incubated for 1 hour at 4°C with the cells. Fol-
lowing an additional wash, cells were resuspended in a solution of 1ml DPBS with 1μl of a 
green fluorochrome anti rabbit (Alexia fluo 488, Thermofisher, US). Cells were incubated for 
ninety minutes and then centrifuged (300g x 15 min), washed three times with DPBS, and re-
suspended in PBS.  
  
Phagemid editing and bacterial cell transformation: 
Phagemid editing: 
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Different techniques have been used to “remove” TeHV3 genomic DNA fragments one at the 
time from the original phagemids, including: 
1) Enzyme restrictions: different sets of enzymes were used to cut the DNA fragments based 
on the phagemid sequence. Only single cutter restriction enzymes were used, to avoid mul-
tiple cutting of the genomic sequence.  
2) PCR direct site mutagenesis  
 
To increase the probability of successful transformation, enzymatic restriction products were 
purified and inserted in a new, smaller cloning vector using ligase reaction. The cloning vector 
used is called pET30C+ and is a high copy number plasmid.  
 
Bacterial cell transformation: 
Transformation was performed according to standard procedures, samples were plated on LB 
agar with added antibiotic solution.  
 
Results: 
Selection of new prospective cases: 
 
Among all the twenty-eight selected cases suspected of infection, only one showed histological 
changes similar to those induced by the TeHV3, and specifically heterophilic glossitis and rhi-
nitis. None of the selected samples were PCR positive and no viral particles were isolated from 
the frozen tissues.  
Genome: 
 
The complete genome of TeHV3 was encoded, although two genome areas characterized by 
the presence of numerous tandem repeats were difficult to complete and the exact sequence was 
uncertain.  
  
Host pathogen interaction study: 
 
Bacteriophage library screening and clones sequencing: 
The optimal working dilution for the bacteriophage suspension was determined to be 10-3. 
The initial screening of the phage library was carried out with hyperimmune sera obtained 
from experimentally infected Greek tortoises [5] revealed 16 positive out of approximately 
5,000 clones, accounting for 0.32%. 
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A second screening carried out on each of the amplified clones confirmed the positivity 
of clones 1 and 6 (12.5%), whereas all the other clones were negative and were detected as 
false positive clone.  
Clone 1 contained a 1.8 Kb long DNA fragment corresponding to the entire gene of the ribo-
nucleotide reductase and to a partial sequence of the major capsid protein encoding gene of 
TeHV3. Clone 6 contained a 2.3 Kb long DNA fragment corresponding to the partial se-
quence of the glycoprotein B encoding gene.  
The initially positive 16 clones were screened a second time by using a mix of both experi-
mentally and spontaneously infected Greek tortoise sera. Among the 16 tortoises 6 showed a 
positive result (37.5%), but only 5 carried DNA inserts (Figure 2).  
Clone 1a contained 2 Kb of DNA containing part of the large sub-unit of ribonucleotide re-
ductase and a fragment of the tegument protein genes. Clone 1b contained 2 Kb of DNA en-
coding for a partial sequence of the glycoprotein B gene. Clone 3 contained 500 bp of DNA 
encoding for part of the envelope protein gene. Clone 6 contained 300 bp of DNA encoding 
for a fragment of the immediate early 2 gene. Clone 7 contained 600 bp of DNA encoding for 
a part of the uracil DNA glycosylase gene.  
Eukaryotic cells transformation and FACS: 
 
The clones that were confirmed positive during the second screening were then selected for 
expression in Vero cells. Expression of the partial sequences of the genes carried by the posi-
tive phagemids was assessed by FACS analysis. We considered that in order to validate the 
selected clones, it was necessary to test them in a different setting from that used initially to 
provide an independent second line of evidence to our results. 
 
New insight: 
Singer sequencing of the phagemid demonstrated that the gB gene was actually antisense to 
the phagemid ORI. Two genes were detected to be in agreement with the phagemid origin of 
replication and were extracted or deleted from the phagemid as described in the materials and 
methods. The extracted samples were inserted in new cloning vectors (pET30C+). Both modi-
fied phagemids and new generated plasmids were used to transform E. coli cells. However, 
despite all efforts, no viable colonies were obtained.  
 
pag. 18 
Discussion: 
This work aimed to start evaluating the host-pathogen interaction between Testudo graeca and 
TeHV3 by investigating the most relevant immunogenic proteins of this virus. 
The viral proteins were expressed in bacteria using a bacteriophage display library, and sero-
logically screened using hyperimmune Testudo graeca sera obtained from a transmission 
study [5]. Phage library is a molecular technique widely used for investigating infectious dis-
eases in human beings [6] and occasionally in veterinary medicine [7,8]. Phage displays have 
been used with pathogens of different mammals [7], birds [8] and fish [9] species, but this was 
the very first time they were applied to reptiles. 
Among the herpesviruses, the most antigenic proteins identified both in human beings and an-
imals [10–12] are the major tegument protein (UL37) and the family of glycoproteins [13].  
Glycoproteins are a class of capsidic proteins involved in the attachment and entry of viral 
particles into the host cell [14].  
Three major classes of glycoproteins have been identified (B, D and G) and all of them seem 
to have a crucial role in the infection of the host cell by the virus [15–17]. 
Among the glycoproteins, the gB is considered a relevant and highly conserved immunogenic 
molecule in herpesvirales [18,19].  
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During this experiment six proteins were serologically detected as immunorelevant, but only 
the gB was positive to the FACS.  
The expression of the selected clones in a eukaryotic system implies the glycosylation of the 
residues to the candidate immunogenic peptides, differently from what occurs in prokaryotic 
systems. Glycosylation was expected to closely reproduce the native state of the viral peptide, 
providing more informative data concerning the actual antigenicity of the candidate peptides. 
Transfected cells were tested either with or without cell membrane permeabilization. Unam-
biguous positivity was confirmed by FACS analysis only for the surface expression of the 
clone 1b, encoding for the partial sequence of the gB gene. No other clones showed convinc-
ing positive signals, despite cell permeabilization, increase of amount of transfected DNA 
phagemids, prolonged expression time of the transfected cells, or the use of other fluorescent 
dyes. 
The expression of the proteins in eukaryotic cells may have led to conformation changes not 
allowing allosteric binding of the antibody to the protein, with consequent misdetection. How-
ever, the possibility of false positives has to be considered and the proteins should be retested 
using a different technique. 
This is the very first study evaluating the immunological response of reptiles to viruses and 
the host-pathogen interaction. As previously demonstrated in other herpesvirus, the gB repre-
sent an immunologically important antigen, based on which new diagnostic tools and vaccina-
tions can be developed. 
Unfortunately, deeper investigation demonstrated the gB sequence was antisense to the plas-
mid ORI, and thus gB cannot be responsible for the immunogenic response we detected in the 
previous experiment.  
We cannot exclude the immunogenic role of gB in TeHV3’s response, but further investiga-
tions are needed to clarify this point. Despite all the attempts we made to transform bacterial 
cells with the new constructs we prepared, no viable colonies were obtained, which might cor-
relate with different problems including: 
- Unsuccessful transformation protocol  
- Genomic toxicity induced by the genes we edited 
Due to the multiple unsuccessful attempts, a biotechnician was requested to perform bacterial 
transformation but again without success.  
We are currently still working on the problem.  
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Chapter 1: History of reptile medicine. 
Herpetoculture (Herpeto= reptile; culture= breeding) is the activity of keeping and breeding 
live reptiles in captivity for both conservational, recreational or commercial purposes.  
Humans and reptile interaction has its roots at the beginning of human history. At the dawn of 
history, cohabitation with dangerous (e.g. crocodiles, caimans, and alligators) or easy to catch 
(e.g. turtles and tortoises) reptiles pushed people to start hunting these animals for both de-
fense and food. Different cultures include reptile meat as traditional food, for example, South 
Africa (crocodiles) or China (turtles and tortoises). As the years went by, human hunting abili-
ties and human population density increased exponentially, leading to the extinction or near 
extinction of different animal species, including numerous reptiles. One of the most relevant 
examples is the hunting of loggerhead (Caretta caretta) and olive riddle (Lepidochelys oliva-
cea) sea turtles during the "Golden age of piracy" (1650-1730). Because of the inability to 
preserve food during ocean crossings, pirates used to hunt sea tortoises for meat, but this habit 
almost caused the extinction of the above-mentioned species. In addition, reptile meat has 
been extensively used in Asian traditional medicine, for example in China. Commercial 
(farming), conservational, and recreational breeding of reptiles had separate historical time-
lines. 
The first attempts of herpetoculture were made to farm reptiles for food and traditional medi-
cine. One of first reptile herpetoculture centers was a Japanese (Fukagawa, Tokyo) tortoise 
breeding center, which dates back to 1866.  
Reptile breeding for conservational purposes only started later. One of the most relevant ex-
amples is the St. Augustine Alligator Farm Zoological Park, Florida (1893). 
Over time the distinction between farming and conservational purposes blurred, and it is now 
more common to find farms that release animals into the wild, and breeding centers that cull 
animals to sell meat and leather. The reason for this is that at least in some areas of the world, 
there is less demand for reptile meat and leather, also because of people’s increased awareness 
of animal welfare and extinction threat of some reptile species. The reduced capture of wild 
animals and the release of reptiles from farms frequently result in breeding centers being over-
populated, forcing them to cull some of their stock.  
Herpetoculture of pet reptiles has a more recent history. First attempts can be dated back to 
the 1950s, but the real success of pet reptiles started in the 1970s.  
Because of the animals’ complex maintenance needs and the limited knowledge about their 
medical conditions and pathology, numerous diseases began to affect pet reptiles’ health. For 
this reason, standard veterinarian knowledge was not enough to take care of reptiles, and vets 
specialized in exotic pets started to become popular.  
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From that time until now, giant steps have been made in reptile medicine, which can now be 
compared to domestic pet medicine.  
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Chapter 2: Reptile trading. 
Reptile trade represents a relevant business in both the USA and Europe. According to Au-
leiya et al. (2016), [1] the import of live reptiles in Europe for the year 2015 was worth 7 mil-
lion dollars, during the same year the import of reptile leather was worth 100 million dollars. 
In 2013 USA legally imported reptiles worth 20 billion dollars; in the same year the illegal 
trade in reptiles seems to account for 232 million dollars.  
Although reptiles represent an economically important trade in the US and various EU coun-
tries, the exchange of allochthonous species accounts for regulatory, biodiversity and health 
problems. 
To regulate the trade in exotic species, the US joined the International Union for Conservation 
of Nature (IUNC) in 1948. To protect the endangered animal and plant species, the IUNC es-
tablished a "Red List", which contains all threatened animals and plant species. The IUNC list 
includes about 45% of the known reptile species, of these 180 are classified as critically en-
dangered, 361 as endangered, and 403 as vulnerable. Despite the established measures, the re-
maining 55% of non-classified reptile species are not subject to trade restriction and are pro-
gressively threatened by the international pet and leather trade. Furthermore, smugglers use 
strategies to export protected animals that include the use of false captive breeding certifi-
cates. [1, 2]  
Within the period 2004–2014, the EU member states officially reported the import of 
20,788,747 live reptiles (CITES and non-CITES species) (Eurostat, 2015). With 6,101,040 
live specimens, Germany was by far the largest importer within the EU, followed by Great 
Britain (US$3,469,109), Spain (US$2,912,171), the Czech Republic (US$1,899,420), and It-
aly (US$1,780,546). 
The introduction of all these allochthonous species, which share the same ecological niches as 
the autochthonous species and may carry exotic diseases, represents a huge risk for local spe-
cies. Among reptiles, this is well represented by the red-eared slider turtle (Trachemys scripta) 
which is characterized by a very high fertility, progressively replacing the allochthonous 
freshwater turtles (Emydid spp.) all over the EU.  
Furthermore, the introduction of allochthonous reptiles represents a risk to human health. One 
of the most relevant pathogens related with reptile import/export is Salmonella spp. [3] Cases 
of reptile mediated salmonellosis have been demonstrated both in the US and the EU, espe-
cially in children. In 2017, the CDC (Center for Disease Control and Prevention) reported a 
multistate outbreak of Salmonella agbeni in the USA, related to the contact with pet turtles.  
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Reptile trade in Italy: 
Although few official data are available about the reptile trade in Italy, this country represents 
one of the most relevant European nations involved in exotic and non-exotic reptile trade. 
Most recent data available about the current reptile trade in Italy are from 2015, and range 
from about US$1.5 million (Erostat, 2015) to US$1.8 million (Assalco-Zoomark 2015). [1, 2] 
The most commonly traded reptiles in Italy are tortoises, turtles and snakes, followed by liz-
ards. These data are more representative than real, as a matter of fact the institution of manda-
tory microchipping and birth certificates for animals included in the CITES list introduced in 
2011, which includes many species from the IUNC “Red list”, made many previously legally 
owned animals illegal. Furthermore, the offspring from these animals are frequently sold on 
the black market at lower prices, representing a true underground economy.  
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Chapter 3: Reptiles’ immune response to viruses. 
The immune response against microorganisms such as viruses is a complex mechanism, 
which involves both innate and acquired immunity.  
The main difference between the two systems is that innate immunity is capable of producing 
a stereotyped response against non-self, using highly conserved recognitions patterns, without 
a previous sensitization of the host. In contrast, acquired immunity is not designed to activate 
on first contact, but is needed to produce very specific and highly effective molecules, specifi-
cally designed against that pathogen.  
Among innate immunity trigger systems, the germline-encoded pathogen pattern recognition 
receptors (PRRs) are the most relevant. Pattern recognition receptors includes C-type lectin 
receptor (CLRs), Toll-like receptors (TLRs), Intracellular retinoic acid inducible gene – I 
(RIG-I)-like receptors (RLRs), nucleotide oligomerization and binding domain (NOD)-like 
receptors (NLRs), and the Pyrin-HIN domain (PYHIN) receptors. Among the receptors men-
tioned above, each group comprises different members that are responsible for recognizing a 
specific pathogen pattern.  
In human medicine, the role of TLRs and RLRs is well established, while the role of NRLs is 
not completely clear. Activation of TLRs and RLRs is associated with the release of the Inter-
feron type I (INF-I), which is responsible for upregulating the genes inhibiting viral replica-
tion and is involved in adaptive immune system activation. Furthermore, a new type of INF 
has been identified as antiviral molecule of the INF type III. The latter has a little structural 
homology with INF-I and activates different heterodimeric receptors.  
The release of INF-I and III induces the activation of innate immunity cells like natural killer 
and dendritic cells, which are responsible for destroying the source of the stimulus and con-
tributing to antigen processing and adaptive immune system activation. While natural killer 
cells only destroy the host cells to try to prevent pathogen replication, dendritic cells are in-
volved in antigen presentation (included in the so-called group of “antigen presenting cells”). 
Once dendritic cells have phagocytized, the pathogen starts to elaborate the most relevant an-
tigens which are then exposed on the cellular surface by a specific molecule named the Major 
Histocompatibility Complex (MHC).  
Another relatively new mechanism involved in host immune regulation is autophagy (auto= 
self and phagy= eating). Autophagy is the mechanism that cells use to adapt to specific meta-
bolic requirements or reduce energy consumption by reducing or increasing the number of 
specific organelles in the cytosol. Autophagy regulation in mammals has been demonstrated 
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to be influenced by some viruses that force cells to regulate their metabolic activity accord-
ingly to viral requirements. Recently (2009) [1], autophagy has been demonstrated to be in-
volved in the process of antigen presentation via MHC I and II.  
Very little information is available about the role of reptiles’ immune system in preventing 
and controlling viral infections.  
In reptiles, the presence of TLRs has been hypothesized based on genome wide sequences 
aligned with birds, fishes, and mammals. [2-6] There seem to be significant differences in 
TLRs total number among both reptile classes and species, but TLRs 2 and 4 are the most rep-
resented among reptiles. [2-6] 
An interferon-like molecule with antiviral activity has been described in reptiles [7, 8] and its 
release has been documented in Testudo graeca kidney primary cultures infected with West 
Nile virus, Semliki Forest virus, Newcastle disease virus, and Sendai virus. A similar factor 
was later documented later in Terrapene heart cell cultures [9] infected with Louis encephali-
tis virus. The chemical structure of these INF-like molecules is similar to the one of mammals, 
but differ for some amino acid sequences.  
Reptiles possess both phagocyte cells and lymphocytes. In contrast to mammals, professional 
phagocytic cells in reptiles not only include macrophages and dendritic cells, but also B-lym-
phocytes. The phagocytic activity of reptiles’ dendritic cells has been documented in splenic 
macrophages of Indian leaf-toed gecko. [10] The ability of reptiles’ macrophages to phagocyt-
ize microorganisms seems to correlate with both daily and seasonal circadian rhythms, and 
peaks in correspondence with the annual reproductive cycle have been observed. [11, 12] Alt-
hough post phagocytosis mechanisms have been investigated in dendritic cells after bacterial 
phagocytosis [13] and they seem similar to those of mammals, there are no studies on viral an-
tigen processing in reptiles. 
Antigen presenting cells express antigen on their cellular surface thanks to MHC, which is 
also described in reptiles. As in mammals, two MHCs have been described in reptiles. 
Natural killer lymphocytes (or functionally similar cells) have been described in different rep-
tile species, including turtles, [14-18] but no information is available about the possible role of 
these cells in antiviral response.  
Autophagy is a highly conserved process in cell biology, although no information is available 
about the presence of this regulatory mechanism in reptiles.  
Mechanisms similar to those described in mammals are present in other vertebrate classes in-
cluding fishes and birds, suggesting the presence of an evolutionary continuum among verte-
brates. [19, 20] 
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The limited knowledge of reptile immune systems makes it difficult to understand host-patho-
gen interaction in these animals, and consequently reduces the therapeutic margin available in 
these species.  
  
pag. 33 
References: 
1.Crotzer VL, Blum JS. Autophagy and its role in MHC-mediated antigen presentation. J Im-
munol. 2009;182(6):3335-41.  
 
2.Boyd AC, Peroval MY, Hammond JA, Prickett MD, Young JR, Smith AL. TLR15 Is 
Unique to Avian and Reptilian Lineages and Recognizes a Yeast-Derived Agonist. The Jour-
nal of Immunology. 2012;189(10):4930-8.  
 
3.Cosia MT, Giacomelli S, Oreste U. Toll-like receptors: an overview from invertebrates to 
vertebrates. Invertebrate Survival Journal. 2011:210-26. 
 
4.Voogdt CGP, Bouwman LI, Kik MJL, Wagenaar JA, van Putten JPM. Reptile Toll-like re-
ceptor 5 unveils adaptive evolution of bacterial flagellin recognition. Scientific Reports. 
2016;6:19046. doi: 10.1038/srep19046. 
 
5.Li Q, Hu L, Yang P, Zhang Q, Waqas Y, Liu T, et al. Expression of TLR2/4 in the sperm-
storing oviduct of the Chinese soft-shelled turtle Pelodiscus sinensis during hibernation sea-
son. Ecology and Evolution. 2015;5(19):4466-79. doi: 10.1002/ece3.1726. 
 
6.Zhou Y, Liang Q, Li W, Gu Y, Liao X, Fang W, et al. Characterization and functional anal-
ysis of toll-like receptor 4 in Chinese soft-shelled turtle Pelodiscus sinensis. Developmental & 
Comparative Immunology. 2016;63:128-35. doi: 10.1016/j.dci.2016.05.023. 
 
7.Galabov AS, Velichkova EH. Interferon production in tortoise peritoneal cells. Journal of 
General Virology. 1975;28:259-63. 
 
8.Galabov AS. Induction and characterization of tortoise interferon. Meth Enzymol. 
1981;78(Pt A):196-208. 
 
9.Mathews JH, Vorndam AV. Interferon-mediated persistent infection of Saint Louis enceph-
alitis virus in a reptilian cell line. J Gen Virol. 1982;61 (Pt 2):177-86. 
 
10.Roy B, Rai U. Dual mode of catecholamine action on splenic macrophage phagocytosis in 
wall lizard, Hemidactylus flaviviridis. General and Comparative Endocrinology. 
2004;136(2):180-91.  
pag. 34 
 
11.Tripathi MK, Ramesh S, Pati AK. Daily and Seasonal Rhythms in Immune Responses of 
Splenocytes in the Freshwater Snake, Natrix piscator. PLOS ONE. 2015;10(2):e0116588.  
12.Tripathi MK, Singh R. Sesonal variation and innate immune response of spleen in fresh-
water snake, Natrix piscator. Journal of Stress Physiology and Biochemestry. 2014;10(1):292-
300. 
 
13.Pasmans F, De Herdt P, Haesebrouck F. Interactions of Salmonella enterica serovar 
Muenchen with macrophages of the turtle Trachemys scripta scripta. Dev Comp Immunol. 
2002;26(3):295-304. 
 
14.Jurd RD, Doritis A. Antibody-dependent cellular cytotoxicity in poikilotherms. Dev Comp 
Immunol. 1977;1(4):341-52. 
 
15.Sherif M, el Ridi R. Natural cytotoxic cell activity in the snake Psammophis sibilans. Im-
munobiology. 1992;184(4-5):348-58. doi: 10.1016/S0171-2985(11)80592-9. 
 
16.Muñoz FJ, Galván A, Lerma M, De la Fuente M. Seasonal changes in peripheral blood leu-
kocyte functions of the turtle Mauremys caspica and their relationship with corticosterone, 17-
beta-estradiol and testosterone serum levels. Veterinary Immunology and Immunopathology. 
2000;77(1-2):27-42. 
 
17.Muñoz FJ, De la Fuente M. The immune response of thymic cells from the turtle Maure-
mys caspica. J Comp Physiol B, Biochem Syst Environ Physiol. 2001;171(3):195-200. 
 
pag. 35 
18.Muñoz FJ, De la Fuente M. The effect of the seasonal cycle on the splenic leukocyte func-
tions in the turtle Mauremys caspica. Physiol Biochem Zool. 2001;74(5):660-7. doi: 
10.1086/323033. 
 
19.Staley M, Bonneaud C. Immune responses of wild birds to emerging infectious diseases. 
Parasite Immunol. 2015;37(5):242-54. Epub 2015/04/08. doi: 10.1111/pim.12191. PubMed 
PMID: 25847450. 
 
20.Adedeji BO OO, Okerentugba PO, Okonko IO. Immune Response of Fish to Viral Infec-
tion. Nature and Science 2012;10(8):70-6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scientific publication related to the research argument: 
Francesco C. Origgi, Marco Tecilla. Chapter 2: Immunology of reptiles in: Infectious disease 
and pathology of reptiles, 2ed. Vol.1 (to be published).  
  
pag. 36 
Chapter 4: Herpesviruses of chelonians.  
The following content will be published in the Italian book: Medicina e chirurgia delle tarta-
rughe e delle testuggini (Medicine and surgery of turtles and tortoises) 
Chapter name: Patologie infettive dei cheloni (Infectious diseases in Chelonians) 
Authors: Marco Tecilla, Francesco C. Origgi.  
 
Introduction:  
Herpesviruses are DNA viruses with envelopes, belonging to the order Herpesvirales, family 
Herpesviridae. Herpesviruses that infect turtles are considered part of the Alphaherpesvirinae 
subfamily, but in most cases this is a hypothetical classification based only on the nature (ne-
crotizing) of lesions induced by these viruses. Only the Chelonian herpesvirus 5 and the Tes-
tudinid herpesvirus 3 have been demonstrated to genetically be part of Alfaherpesvirus. [1-3] 
The classification of herpesviruses in turtles is complex and not yet entirely clear. Among the 
Chelonians’ herpesvirus only the Chelonian herpesvirus 5 is included in a new and specific 
genus called Scutavirus, which currently contains only this virus. [2] Herpesviruses of turtles 
are distributed as follows:  
1. Herpesvirus of marine turtles: Chelonid herpesviruses (ChHVs: 1,5,6, Loggerhead geni-
tal-respiratory herpesviruses, Loggerhead orocutaneous herpesvirus).  
2. Herpesvirus of freshwater turtles: Chelonid herpesvirus 2 and 3; Emydid herpesvirus type 
1 and 2; Glyptemys herpesvirus type 1 and 2, Terrapene herpesvirus 1.  
3. Herpesvirus of tortoises: Testudinid herpesvirus [TeHV-genotype 1 (TeHV-1), 2 (TeHV-
2), 3 (TeHV-3), 4 (TeHV-4)].  
For the sake of readability, individual species of herpesviruses that infect turtles will be ad-
dressed individually. 
 
Herpesvirus of chelonians: 
1 Chelonid herpevirus (ChHVs):  
ChHVs herpesviruses are the most commonly isolated and among the best characterized her-
pesviruses in turtles. [4] These viruses have been reported in different species of aquatic tur-
tles, including Clemmys marmorata, Chrysemys picta, Graptemys spp., and Chelonia Mydas. 
[4] Within the Chelonian herpesviruses, different viruses are identified:  
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1.2 Chelonian herpesvirus 1,2,3,4,5,6.  
1.2.1 Chelonid herpesvirus 1(ChHV-1) or gray plaque disease 
 
Description/Overview: this was the first herpesvirus to be described and was associated with 
the onset of gray plaque (Gray Patch Disease) on the skin of green turtles (Chelonia mydas). 
The disease was first described in a population of green turtles located in the west of India, 
and subsequently recognized in other subpopulations of Chelonia mydas located all over the 
world. [5, 6]  
 
Zoonotic potential: not reported.  
 
Clinical presentation: The virus has only been reported in captive bred green turtles (Chelonia 
mydas), with clinical signs onset ranging between 56 days and one year of age. [7]  
 
Clinical presentation: the pathology is associated with the appearance of cutaneous circular 
papules, which often ulcerate. Papules usually regress spontaneously in a generally short time, 
although variability has been observed. In animals with severe symptoms, mortality varies be-
tween 5% and 20%. [7]  
 
Risk factors: animals bred in captivity. It is believed that a high density of animals favors the 
spread of the virus. [7]  
 
Pathology: this disease is associated with the appearance of areas of hyperkeratosis on the 
head, neck and flippers. Hyperkeratotic areas frequently undergo focal necrosis of the spinous 
and granular layers, leading to the formation of papules. Histologically, the lesions are charac-
terized by the presence of intranuclear amphophilic inclusion bodies in epidermal keratino-
cytes. [6, 7]  
 
Transmission: the disease has been experimentally transmitted through skin scraping but the 
route of transmission in nature is not known.  
 
Distribution of the virus: between the end of the 70s and the beginning of the 90s the virus 
was isolated in different populations of captive bred Chelonia mydas in Asia. Subsequently, 
the pathology was no longer observed until relatively recently. Today it is believed that the 
disease has a world-wide distribution.  
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Treatment: there is no pharmacological treatment to contain the effects of the virus. Interna-
tional guidelines suggest to quarantine infected animals for a minimum of three months, re-
duce the herd stress and reduce the concentration of animals in the tub. It has been observed 
that lesion severity and incubation time are influenced by tank water temperature. The optimal 
water temperature to prevent or reduce the onset of viral related lesions is 25°C; it is advisable 
to use this parameter of reference both for prophylactic and curative purposes. [8] If the cuta-
neous lesions undergo ulceration, the administration of a prophylactic antibiotic for the pre-
vention of secondary infections is advisable.  
 
Differential diagnosis: lesions induced by this virus are very peculiar, however a differential 
diagnosis should include a possible dermatophytoses and the ulcerative septicemic skin dis-
ease (SCUD).  
 
1.2.2 Chelonian herpesvirus 2 (ChHV-2)  
 
Description/Overview: this was identified for the first time in two western pond turtles  
 (Clemmys marmorata) and subsequently in the false map turtle (Graptemys pseudogeograph-
ica).  
 
Signaling: The virus was reported in the western pond turtle (Clemmys marmorata) and subse-
quently in the false map turtle (Graptemys pseudogeographica).  
 
Clinical presentation: the pathology is associated with the appearance of lethargy, anorexia 
and subcutaneous acute edema (approximately one week). [9, 10]  
 
Risk factors: in one of the two reports of the disease, the animals were kept with others 
aquatic turtles (Graptemys spp.). Herpesvirus associated lesions detected in Graptemys spp., 
including subcutaneous edema, pulmonary edema and necrotizing hepatitis were subsequently 
reported in other aquatic turtles of the genera Clemmys marmorata and Chrysemys picta 
which could therefore have had the function of reservoirs. [10] The lesions in the turtles men-
tioned above are very similar to those found subsequently in other turtles of the group 
Emydidiae spp., in which Emydid herpesvirus 1 was identified; a direct correlation, however, 
between these viruses has never been investigated. [11]  
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Pathology: macroscopically the subjects are characterized by the presence of diffuse subcuta-
neous edema, pulmonary edema and a fatal necrotizing hepatitis. Upon microscopic examina-
tion, the classic intranuclear, amphophilic inclusion bodies from herpesvirus were identified in 
the liver, kidney and pancreas. [10]  
 
Zoonotic potential: not reported.  
 
Transmission: unknown.  
 
Distribution of the virus: all the above-mentioned reports are from North America, but the true 
distribution is not known.  
 
Treatment: there is no pharmacological treatment to contain the effects of the virus. The trend 
of the acute disease with severe hepatic dysfunction does not leave much therapeutic margin. 
It is suggested to isolate animals immediately upon the onset of symptoms.  
 
Differential diagnosis: the presence of diffuse subcutaneous edema is typical enough, however 
septicemic forms with severe hepatic impairment and ranavirus infections should be taken 
into account. 
 
1.2.3 Chelonian herpesvirus 3 (ChHV-3)  
 
Description/Overview: it was described for the first time in 1980, in a Chrysemys scripta. [9]  
 
Clinical presentation: the virus has only been identified in the American pond turtle (Trache-
mys [Chrysemys] scripta).  
 
Clinical presentation: the only report is from one turtle previously treated for the presence of 
an aural abscess that suddenly died within after a week after the end of the antibiotic therapy.  
 
Risk factors: not known.  
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Pathology: macroscopically the subject was characterized by the presence of pulmonary 
edema, friable liver with a brownish-green discoloration, and the gall bladder was severely ex-
tended by the presence of bile. The histological examination highlighted numerous foci of co-
agulative necrosis in the liver, associated with a minimal inflammatory response and the pres-
ence of intranuclear amphophilic inclusion bodies. In both the lungs a fibrinous bronchopneu-
monia, associated with the presence of micro-hemorrhage and numerous desquamate epithe-
lial cells, often containing bodies similar to those of the liver were observed. [9]  
 
Zoonotic potential: not reported.  
 
Transmission: unknown.  
 
Distribution of the virus: at the moment it is only reported in North America.  
 
Treatment: there is no pharmacological treatment to contain the effects of the virus. The trend 
of the acute disease with severe hepatic dysfunction does not leave much therapeutic margin.  
 
Differential diagnosis: the symptomatology is unspecific enough; the presence of pulmonary 
edema and liver degeneration with acute trend includes forms of septicemic bacterial, proto-
zoal (e.g. amoebiasis) and viral diseases (e.g. Iridovirus). 
 
1.2.4 Chelonian herpesvirus 4 (ChHV-4)  
 
Description/Overview: this virus was described for the first time in 1985, in a mixed consign-
ment composed of Argentine turtles (Geochelone chilensis) and red-footed tortoises (Geoche-
lone carbonaria). However, only the Argentine tortoises showed clinical signs of infection.  
 
Clinical presentation: the virus was identified in Argentine turtles.  
 
Clinical presentation: the classic signs related to the infection are the presence of necrotizing 
stomatitis and glossitis, which often becomes purulent for the onset of secondary bacterial in-
fections (mouth rot).  
 
Risk Factors: unknown.  
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Pathology: macroscopically necrotizing glossitis and stomatitis that can extend to involve the 
retropharyngeal tissues, the hard palate and nasal cavities tissues are present. Serous atrophy 
of the liver is often present. Histologically, the tissues of the oral and the nasal cavities are ex-
tensively necrotic and ulcerated, and pseudo membranes are present. The intranuclear ampho-
philic, inclusion bodies are generally numerous and mainly identifiable in the degenerated and 
necrotic cells. Often mixed morphology bacteria (cocci, bacilli, and coccobacilli) of secondary 
eruption are detected.  
 
Zoonotic potential: not reported.  
 
Transmission: not known.  
 
Distribution of the virus: at the moment it is only reported in North America.  
 
Treatment: not known.  
 
Differential diagnosis: the symptomatology is specific enough; a tentative diagnosis can be 
issued for the presence of stomatitis and glossitis in an Argentine turtle. 
 
1.2.5 Chelonid herpesvirus 5 (ChHV-5) or Cheloninan fibropapilloma-associated herpesvirus 
(CFPHV) or Fibropapillomatosis (FP) 
 
Description/Overview: this virus is associated with the occurrence of cutaneous fibropapillo-
mas and visceral fibromas in marine turtles. This is a virus with global distribution and is able 
to infect various marine turtles. [4] Recent molecular investigations have suggested that the 
virus can be maintained in the environment by the presence of healthy carriers, in which con-
centration of the virus in the skin seem higher compared to healthy turtles. [12] Although 
ChHV5 has actually been classified as Alfaherpesvirus, is not yet known with certainty if it 
goes latent within the trigeminal nerve ganglion or in other in structures. The viral genome se-
quencing highlighted that the ChHV5 genome contains some genes typically identified in 
gamma- and beta-herpesviruses’ genes; this feature allowed to classify this virus in a new ge-
nus, the Scutavirus. However, the oncogenic mechanism behind the onset of tumors is not yet 
known. [2]  
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Signaling: the virus is able to infect marine turtles of the species: Caretta caretta, Eretmo-
chelys imbricata, and Lepidochelys olivacea. [4]  
 
Clinical presentation: the virus is associated with the formation of pedunculated or sessile tu-
mors, with a smooth or rough surface at skin and visceral level. The cutaneous neoplasms are 
associated with problems in capturing food, in movement and in vision. The visceral tumors 
are associated with the obstruction and compression of hollow organs and, less frequently, of 
parenchymatous organs.  
 
Risk factors: are not known. It is believed that, given the behavioral habits of these animals, a 
critical moment for the transmission is the coupling. Anecdotally, leeches were deemed possi-
ble carriers and vectors of the disease but there is no scientific evidence in this respect.  
 
Pathology: it is believed that the virus gives rise to a viremia as soon as it enters the body, and 
that it subsequently replicates in the skin (including in the slab and the carapace) and mucosa 
(especially conjunctiva). The replication of the virus gives rise to the formation of sessile tu-
mors, with a central axis of connective tissue, whether or not associated with the presence of 
irregular hyperplasia of the epidermis, identified as fibropapillomas. When the disease pro-
gresses temporally, many fibropapillomas transform into tumors with exophytic but not ses-
sile growth, originating from the connective tissue; these tumors are characterized by a central 
core composed of well differentiated fibroblasts and collagen coated by epidermis that are 
regularly or irregularly hyperplastic, called fibromas. Subsequently to the appearance of skin 
fibromas, in the terminal phases of the disease, viral replication gives rise to the formation of 
fibromas even at visceral level. Occasionally, the collagen matrix of the visceral fibropapillo-
mas may have a gelatinous (mixoid) appearance and for this reason have also been identified 
as mixofibromas. More rarely, connective tissue tumors were also identified with criteria of 
cellular atypia suggestive of low grade fibrosarcomas. Although they have been reported at 
the level of different organs, fibrosarcomas would seem to be the most common at the level of 
the heart and in particular of the right atrium. [13-15]   
 
Zoonotic potential: not reported.  
 
Transmission: the route of transmission of the virus seems to be horizontal.  
 
Distribution of the virus: the virus has a global distribution. [16]  
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Treatment: there is no treatment. Surgical resolution attempts have been reported in literature 
attempts to treat skin tumors in subjects that have few lesions, however the tumors tend to re-
cur.  
 
Differential diagnosis: lesions are typical of this disease. 
 
1.2.6 Chelonid herpesvirus 6 (ChHV-6) or Lung, Eye, Trachea disease (LETD)  
 
Description/Overview: this is a pathology described only in marine turtles, characterized by 
the appearance of lesions of the ocular globes, oropharynx and lungs. The pathology was de-
scribed for the first time in a herd of turtles of the Cayman Islands, where it occurred as an ep-
izootic disease in animals aged between 1 and 2 years. [17] Unlike other viruses that infect the 
turtles, this was isolated and cultured in tissue cultures, allowing to develop molecular meth-
ods for its identification. [4, 18] In literature the acronyms LETD is used to indicate the dis-
ease while LETV is used as a synonym for ChHV-6.  
 
Signaling: the virus is able to infect marine turtles of the species Chelonia mydas and would 
seem to have a higher tropism toward subjects aged between 1 and 2 years. Typically, the pa-
thology occurs between January and August. [7] The presence of antibodies against this virus 
has also been demonstrated in turtles of the species Caretta caretta, in which, however, symp-
tomatic forms of the disease have never been reported. [17]  
 
Clinical presentation: infection is associated with the formation of skin ulcers, linked with the 
accumulation of mucus at the level of the eyes and oropharynx. During the acute phase of the 
disease animals have dyspnea, difficulties in staying afloat, keratitis, conjunctivitis, tracheitis 
and pneumonia, that persist for 2-3 weeks. Subsequently the symptomatology loses intensity. 
However, infected subjects usually die within some weeks to several months after the disap-
pearance of the signs, probably because of the respiratory functional damage caused by the vi-
rus. [7, 18] Secondary eruption gram-negative associated bacterial diseases have been demon-
strated in an incidence study over a ten-year period. [7] The mortality associated with this dis-
ease varies from 8% to 38% and rises to 70% in the case of secondary infections. It is believed 
that the virus has an incubation period of 2-3 weeks.  
 
pag. 44 
Risk factors: are not known, however the presence of this disease in mainly farmed and aquar-
ium animals suggests that overcrowding and poor hygienic conditions may play a fundamen-
tal role in the onset of clinical symptoms.  
 
Molecular diagnostics: the virus can be identified through PCR, ELISA on plasma, Western 
blot and immunohistochemistry.  
 
Pathology: at external examination, the presence of a grayish exudate with a mucoid aspect at 
the level of the eyes and mouth is the most typical finding. The presence of skin ulcers is rela-
tively constant. At the opening of the oral cavity there is edema of the glottis and pharynx 
with mucus, and sometimes with necrotic material. Hepatomegaly can be observed, but the 
main feature is the presence of multifocal whitish foci, which in cross-section are also present 
within the parenchyma (foci of necrosis). The lungs are often hyperemic and decreased in 
consistency; on cut sections an abundant grayish to yellow exudate is often present. Histologi-
cally, the presence of necrosis associated with a mixed inflammatory infiltrate affecting phar-
yngeal tissues, liver, trachea and lungs is often detected. At the pulmonary level there is se-
vere bronchopneumonia, which can often be associated with secondary bacterial infection.  
 
Zoonotic potential: not reported.  
 
Transmission: the mechanism of transmission is not clear, but it is supposed to occur by direct 
contact. It has been demonstrated that the LETV remains contagious in salt water for five 
days.  
 
Distribution of the virus: the virus has a global distribution. [16]  
 
Treatment: there is no pharmacological treatment suitable to contain the viral infection, how-
ever the use of antibiotics is recommended to prevent the complications caused by secondary 
bacterial infections. In the context of the introduction of new animals to preexisting collec-
tions, it is recommended that a quarantine of at least three months is performed, both preceded 
and followed by complete physical examination.  
 
Differential diagnosis: lesions are typical of this disease. 
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1.3 Genito-respiratory syndrome of the Caretta caretta (Loggerhead genital-respiratory her-
pesvirus - LGRV)  
 
Description/Overview: this is a relatively little investigated pathology. Although the disease 
has been described previously, an effective characterization of the etiologic agent was only 
made in 2007. [19] All cases reported to date have been identified in wild animals, especially 
from Florida. [19] The disease is characterized by the presence of ulcers affecting the trachea 
(identifiable endoscopically), cloaca and penis. Outbake reports in literature usually involves 
single individuals, with the only exception of a Caretta caretta die-off of no better specified 
cause, in which tortoise were LGRV positive. [19] It is not clear if the cause of the death of 
affected animals is actually the virus, or whether it is a combination of factors.  
 
Signaling: the virus has been isolated only in marine turtles of the species Caretta caretta, 
both male and female. [7]  
 
Risk factors: are not known.  
 
Molecular diagnostics: the virus can be identified through PCR.  
 
Pathology: at external examination, a grayish exudate of a mucoid aspect at the level of the 
eyes and mouth is noted. Skin ulcers are not always present. At the opening of the oral cavity 
there is edema of the glottis and pharynx with mucus, and sometimes with necrotic material. 
The liver can be increased in volume, but the main characteristic is the presence of multifocal 
whitish foci, which in cross-section are also present within the parenchyma (foci of necrosis). 
The lungs are often hyperemic and decreased in consistency; cross sections often present 
abundant grayish yellow exudate. Histologically, the disease is characterized by the presence 
of hyperplasia of the epidermis, hyperkeratosis, heterophilic inflammation, edema and bal-
looning degeneration. The inclusion bodies are observable in the epithelial cells of the skin le-
sions in oral ulcers and in the epithelial cells of the respiratory tract. Most of the lesions in-
duced by this virus are shared with the ChHV6, and it has been proposed that these two vi-
ruses are actually one, inducing distinctive lesion patterns in different marine turtle species. 
 
Zoonotic potential: not reported.  
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Transmission: the mechanism of transmission is not clear, but it is supposed to occur by direct 
contact. Leeches could be involved in the transmission of the disease.  
 
Distribution of viruses: The virus has a global distribution.  
 
Treatment: there is no pharmacological treatment suitable to contain the viral infection, how-
ever the use of antibiotics is recommended to prevent the complications of a secondary burst, 
caused by bacteria. In the context of the introduction of new animals to preexisting collec-
tions, it is recommended that a quarantine of at least three months is performed, both preceded 
and followed by complete physical examination.  
 
Differential diagnosis: the main differential diagnosis is the ChHV6. 
 
1.4 Loggerhead orocutaneous syndrome (orocutaneous herpesvirus - LOHV)  
 
Description/Overview: the LOH syndrome of Caretta caretta is a poorly investigated pathol-
ogy that is characterized by the onset of ulcers at the level of the oral cavity, pharynx and 
skin, associated with hyperkeratotic plaques on the tongue and the presence of abundant mu-
coid exudate in the oral cavity. The virus has also been associated with the occurrence of 
pneumonia. The virus has only been identified in populations of Caretta caretta.  
 
Signaling: The virus has only been isolated in marine turtles of the Caretta caretta species. 
[19]  
 
Risk factors: are not known.  
 
Molecular diagnostics: The virus can be identified through PCR.  
 
Pathology: macroscopically the presence of ulcers at skin level, of the oral cavity and pharynx 
is observed. On the tongue hyperkeratotic plaques are often present. In the oral cavity abun-
dant mucoid material is often present. Pneumonia is a common finding. Histologically, the ep-
idermis and the mucosa ulceration have ballooning degeneration and intranuclear inclusion 
bodies, associated with hyperkeratosis and hyperplasia of the epidermal areas nearby. Hetero-
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philic inflammation is commonly detected, especially at the margins of the lesions. At the pul-
monary level, hyperemia and heterophilic inflammation are frequently observed, occasionally 
complicated by the presence of secondary bacteria.  
 
Zoonotic potential: not reported.  
 
Transmission: the mechanism of transmission is not clear, but it is supposed to occur by direct 
contact. Leeches are considered to be a potential vector for herpesviruses of sea turtles.  
 
Distribution of viruses: The virus has a global distribution.  
 
Treatment: there is no treatment. The use of antibiotics is recommended to contain any sec-
ondary bacterial infections. It is always advisable to quarantine new animals for at least three 
months before introducing them, and to isolate infected individuals as soon as compatible 
clinical signs are observed.  
 
Differential diagnosis: lung, eye, and trachea syndromes must be taken into consideration for 
a potential differential diagnosis. 
 
2 Emydid herpevirus (EmyHVs): 
This group contains two herpesviruses that infect turtles of family Emydidae spp. Emydidis 
includes two subfamilies and ten genres:  
Family: Emydidae  
Subfamily: Emydinae  
generes: Clemmys spp., Emys spp., Glyptemys spp., Terrapene spp.  
 
Subfamily: Deirochelyinae  
generes: Chysemys spp., Deirochelys spp., Graptemys spp., Malaclemys spp., Pseudo-
mys spp., Trachemys spp. 
 
2.1 Emydid herpesvirus 1 (EmyHV-1)  
Description/Overview: the first case was reported in 2012 in a private collection. A northern 
map turtle (Graptemys geographica) just purchased and held in a quarantine tank, began to 
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show weakness and nasal drainage; upon radiographic examination multifocal radiopaque ar-
eas were highlighted at the pulmonary level. Despite the antibiotic support (cefazidime) the 
subject died. [11]  
 
Signaling: the disease seems to occur only clinically in Graptemys geographica, however four 
asymptomatic Chrysemys picta were PCR positive.  
 
Risk factors: are not known.  
 
Molecular diagnostics: the virus can be identified through PCR.  
 
Pathology: microscopically, the lungs are characterized by hyperemia and edema. The liver is 
pale in color and moderately enlarged. Histologically, the lungs are characterized by the pres-
ence of necrosis of the epithelial cells, inside of which intranuclear amphophilic inclusion 
bodies (Cowdry type A) can be detected. In the pulmonary interstitium and peri-bronchial 
submucosa an heterophilic inflammatory infiltrate, often associated with lymphocyte and hy-
peremia and occasional hemorrhages is observed. In the liver there are multifocal areas of ne-
crosis, often associated with included bodies from herpes similar to those observed in the 
lungs. In the spleen fibrinoid necrosis is present, associated with occasional viral inclusions at 
the endothelial level. From the same individual Flavobacterium spp. and Chryseobacterium 
indologenes were also isolated. [11]  
 
Zoonotic potential: not reported.  
 
Transmission: not known, but probably by direct contact. It is not known how long the virus 
can survive in water.  
 
Distribution of the virus: at the moment the virus has only been identified in the United States.  
 
Treatment: there is no treatment. The use of antibiotics is recommended to contain any sec-
ondary bacterial infections.  
 
Differential diagnosis: lesions are similar to those induced by TeHV-3, however the difference 
between target species of tortoise (Chrysemys picta, the first and Graptemys geographica, the 
second) allows to distinguish the two viruses. 
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2.2 Emydid herpesvirus 2 (EmyHV-2)  
Description/Overview: this virus has been identified exclusively in a molecular way, during a 
screening of a mixed bog turtle and spotted turtle population in the United States for conserva-
tional purposes. [20]  
 
Signaling: the virus was identified in a small number of bog turtles (Glyptemys muhlenbergii) 
and in a single spotted turtle (Clemmys guttata). 
 
Risk factors: are not known.  
 
Molecular diagnostics: the virus can be identified through PCR.  
 
Pathology: not known.  
 
Zoonotic potential: not reported.  
 
Transmission: not known but probably by direct contact. It is not known how long the virus 
can survive in water.  
 
Distribution of the virus: at the moment the virus has only been identified in the United States.  
 
Treatment: not known.  
 
Differential diagnosis: not knowing the clinical profile of this pathology, it is not possible to 
establish a differential diagnosis. 
 
3 Glyptemys herpesviruses (GlyHV):  
Description/Overview: this virus was identified exclusively in a molecular way, during the 
same screening in which Emydid herpesvirus 2 was identified. Two genotypes of this virus 
have been identified [20]:  
1) GlyHV-1: exclusively in bog turtles (Glyptemys muhlenbergii)  
2) GlyHV-2: exclusively in wood turtles (Glyptemys insculpta).  
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Signaling: the virus was identified in a small number of bog turtles (Glyptemys muhlenbergii) 
and wood turtles (Glyptemys insculpta).  
 
Risk factors: not known.  
 
Molecular diagnostics: the virus can be identified through PCR.  
 
Pathology: not known.  
 
Zoonotic potential: not reported.  
 
Transmission: not known but probably by direct contact. It is not known how long the virus 
can survive in water.  
 
Distribution of the virus: at the moment the virus has only been identified in the United States.  
 
Treatment: not known.  
 
Differential diagnosis: the clinical profile is unknown. 
 
4 Terrapene herpesviruses (TerrHV):  
Description/Overview: This virus was identified for the first time in 2011 in eastern box tur-
tles (Terrapene carolina carolina) held in captivity at two zoos in the south of the United 
States. In one of the two zoos no clinical signs were detected, while in the other one, about 
46% of the individuals presented lethargy, stomatitis, cloacitis, conjunctivitis and 
blepharedema. In one of the zoos, the one characterized by the presence of gross lesions (see: 
"Pathology"), subjects were demonstrated to also be infected by ranavirus. [21, 22]  
 
Signaling: the virus was identified in eastern box turtles (Terrapene Carolina Carolina).  
 
Risk factors: not known.  
 
Molecular diagnostics: the virus can be identified through PCR. [23]  
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Pathology: very variable. Generally, the presence of fibrinonecrotizing stomatitis and cloaci-
tis, associated and conjunctivitis and blepharedema is detected. Unfortunately, the macro-
scopic finds are all compatible with a ranavirus infection. Histologically, the most common 
lesions are: presence pseudomembranes at the level of lungs and gums, esophagitis, gastritis, 
colitis, fibrinoid necrosis of the splenic vases, hepatitis with multi-focal areas of necrosis, in-
terstitial nephritis and edema with pulmonary hyperemia. No herpesvirus associated intranu-
clear amphophilic inclusion bodies were identified in any of the organs or subjects examined. 
As for the gross lesions, the presence of stomatitis, esophagitis, hepatitis and splenitis has also 
been attributed to the presence of ranavirus in a population, it is therefore not clear exactly 
whether the lesions were induced by this virus. [21]  
 
Zoonotic potential: not reported.  
 
Transmission: not known but probably by direct contact. It is not known how long the virus 
can survive in water.  
 
Distribution of the virus: at the moment the virus has only been identified in the United States.  
 
Treatment: not known.  
 
Differential diagnosis: not knowing the clinical profile of this pathology, it is not possible to 
establish a differential diagnosis. This disease must be included as differential for the ra-
navirus infection.  
 
5 Testudinid herpesvirus (TeHV): 
All herpesviruses recently isolated or detected in tortoises (Testudinidae) were grouped under 
the Testudinid herpesvirus (TeHVs) family. The first virus to be genetically characterized as 
part of this group was identified in an outbreak of mixed group of animals with russian turtles 
(Agrionemys [Testudo] horsfieldii), pancake turtles (Malacochersus tornieri) and greek turtles 
(Testudo graeca); this strain of herpesvirus is named TeHV-1 (Testudinid herpesvirus 1). 
Subsequently, in an outbreak in California, a herpesvirus was isolated with genetic character-
istics different from TeHV-1; this virus is referred to as TeHV-2 (Testudinid herpesvirus 2). 
[24-26] Another strain was isolated from an individual belonging to a group of 16 T. hors-
feldii, this had a lesion profile similar to those of TeHV1 and TeHV2, but some genetic differ-
ences were detected; this strain is called TeHV-3 (Testudinid herpesvirus 3). [27] In 2010 a 
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new genotype from Africa was then identified, called TeHV-4 (Testudinid herpesvirus 4). 
[28] It should be noted that some authors [28] relate to this virus with the acronym THV 
(THV-1, THV-2, THV-3, THV-4), or tortoise herpesvirus. The genotypes (serotypes viral) 
currently identified in as TeHVs are [28, 29]: 
 
5.1 Testudinid herpesvirus 1 (TeHV-1) 
Description/Overview: one of two genotypes that are assumed to originate in the Eurasian 
area. This genotype has a high incidence in Agrionemys [Testudo] horsfieldii, but has also 
been observed in other tortoise species. It is generally considered less virulent than genotype 3 
(the second Eurasian genotype), but this conclusion is based only on anecdotic data. Because 
of the non-evident clinical signs, the Agrionemys [Testudo] horsfieldii is considered as vectors 
for this virus.  
 
Signaling: the virus was identified in the Agrionemys [Testudo] horsfieldii, Malacochersus 
tornieri, Testudo graeca and Testudo hermanni. [29]  
 
Risk factors: the presence of numerous turtles in confined spaces and non-compliance with the 
rules of quarantine.  
 
Molecular diagnostics: The virus can be identified through PCR. [30]  
 
Pathology: macroscopically, the virus causes the onset of necrotizing lesions of the oral cav-
ity, pharynx and tongue, with the possible presence of diphthero-necrotic plaques. Less com-
monly, splenomegaly with ecchymosis and presence of pseudo membranes at the gastric level 
are also reported. Histologically, necrosis and fibrin at the level of the oral mucosa associated 
with the presence of heterophilic inflammation are commonly detected. Necrotic lesions may 
extend aborally to involve the cranial portion of the trachea. Less frequently necrotic lesions 
may also affect the liver, spleen, adrenals, kidneys, esophagus, duodenum, jejunum, colon and 
pancreas. Epithelial cells of the affected organs’ intranuclear inclusion bodies can occasion-
ally be found. [31]  
 
Zoonotic potential: not reported.  
 
Transmission: transmission can occur either through direct contact or via the environment.  
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Distribution of the virus: Europe.  
 
Treatment: the use of antibiotics is recommended to prevent the onset of secondary bacterial 
infections.  
 
Differential diagnosis: the main differential diagnosis is TeHV-3.  
 
5.2 Testudinid herpesvirus 2 (TeHV-2)  
 
Description/Overview: This genotype was detected only in Gopherus agassizii (desert tor-
toise) in the USA. [25] The lesions associated with this genotype are similar to those observed 
in the turtles infected with genotype 1 (TeHV-1) or 3 (TeHV-3).  
 
Signaling: the virus was identified in desert tortoises (Gopherus agassizii).  
 
Risk factors: the presence of numerous turtles in confined spaces and non-compliance with the 
rules of quarantine.  
 
Molecular diagnostics: The virus can be identified through PCR and ELISA. [26] It is neces-
sary to specify that the ELISA test used was developed for the identification of TeHV-3 and 
cross reacted with TeHV-2. [26]  
 
Pathology: macroscopically the infection is characterized by the appearance of necrotizing le-
sions of the oral cavity, pharynx and tongue, with the possible presence of diphthero-necrotic 
plaques. Histologically, necrosis and fibrin at the level of the oral mucosa associated with the 
presence of heterophilic inflammation are observed in most of the cases. Less frequently, ne-
crotic lesions may also involve other organs. The presence of intranuclear amphophilic inclu-
sion bodies compatible with herpesvirus in epithelial cells is variable. [25]  
 
Zoonotic potential: not reported.  
 
Transmission: transmission can occur either through direct contact or via the environment.  
 
Distribution of viruses: North America.  
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Treatment: the use of antibiotics is recommended to prevent the onset of secondary bacterial 
infections.  
 
Differential diagnosis: the main differential diagnosis is with an infection by TeHV-3. 
 
5.3 Testudinid herpesvirus 3 (TeHV-3)  
 
Description/Overview: although considered the second Eurasian strain, TeHV-3 is the virus 
observed with greater frequency all over the world, and it is considered the most virulent of 
the four known genotypes up to now. The disease develops in the upper airways and in the 
cranial portion of the digestive tract. Clinically the infection is associated with the presence of 
nasal (from which it takes its origin, the classic English name "running nose") and oral dis-
charge, which however cannot be considered specific findings. [29] The oral lesions are char-
acterized by the formation of diphthero-necrotic plaques at the level of the tongue, which may 
extend to involve the esophagus and trachea. The severity of the injury is related to the infec-
tive dose of the virus. [29] Testudo graeca is, anecdotally, considered as vectors of TeHV-3.  
 
Signaling: The virus was identified in Testudo hermanni, Testudo graeca, Agryonemis [Tes-
tudo] horsfieldii, Testudo marginata and Testudo kleimnanni. [4, 26]  
 
Risk factors: the presence of numerous turtles in confined spaces and non-compliance with 
quarantine rules. 
 
Molecular diagnostics: the virus can be identified through PCR and ELISA. [29]  
 
Pathology: infected animals are largely characterized by the onset of necrotizing lesions of the 
oral cavity, pharynx and tongue, which are associated with the presence of diphero-necrotic 
plaques. Plaques may extend to involve the first tract of the digestive system. In Testudo 
graeca necrotic plaques may extend to involve the tracheal bifurcation. If the infective dose of 
virus is low, the subject may survive the viraemia; this is associated with the vanishing of the 
oral plaques within 24 days with consequent, complete, recovery of the mucosa. Hepatomeg-
aly and edema of the head are other signs reported in the literature. [29] Histologically, necro-
sis and fibrin at the level of the cranial portions of digestive and respiratory tracts are com-
monly described. The presence of amphophilic intranuclear inclusion bodies compatible with 
herpesvirus in epithelial cells is variable, and depends on the timing of the lesions. Usually, 
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inclusion persists for three weeks after the onset of viremia. [29] Secondary bacterial or viral 
infections are not uncommon.  
 
Zoonotic potential: not reported.  
 
Transmission: transmission can occur either through direct contact or via the environment.  
 
Distribution of the virus: worldwide.  
 
Treatment: the use of antibiotics is recommended to prevent the onset of secondary bacterial 
infections. Aciclovir has proved effective in the containment of the clinical signs.  
 
Differential diagnosis: the main differential diagnosis includes TeHV-1, Iridovirus (Ra-
navirus), picornaviruses (virus "X") and Mycoplasma spp. TeHV-2 must be considered as dif-
ferential if the animals are imported from the US.  
 
5.4 Testudinid herpesvirus 4 (TeHV-4)  
 
Description/Overview: the virus was reported for the first time in two wild caught angulate 
tortoises (Chersina angulata) from South Africa that were exported to the USA. Both animals 
were asymptomatic and the virus was identified during the import controls. [28] More re-
cently (2016), TeHV-4 has been reported in a leopard turtle (Stygmochelys pardalis) in a pri-
vate collection in Germany, which exhibited respiratory distress. [28, 32] However, it is to be 
pointed out that the subject was co-infected with Mycoplasma spp. and that the clinical signs 
reported may be attributable to the bacterial infection.  
 
Signaling: the virus was identified in the angulate tortoise (Chersina anulata) and in a leopard 
tortoise (Stygmochelys pardalis).  
 
Risk factors: the presence of numerous turtles in confined spaces and non-compliance with 
quarantine rules.  
 
Molecular diagnostics: the virus can be identified through PCR. [28, 32]  
Pathology: not reported.  
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Zoonotic potential: not reported.  
 
Transmission: can occur either through direct contact or via the environment.  
 
Distribution of the virus: the virus was only identified in turtles from Africa, but is probably 
distributed world-wide.  
 
Treatment: the use of antibiotics is recommended to prevent the onset of secondary bacterial 
infections.  
 
Differential diagnosis: without a true lesion profile, only the differential diagnosis remains 
Mycoplasma spp. 
 
Discussion: 
Thus, the amount of information is progressively increasing, most of the biology and host-
pathogen interaction of most of chelonian’s herpesvirus is still unclear or underinvestigated. 
The understanding of Chelonivirus genomics and host-pathogen interaction will lead to de-
velop new therapeutic approaches allowing veterinarian to treat these lethal diseases and pro-
mote the conservation of turtles and tortoises worldwide.  
  
pag. 57 
References: 
1.Gandar F, Wilkie GS, Gatherer D, Kerr K, Marlier D, Diez M, et al. The Genome of a Tor-
toise Herpesvirus (Testudinid herpesvirus 3) Has a Novel Structure and Contains a Large Re-
gion That Is Not Required for Replication In Vitro or Virulence In Vivo. J Virol. 
2015;89(22):11438-56.  
 
2.Ackermann M, Koriabine M, Hartmann-Fritsch F, de Jong PJ, Lewis TD, Schetle N, et al. 
The genome of Chelonid herpesvirus 5 harbors atypical genes. PLoS One. 
2012;7(10):e46623. Epub 2012/10/12.  
 
3.Origgi FC, Tecilla M, Pilo P, Aloisio F, Otten P, Aguilar-Bultet L, et al. A Genomic Ap-
proach to Unravel Host-Pathogen Interaction in Chelonians: The Example of Testudinid her-
pesvirus 3. PLoS One. 2015;10(8):e0134897. Epub 2015/08/06. doi: 10.1371/jour-
nal.pone.0134897.  
 
4.Marschang RE. Viruses infecting reptiles. Viruses. 2011;3(11):2087-126. Epub 2011/12/14. 
doi: 10.3390/v3112087.  
 
5.Haines H. A herpesvirus Disease of Green Sea Turtles in Acquaculture. Marine Fisheries 
Review. 1978;40(3):33-7. 
 
6.Rebell G, Rywlin A, Haines H. A herpesvirus-type agent associated with skin lesions of 
green sea turtles in aquaculture. Am J Vet Res. 1975;36(08):1221-4.  
 
7.Ritchie B. Virology. In: Mader DR, editor. Reptiles medicine and surgery. 2nd ed2005. p. 
393-4. 
 
8.G. L. Hoff DMH. Herpesvirus of reptiles. In: Gerald L. Hoff, Elliott R. Jacobson, editor. 
Disease of Amphibians and Reptiles. New York: Plenum Press; 1984. p. 164. 
9.Cox WR, Rapley WA, Barker IK. Herpesvirus-like infection in a painted turtle (Chrysemys 
picta). J Wildl Dis. 1980;16(3):445-9.  
 
pag. 58 
10.Jacobson ER, Gaskin JM, Wahlquist H. Herpesvirus-like infection in map turtles. J Am 
Vet Med Assoc. 1982;181(11):1322-4. 
 
11.Ossiboff RJ, Newton AL, Seimon TA, Moore RP, McAloose D. Emydid herpesvirus 1 in-
fection in northern map turtles (Graptemys geographica) and painted turtles (Chrysemys 
picta). J Vet Diagn Invest. 2015;27(3):392-5.  
 
12.Alfaro-Nunez A, Bojesen AM, Bertelsen MF, Wales N, Balazs GH, Gilbert MT. Further 
evidence of Chelonid herpesvirus 5 (ChHV5) latency: high levels of ChHV5 DNA detected in 
clinically healthy marine turtles. PeerJ. 2016;4:e2274.  
 
13.Work TM, Balazs GH, Rameyer RA, Morris RA. Retrospective pathology survey of green 
turtles Chelonia mydas with fibropapillomatosis in the Hawaiian Islands, 1993--2003. Dis 
Aquat Organ. 2004;62(1-2):163-76.  
 
14.Jones K, Ariel E, Burgess G, Read M. A review of fibropapillomatosis in Green turtles 
(Chelonia mydas). Vet J. 2016;212:48-57.  
 
15.Norton TM, Jacobson ER, Sundberg JP. Cutaneous fibropapillomas and renal myxofi-
broma in a green turtle, Chelonia mydas. J Wildl Dis. 1990;26(2):265-70. Epub 1990/04/01.  
 
16.Alfaro-Nunez A, Frost Bertelsen M, Bojesen AM, Rasmussen I, Zepeda-Mendoza L, 
Tange Olsen M, et al. Global distribution of Chelonid fibropapilloma-associated herpesvirus 
among clinically healthy sea turtles. BMC Evol Biol. 2014;14:206.  
 
17.Jacobson ER. Virus and Viral diseases of reptiles. In: Jacobson ER, editor. Infectious dis-
eases and pathology of reptiles. CRC press2007. p. 396-7. 
 
18.Ariel E. Viruses in reptiles. Vet Res. 2011;42:100. Epub 2011/09/22. doi: 10.1186/1297-
9716-42-100. PubMed PMID: 21933449; PubMed Central PMCID: PMCPMC3188478. 
 
pag. 59 
19.Stacy BA, Wellehan JF, Foley AM, Coberley SS, Herbst LH, Manire CA, et al. Two her-
pesviruses associated with disease in wild Atlantic loggerhead sea turtles (Caretta caretta). Vet 
Microbiol. 2008;126(1-3):63-73.  
 
20.Ossiboff RJ, Raphael BL, Ammazzalorso AD, Seimon TA, Newton AL, Chang TY, et al. 
Three novel herpesviruses of endangered Clemmys and Glyptemys turtles. PLoS One. 
2015;10(4):e0122901.  
 
21.Sim RR, Norton TM, Bronson E, Allender MC, Stedman N, Childress AL, et al. Identifica-
tion of a novel herpesvirus in captive Eastern box turtles (Terrapene carolina carolina). Vet 
Microbiol. 2015;175(2-4):218-23.  
 
22.Kane LP, Allender MC, Archer G, Dzhaman E, Pauley J, Moore AR, et al. Prevalence of 
Terrapene herpesvirus 1 in Free-Ranging Eastern Box Turtles (Terrapene Carolina Carolina) 
in Tennessee and Illinois, USA. J Wildl Dis. 2017;53(2):285-95.   
 
23.Kane LP, Bunick D, Abd-Eldaim M, Dzhaman E, Allender MC. Development and valida-
tion of quantitative PCR for detection of Terrapene herpesvirus 1 utilizing free-ranging east-
ern box turtles (Terrapene carolina carolina). J Virol Methods. 2016;232:57-61.  
 
24.Origgi FC RC, Klein PA, Berry KH, Jacobson ER, editor Preliminary serological and mo-
lecular evidences of herpesvirus exposure in desert tortoises, Gopherus agassizii from the Mo-
jave and Colorado Desert of California. 9th conference of the association of Reptilian and 
Amphibian Veterinarians; 2002 October 9-12, 2002; Nevadas. 
 
25.Johnson AJ, Pessier AP, Wellehan JF, Brown R, Jacobson ER. Identification of a novel 
herpesvirus from a California desert tortoise (Gopherus agassizii). Vet Microbiol. 
2005;111(1-2):107-16.  
 
26.Jacobson ER, Berry KH, Wellehan JF, Jr., Origgi F, Childress AL, Braun J, et al. Serologic 
and molecular evidence for Testudinid herpesvirus 2 infection in wild Agassiz's desert tor-
toises, Gopherus agassizii. J Wildl Dis. 2012;48(3):747-57.  
 
pag. 60 
27.Marschang RE, Frost JW, Gravendyck M, Kaleta EF. Comparison of 16 chelonid herpesvi-
ruses by virus neutralization tests and restriction endonuclease digestion of viral DNA. J Vet 
Med B Infect Dis Vet Public Health. 2001;48(5):393-9.  
 
28.Bicknese EJ, Childress AL, Wellehan JF, Jr. A novel herpesvirus of the proposed genus 
Chelonivirus from an asymptomatic bowsprit tortoise (Chersina angulata). J Zoo Wildl Med. 
2010;41(2):353-8. Epub 2010/07/06. doi: 10.1638/2009-0214R.1. PubMed PMID: 20597234. 
 
29.Origgi FC. Testudinid herpesvirus: A review. Journal of Herpetological Medicine and Sur-
gery. 2012;22(1-2):42-54. 
 
30.Une Y, Murakami M, Uemura K, Fujitani H, Ishibashi T, Nomura Y. Polymerase chain re-
action (PCR) for the detection of herpesvirus in tortoises. J Vet Med Sci. 2000;62(8):905-7.  
31.Une Y, Uemura K, Nakano Y, Kamiie J, Ishibashi T, Nomura Y. Herpesvirus infection in 
tortoises (Malacochersus tornieri and Testudo horsfieldii). Vet Pathol. 1999;36(6):624-7. 
Epub 1999/11/24.  
 
32.Kolesnik E, Mittenzwei F, Marschang RE. Detection of Testudinid herpesvirus type 4 in a 
leopard tortoise (Stigmochelys pardalis). Tierarztl Prax Ausg K Kleintiere Heimtiere. 
2016;44(4):283-6.  
  
pag. 61 
Chapter 5: Detection of TeHVs in Italy. 
Introduction: 
The presence of tortois herpesvirus in Italy has only been marginally investigated. In 2003 
Origgi et al. [1], detected the presence of an outbreak of tortoise herpesvirus in Italy, more re-
cently (2017), Marschang et al. [2], found no herpesvirus positive samples from 11 tortoise 
sera submitted from Italy to a German laboratory.  
Although little work has been done to detect the presence of tortoise herpesvirus in Italy, signs 
correlating with this infection are constantly reported by Italian veterinarians.  
To verify the presence of the virus in Italy, we decided to use three different approaches: 
1) We started monitoring the tortoise population of a WWF oasis located in Northern Italy, 
which is responsible for collecting wildlife and abandoned exotic animals and pets from 
the north-west of the country.  
The oasis manager stated that since 2010, the Testudo spp. population housed in the 
WWF wildlife rescue center of Vanzago has started exhibiting various clinical signs of 
severe lethargy, nasal discharge, conjunctivitis, and diphtheronecrotic glossitis. During 
that period 50 tortoises died, with reported mortality peaks during March and October. In 
Spring 2014, the Vanzago center’s population consisted of 9 T. marginata, 7 T. hermanni 
and 2 T. graeca, still variably exhibiting the same, abovementioned clinical signs, which 
were compatible with a herpesvirus infection in these species. 
To verify our hypothesis, in late spring 2014 we collected serological samples from the 
affected animals, which we used to perform ELISA tests. All spontaneously dead tor-
toises were submitted to the Department of Veterinary Medicine of the University of Mi-
lan for routine necropsy. By the end of 2015 all animals had died. 
2) During our routine necropsy, both on Vanzago’s and external cases, macroscopic and mi-
croscopic lesion profiles compatible with TeHVs infection were noted on a specific data 
sheet, and for each case tissue samples for molecular biology and histopathology were 
collected.  
3) To increase our sample size and understand the history of TeHVs in Italy, we also decide 
to include retrospective samples from tortoises examined from 1999 to 2013.  
Material and methods: 
Serological screening: 
The tortoises’ blood was collected by jugular venipuncture with a sterile, 29G, and 12.7 mm 
long insulin needle. Before and after venipuncture the skin area was disinfected with a 10% 
Povidone-iodine solution.  
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One hundred-fifteen microliters of blood were collected from each animal but one, which was 
too small (from a total of 17 animals). 
One milliliter lithium-heparin test tubes were used to collect and store the blood at +4°C.  
Later on, blood was centrifuged at 350g for 5 minutes at room temperature and frozen at -
80°C until analyses were performed. 
 
ELISA test: 
Viral antigen was obtained by infecting tortoise tissue cultures, namely Terrapene Heart 1 
(TH-1). To obtain the viral antigens the protocol described by Origgi et al. (2003) [1] was 
used. Briefly, once the onset of cytopathic effects was detected, cell cultures were consecu-
tively frozen and thawed three times. The obtained solution was centrifuged at 4,500g for half 
an hour for three consecutive times to precipitate cellular debris. 
The purified supernatant was centrifuged one more time at 53,644g for 3.5 hours at 4°C to al-
low viral particles to pellet. The viral pellets were collected, and resuspended in test tubes 
containing a continuous sucrose gradient ranging from 20% to 60% in TNE (100 mM Tris, 2 
M NaCl, 10 mM EDTA, pH 7.4). Viral particles were centrifuged at 156,194g for 2 hours at 
4°C, obtaining nine viral fractions. Viral concentration was estimated for each fraction using 
three different techniques: 
 Protein assay 
 Speed of onset and severity of cytopathic effects in TH-1 tissue cultures 
 Negative-straining electron microscopy (NEM) 
Among the nine fractions, only two were considered pure and concentrated enough to be used 
for antigen preparation. The two selected were than centrifuged at 53,644g for 3.5 hours at 
4°C. The obtained viral pellets were than suspended in 7.2 pH PBS solution and stored at -
80°C. 
ELISA tests were performed using 96 well (Sigma-Aldrich, Milan, Italy) coated with viral an-
tigen. Each well was prepared using 50l of 0,001 M PBS-A (0.15 M NaCl plus 0.02% of 
N3Na, with 7.2 pH) solution containing 5g/ml of viral antigen, and incubated overnight at 
4°C.  
The morning after, wells were washed four times each with PBS-T (PBS-A plus 0.05% 
Tweed 20), following that antigen blocking was performed, using 5% skimmed milk PBS-A 
solution incubated at room temperature for 60 minutes. Protein biotinylation was performed 
using PBS-A solution containing 1g/ml biotin (Mab HL1546) incubated for 60 minutes at 
room temperature, wells were than washed four times with PBS-A.  
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Each well was filled with 50l Streptavidin conjugated alkaline phosphatase for 90 minutes, 
and then washed four times with PBS-T. One hundred microliters of p-nitrophenyl disodium 
phosphate solution (1mg/ml of p-nitrophenyl diluted in a 0.01M bicarbonate solution [pH 9.6] 
with 2 mM MgCl2) were added to each well and incubated in the dark for 90 minutes, to allow 
the colorimetric reaction. 
Colorimetric reaction intensity was evaluated using an ELISA plate reader (MTX Lab system, 
Spectramax 190) at 405 nm of absorbance.  
 
Necropsy protocol: 
Necropsy was performed on 28 tortoises. Eighteen were from Vanzago, subdivided into 7 Tes-
tudo hermanni, 9 Testudo marginata, and 2 Testudo graeca. Among the remaining ten routine 
cases, only those coming from the same geographical area of Vanzago (North-West Italy) 
were included in the study, the reason for this choice was to have a more homogenous distri-
bution of the sample. Ten external cases fitted the requirements, and were subdivided into 1 
Testudo graeca, 5 Testudo hermanni hermanni, 3 Testudo hermanni botgeri and 1 Testudo 
horsfieldii.  
To standardize the necropsy data collection, a printable form that could be filled online was 
created in Google Drive (Google inc. ) (See Annex I). 
All examined animals had died spontaneously, and owner authorization was requested before 
necropsy. Unfortunately, most of the cases were frozen before submission to the Veterinary 
anatomic pathology unit of the Department of Veterinary Medicine of the University of Mi-
lan.  
All the submitted animals had a history of lethargy with abnormal hibernation behavior (late 
onset, multiple wake-ups during the hibernation season, and unusual burrowing), and some of 
them were reported to have ocular and nasal discharge.  
For each of the examined cases the following parameters were recorded: 
1. Morphological parameters (species, gender, weight, width, length). To assess the right 
species the CITES guideline for tortoise identification was used [3].  
2. Necropsy findings 
3. Histological findings 
Before necropsy, each animal underwent an oral swab that was placed in a 2.0 ml sterile cryo-
vial tube containing DMEM. Due to the small size of the animals and the resistance opposed 
by the mandibular musculature, surgical forceps immersed for 30 minutes in a 6 volumes so-
dium hypochlorite solution (NaOCl) were used to keep the mouth open.  
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The swab was performed avoiding contact with oral cavity surfaces except for the tongue, and 
then stored in a 2ml Eppendorf tube containing Dulbecco’s Modified Eagle Medium (DMEM 
– ThermoFisher, Milan, Italy) and cell culture antibiotic solution at 4°C for less than one 
month. During necropsy, organs were collected for both histopathology and molecular biol-
ogy. Because of the poor conservation status, three tortoises (Testudo hermanni hermanni) 
from Vanzago’s oasis (PC 184/14, PC 197/15, PC 198/15) were excluded from the histo-
pathology study, but samples were included anyway in the molecular biology evaluation.  
All tortoises were opened and examined for the presence of gross lesions, which were noted 
on the form (Annex I). Samples for histopathology were collected in formalin proof buckets 
and stored one week before processing for histopathology. 
Two 5x5 mm fresh tissue sections were collected during necropsy for molecular biology. 
Samples were stored in sterile 2.0 ml cryovials (Nalgene, New Jersey, USA), one with and 
one without DMEM, and frozen at -20°C until the diagnostic procedures were carried out.  
The samples collected for both histopathology and molecular biology were brain, tongue and 
pharynx, trachea, esophagus, liver, lungs, stomach and intestine, genital system, kidneys, and 
heart. The carapace was collected for histology only.  
After one-week fixation in 10% buffered formalin (Sigma-Aldrich, Milan, Italy) tissue sam-
ples were processed for histopathology, except for the carapace that was demineralized for 
one week in a 10% formic acid solution; the acidity was then quenched by one hour of immer-
sion in tap water. Due to the heavy keratinization of tortoise shells, demineralized samples 
were also immersed in a 50% solution of Marseille soap for three days before paraffin inclu-
sion.  
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Prospective collection protocol: 
The formatted fixed samples were routinely processed, subsequently paraffin was included. 
From each sample, a 5m section was placed on a standard histology slide. Thicker sections (6-
7 m) were sliced for harder to cut tissues (such as bone or intestine) and placed on histology 
glue auditioned slides (poly-lysine coated slides).  
Sections were standardly stained with Haematoxylin-Eosin; additional histochemical stains, 
such as Gram, PAS, Ziehl-Neelsen, and Fite-Faraco were performed when needed.  
Retrospective sample collection protocol: 
To increase the sensibility and significance level of the study about the prevalence of TeHVs 
(Testudinid herpesvirus) in Italy, retrospective samples of tortoises were selected from the 
Veterinary anatomical pathology archive of the Department of Veterinary Medicine of the 
University of Milan.  
Samples were retrieved from the electronic archive using the following keyword combina-
tions: “tortoises”, “herpes”, “diphthero-necrotic plaques”, “stomatitis”, “fat-bodies atrophy”, 
“mucopurulent discharge”, and ulcerative glossitis”.  
The case selection was further refined using the following criteria: 
1. Animals that according to the necropsy or histopathology report were strongly suspected 
of a herpesvirus infection, either because of classic intranuclear inclusion bodies or diph-
thero-necrotic lesions of the oral cavity.  
2. Animals that had gross or histological lesions that were compatible with, but not classi-
cally associated with a herpesvirus infection.  
To avoid possible contamination between routinely processed histology cassettes and the se-
lected retrospective samples, one of the old microtomes of the Department of Veterinary Med-
icine of the University of Milan was designated for PCR sample preparation and placed in a 
different room. 
Microtome cleaning procedures consisted of rubbing all the visible surfaces with acetone and 
hydrogen peroxide before starting the procedure, and after processing each sample. The com-
bination of the reagents guaranteed the inhibition of the viral particles and made it easier to 
remove paraffin residue before processing a new histology block. To avoid contamination as 
far as possible, a single microtome blade was used for each histology block.  
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From each retrospective case, a 30 m slice was obtained and stored in a sterile, 2 ml, RNase-
free cryovial (Nalgene, New Jersey, USA). Cryovials containing retrospective samples were 
closed and stored at room temperature until processed.  
Most of the retrospective cases were surgical pathology samples or necropsy in a bottle com-
prising only a few organs, with no macroscopic descriptions.  
Samples included in the study are reported in the table below (Table 1): 
 
PROTOCOL NUMBER HISTOLOGICAL DIAGNOSIS 
EX 6/12 SUSPECT HERPESVIRUS INFECTION 
EX 33/12 SUSPECT HERPESVIRUS INFECTION 
EX 34/12 SUSPECT HERPESVIRUS INFECTION 
EX 23/12 CATARRHAL STOMATITIS 
EX 179/10 SEPTICEMIA WITH FUNGAL HYPHAE 
EX 169/10 SEPTICEMIA WITH INTRAVASCULAR 
BACTERIA 
EX 66/10 HERPESVIRUS INTRANUCELAR INCLU-
SIONS 
EX 137/08 SUSPECT HERPESVIRUS INFECTION 
EX 122/08 SUSPECT HERPESVIRUS INFECTION 
EX 96/08 SUSPECT HERPESVIRUS INFECTION 
Table 1: Retrospective samples selected from the archive to be PCR tested for TeHVs be-
cause of the lesion profile. Cells with a light-yellow background are samples with originally 
suspected herpesvirus infection. 
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PROTOCOL NUMBER HISTOLOGICAL DIAGNOSIS 
EX 67/05 NECROTIZING HEPATITIS 
EX 221/04 HETEROPHILIC TRACHEITIS AND 
PNEUMONIA 
EX 17/04 GRANULOMATOUS HEPATITIS OF 
UNKNOWN ORIGIN 
EX 184/02 GRANULOMATOUS HEPATITIS OF 
UNKNOWN ORIGIN 
EX 27/02 LIVER LIPIDOSIS WITH INCREASED 
NUMBER OF MELANO-MACRO-
PHAGE CENTERS 
EX 12/00 LEUKEMYA 
EX 32/00 HETEROPHILIC RHINITIS 
EX 43/00 UKCREATIVE DERMATITIS OF UN-
KONWN ORIGIN 
EX 45/00 HETEROPHILIC HEPATITIS 
Table 1 (continued): Retrospective samples selected from the archive to be PCR tested for 
TeHVs because of the lesion profile. Cells with a light-yellow background are samples with 
originally suspected herpesvirus infection. 
 
PCR protocol: 
Two different PCR protocols were used to detect herpesvirus DNA in both prospective and 
retrospective samples.  
 Pan-herpes protocol: 
The Pan-herpes PCR protocol was first developed by VanDervanter et al. (1996), and 
can detect a very conserved region of the herpesvirus DNA-polymerase, allowing to 
detect the presence of a wide range of herpesviruses. Briefly, this a nested PCR using 
two sets of primers containing degenerate nucleotides. Degenerate nucleotides are syn-
thetic nucleotides that do not respect the classic base pairing (C-G, A-T), thus allowing 
the PCR probe to bind to template DNA sequences that present variations in the nucle-
otide sequence.  
Standard and degenerate nucleotides are reported in Table 2. 
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Une et al. (1999), Origgi et al. (2004), and Kolesing et al. (2016) [2-4] demonstrated 
that this PCR protocol is able to amplify the DNA polymerase sequence of all known 
TeHVs genotypes.  
Primers used for the first amplification step: 
1) DFA – 5’ - GAYTTYGCNAGYYTNTAYCC-3’;  
2) ILK – 5’ - TCCTGGACAAGCAGCARNYSGCNMTNAA-3’;  
3) KG1 – 5’ -GTCTTGCTCACCAGNTCNACNCCYTT-3’;  
Primers used for the second amplification step: 
1) TGV – 5’ -TGTAACTCGGTGTAYGGNTTYACNGGNGT-3’;  
2) IYG – 5’ -CACAGAGTCCGTRTCNCCRTADAT-3’; 
Amplification steps 1 and 2 used to detect herpesvirus in our samples are reported in 
Table 3 and Table 4 respectively.  
 
UPAC nucleotide code Base Notes 
A Adenine  
B C or G or T (U) 
This degenerate nucleotide 
does not bind A 
C Cytosine  
D A or G or T (U) 
This degenerate nucleotide 
does not bind c 
G Guanine  
H A or C or T (U) 
This degenerate nucleotide 
does not bind G 
K G or T (U) Ketoses 
M A or C Amine 
N All the possible bases 
The letter N comes from 
any 
R A or G Purines 
 
Table 2: Synthetic and natural nucleotide list, in alphabetical order. 
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Step 1: 
 
 
2x Qiagen Hot Star MM 
µl 
 
12.50 
  
DFA 0.25 1.0 µM  
ILK 0.25 1.0 µM  
KG1 0.25 1.0 µM  
DNA 250 ng *   
H2O *   
 25.00   
    
    
Cycling 15 min. 95ºC Hotstar Activa-
tion 
    
 30 sec. 95ºC  
 1 min. 46ºC 45x 
 1 min. 72ºC  
    
 10 min. 72°C Extension 
    
 4ºC ∞ 
 
  
 
 
Table 3: TeHV3 step 1 amplification protocol. 
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Table 4: TeHV3 step 2 amplification protocol. 
 
 Semi-quantitative PCR for TeHV3 protocol: 
TeHV3 PCR was carried out according to the protocol established by Origgi et al. 
(2003). [1] This PCR amplified the partial sequence of the gene homologous to the ri-
bonucleotide reductase (UL39 homologous gene). 
Two primers were used to amplify the sequence: 
1) THV1 –5′-TGCACTTTGATGCGTGGGAT-3′. 
2) THV2 –5′-TTGATCGTATTCGAATGCCG-3′ 
The amplification protocol is reported in Table 5. 
 
Step 2: 
 
 
 
µl 
 
  
2x Qiagen Hot Star MM 12.50   
TGV 0.25 1.0 µM  
IYG 0.25 1.0 µM  
DNA of 1° PCR 2.50 1.0 µM  
H2O 9.50   
 25.00   
    
Cycling 15 min.   
  95ºC Hotstar Activation 
 30 sec.   
 1 min. 95ºC  
 1 min. 46ºC 45x 
  72ºC  
 10 min.   
  72°C Extension 
 4ºC ∞   
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 µl   
2x Qiagen Hot Star MM 12.50   
THV1F 0.50 1.0 µM  
THV2R 0.50 1.0 µM  
DNA 2.50   
H2O 9.00   
 25.00   
    
Cycling 15 min. 95ºC Hotstar activation 
 
1 min. 95ºC 
 
 
30 sec. 54ºC 
35x 
 
30 sec. 72ºC 
 
    
 
10 min. 72ºC 
Extension 
 
4°C∞ 
  
  
Table 5: PCR amplification protocol for TeHV3. 
 
Both PCR protocols were carried out using a standard PCR thermocycler (DNAengine, MJ 
Research, Waltham, MA, USA). Each PCR was run with both negative and positive control to 
verify the correct PCR implementation and the possible presence of contamination.  
Samples that tested negative for TeHV3 but positive for the PanHerpes PCR were also tested 
for the presence of TeHV1, TeHV2, and TeHV3 according to the protocol suggested in litera-
ture [4-6]. 
 
Nucleotide titering: 
The total concentration of DNA extracted from both fresh and paraffin embedded samples 
was titered using absorbance and fluorescence (Nanodrop, ThermoFisher, Ecumblens, Swit-
zerland) simultaneously.  
 
Electrophoresis: 
The presence of amplification bands was verified by mixing 2l of each PCR product with 
0.5 l of loading dye (Thermo Scientific, Switzerland) and 0.5 l of Red-Safe (Applied Bio-
logical Materials, Vancouver, Canada) and then loaded on a 2% Agarose gel. Gels were 
loaded in an electrophoresis machine (Bio Rad, Hercules, CA, USA) and run for 90 minutes 
at 85V. Both negative and positive controls were always loaded on each gel.  
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Tissue cultures: 
TeHV virions were grown on Terrapene Heart 1 (TH-1, American Type Culture Collection 
[ATCC], Rockville, MD, USA) cell line. TH-1 is a cardiomyocytes  cell line obtained from 
the heart of box turtles (Terrapene carolina carolina). [7] 
TH-1cell line requires a temperature of 28°C with 5% CO2 to adequately replicate and grow. 
TH-1 cell stock stored at -80C was defrosted, partitioned and placed in small flasks (Green 
house, Baton Rouge, LA, USA) of 9cm x 5cm x 2,5cm (25cm³) to increase cells replication 
speed. To each vial, a total volume of about 250x103 cells with 5ml of DMEM (Life technol-
ogies, Zug, CH) was added.  
Once tissue culture monolayer was obtained, cells were split and transferred into 75cm³ flasks 
(Green house, Baton Rouge, LA, USA). 
The following procedure was used to split the cells: 
1)  The DMED was removed from the flask using a sterile pipet tip 
2)  Three washes with sterile PBS were made 
3)  Zero point five milliliters of sterile and cold trypsin were poured into the flask 
4)  The flask with trypsin was incubated at room temperature for 3-5 minutes, to allow cells to 
detach from the flask floor 
5)  Five milliliters of fresh DMEM with Bovine Sero-Albumin was added to the flask to stop 
trypsin activity and resuspend cells.  
6)  The DMEM with cells in suspension was transferred to a new flask  
7)  Another 5ml of fresh DMEM was added to the flask 
8)  Flasks were then incubated as previously described  
 
Viral isolation: 
Although todays’ molecular techniques allow to rapidly identify a virus with a very high sen-
sitivity and specificity, these techniques do not work on viral particles. The main advantages 
of using viral isolation are: 
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 Verify the presence and the virulence of a virus  
 Have a large number of virions to perform other tests like ELISA or DNA sequencing  
Previously collected tissue samples and oral swabs added with DMEM were used to perform 
viral isolation.  
Cryovial content was extracted in sterile mortar and reduced to paste with the use of a sterile 
pestle and quartz sand. Once tissue destruction was completed, fresh DMEM was added to the 
mortar until a viscous solution was obtained. The obtained solution was transferred to a 15 ml 
Falcon tube and centrifuged for 10 minutes at 1500g and 4°C (Thermo/Heraeus Multifuge 
3SR+, Osterode, D). Using a 50ml sterile syringe the supernatant, without quartz sand, was 
transferred to a new sterile15ml Falcon tube.   
According to standard procedures, half of the supernatant was filtrated using a 2cm in diame-
ter, glass fiber syringe filter with 0.45m wide pores (Sigma-Aldrich, Buchs, Switzerland), 
connected to a 5ml syringe. The other half was not filtrated. 
Filtrated and non-filtrated supernatant were diluted 1:10 with fresh DMEM with no bovine 
Sero Albumin to which cell cultures in antibiotic solution were added (Ciprofloxacin, Sigma-
Aldrich, Buchs, Switzerland).  
Two milliliters of each supernatant dilution were added to separate cell culture flasks contain-
ing a monolayer of Terrapene Heart 1 (TH-1, American Type Culture Collection [ATCC], 
Rockville, MD, USA) close to confluence (80% of the flask).  
After one hour of incubation at 25°C (room temperature), flasks were washed three times with 
sterile PBS, and 5ml of a solution containing sterile DMEM, Ciprofloxacin (Sigma-Aldrich, 
Buchs, Switzerland) and 10% Bovine Sero-Albumin was added. The flasks were then placed 
in a cell culture incubator at 28°C with 5% CO2 and monitored daily.  
 
Results: 
Serological screening: 
Seventeen of the 18 animals present in the Oasis were ELISA tested for the presence of 
TeHV3. One of the animals was excluded from the study because it was too small to collect 
enough serum to perform the ELISA test.  
According to the information provided by Origgi et al. (2003) [1], the ELISA test positivity 
cut-off was set to an optical density of 0.48.  
Sixteen of the 17 tested animals were seropositive for TeHV3, for a total TeHV3 seropreva-
lence in the Oasis of 94.73%. The only negative ELISA test was from a T. hermanni (case 
one, identification number 14347) with an optical density of 0.1.  
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Results of all the ELISA tests are reported in Table 6. 
CASE 
# 
IDENTIFICATION 
CHIP 
TORTOISE SPE-
CIES 
OPTICAL 
DENSITY 
(O.D.) 
1 14347 Hermanni 
hermsanni 
0.1 
2 2p Hermanni 2.4 
3 17604 Greca 1.2 
4 Not detected Marginata 2.6 
5 09259 Marginata 2.6 
6 13928 Marginata 2.7 
7 17461 Marginata 2.6 
8 T1H-1p Hermanni 0.51 
9 11389 Hermanni 0.98 
10 17593 Hermanni 0.54 
11 15516 Marginata 2.8 
12 18603 Marginata 2.8 
13 17425 Maginata 3.0 
14 16020 Hermanni 0.48 
15 T1H-2p Hermanni 0.8 
16 10989 Greca 1.3 
17 09474 Marginata 4.0 
 
Table 6: ELISA test results for Vanzago’s Oasis tortoises. Positivity cut-off was set at 0.48, 
based on the parameters reported by Origgi et al., 2004. The sample with a light-yellow back-
ground was the only negative, among the tested animals.  
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Mean optical density value obtained for each tortoise species recorded in the study is reported 
in Table 7. 
SPECIES MEAN O.D. VALUE 
NUMBER OF EXAMINED 
TORTOISES 
Testudo marginata 2,92 9 
Testudo hermanni 0,83 6 
Testudo graeca 1,25 2 
 
Table 7: Mean optical density value (O.D.) obtained for each examined tortoise species.  
 
Necropsy: 
Necropsy were performed on a total of 28 tortoises, 18 from Vanzago’s oasis and 10 animals 
submitted from the North-East of Italy for routine diagnostics. The examined population con-
sisted of 37.04% females and 62.97% males. The mean age was extremely variable, from a 
few months up to ten years.  
The species were distributes as follows: 12 Testudo hermanni hermanni, 9 Testudo hermanni 
boettgeri, 4 Testudo marginata, and 3 Testudo graeca. A summary of the main phenotypical 
characteristics of the examined tortoises is presented in Table 8. 
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CASE # 
IDENTIFI-
CATION 
PROTOCOL 
SPECIES GENDER 
LENGTH 
(cm) 
WIDTH 
(cm) 
WEIGHT 
(g) 
1 PC 184/14 
Testudo her-
manni her-
manni 
M 14 12 102 
2 PC 185/14 
Testudo her-
manni her-
manni 
F 17 12 430.8 
3 PC 186/14 
Testudo her-
manni her-
manni 
M 12 10 76.3 
4 PC 191/14 
Testudo 
graeca 
F 23 15 800 
5 PC 192/14 
Testudo her-
manni her-
manni 
M 14 10 228.74 
6 PC 193/14 
Testudo her-
manni her-
manni 
M 20 13 500 
7 PC 226/14 
Testudo her-
manni boett-
geri 
M 18 15 172.35 
8 PC 227/14 
Testudo 
graeca 
F 14 12 120.4 
9 PC 112/15 
Testudo her-
manni her-
manni 
M 12 8 98 
10 PC 113/15 
Testudo her-
manni boett-
geri 
F 12 10 102 
11 PC 114/15 
Testudo her-
manni boett-
geri 
M 17 12 450 
12 PC 127/15 
Testudo mar-
ginata 
F 16 12,3 310 
13 PC 134/15 
Testudo mar-
ginata 
M 25 17 819 
14 PC 135/15 
Testudo mar-
ginata 
M 17 12 203 
15 PC 136/15 
Testudo boett-
geri 
M 15 12 205 
16 PC 197/15 
Testudo her-
manni boett-
geri 
M 20 14 483 
 
Table 8: Main phenotypical characteristics of tortoises that underwent necropsy during the 
study. 
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CASE # 
IDENTIFI-
CATION 
PROTOCOL 
SPECIES 
GEN-
DER 
LENGTH 
(cm) 
WIDTH 
(cm) 
WEIGHT 
(g) 
17 PC 198/15 
Testudo her-
manni boettgeri 
F 18 15 429 
18 PC 199/15 
Testudo her-
manni sp. 
M 21 16 495 
19 EX 116/14 Testudo graeca M 27 18 550 
20 EX 90/15 
Testudo margi-
nata 
F 16 12.5 500 
21 EX 114/15 
Testudo her-
manni her-
manni 
M 15 10 300 
22 EX 126/16 A 
Testudo her-
manni her-
manni 
F 15 9 300 
23 EX 126/16 B 
Testudo her-
manni her-
manni 
M 10 7 230 
24 EX 126/16 c 
Testudo her-
manni boettgeri 
F 17 12 450 
25 EX 149/16 
Testudo her-
manni boettgeri 
M 20 17 600 
26 EX 156/16 
Testudo her-
manni boettgeri 
F 24 18 800 
27 EX 191/16 
Testudo her-
manni her-
manni 
M 17 13 450 
28 EX 24/17 
Testudo her-
manni her-
manni 
M 21 15 600 
 
Table 8 (Continued): Main phenotypical characteristics of tortoises that underwent necropsy 
during the study. 
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The most common gross findings on severity and distribution are recorded in Table 9.  
Lesion severity and distribution recorded in Table 9 is expressed as a score ranging from 1 to 
5, the score legend is reported below: 
LESION SEVERITY: LESION DISTRIBUTION: 
1. Mild 
2. Moderate 
3. Moderate to Severe 
4. Severe 
5. Most severe 
1. Focal 
2. Multifocal (<5 lesions) 
3. Multifocal (5 lesions) 
4. Scattered 
5. Diffuse 
 
ORGAN SYSTEM 
MEAN  
SEVERITY 
MEAN  
DISTRIBUTION 
MEAN 
PREVALENCE 
GENITAL SYSTEM 3.3 2.5 37.5% 
FAT-BODIES 3 3 13% 
SKIN 1 1 13% 
ESOPHAGUS 1 1 13% 
LIVER 3 3 13% 
TONGUE AND 
PHARINX 
1.7 2.3 37.5% 
EYES 1 1 13% 
KIDNEYS 3 2 13% 
STOMACH AND GUT 3.5 4 25% 
 
Table 9: Mean lesion severity, distribution, and prevalence of the most common gross find-
ings identified during necropsy. 
 
Histopathology: 
Prospective samples: 
The presence of severe histological autolytic changes not detectable grossly did not allow to 
evaluate histopathological changes on individual organs or entire bodies.  
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Among the cases from Vanzago's Oasis, three bodies were considered severely autolytic at 
the necropsy (PC 184/14, PC 197/15, and PC 198/15) and other two cases were excluded dur-
ing the histological evaluation because more than 70% of the organ systems routinely evalu-
ated were histologically unreadable (PC 191/14, PC 193/14), for a total of five cases. Exclud-
ing the cases mentioned above, the total number of histological cases from Vanzago was 13.  
Autolytic changes in routine cases (EX116/14, 90/15, EX114/15, EX126/16 A/B/C, 
EX149/16, EX156/16, EX191/16, and EX24/17) were not so severe, and all the tortoises were 
included in the histological evaluation.  
The overall histopathologically evaluated cases from both Vanzago and the necropsy service 
was 23 (28 selected cases, subtracting 3 autolytic bodies and 2 histologically unreadable 
cases). 
The most commonly encountered histological change was the presence of bacteria in the tra-
chea, lungs, esophagus, and coelomic cavity, frequently associated with an heterophilic and 
macrophagic inflammatory infiltrate. 
Most commonly TeHVs associated injuries was heterophilic inflammation of tongue, gum, 
and trachea. Frequently tongue chorion inflammation was associated with mucosal ulceration, 
necrosis, and hemorrhages.  
Heterophilic granulomas of the liver and kidneys were not an uncommon finding. All the 
granulomatous lesions were negative for the presence of fungi (PAS stain), mycobacteria 
(Ziehl-Neelsen), and atypical mycobacteria (Fite-Faraco). 
 
Evaluation of histopathology as screening technique on prospective samples: 
Histopathology is a routine diagnostic technique in veterinary pathology, whereas molecular 
and serological investigations are not as widespread as would be desired. To better comple-
ment the sensitivity and specificity of histopathology to detect TeHVs infections, two tables 
were prepared. Table 10 contains results of TeHV3 PCR subdivided by case and organ. Table 
11 contains detected histological lesion compatible with TeHVs infection. Both tables’ results 
are expressed with a score ranging from 0 to 2. 
PCR results listed in Table 11 are expressed with the following grading system: 
0) Negative 
1) Mild positivity  
2) Strong positivity 
TeHV3 related or possibly related histological lesions are expressed as follows: 
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0) No TeHV3 indicative lesion 
1) TeHV3 suggestive lesions  
2) Presence of herpesvirus associated intranuclear amphophilic inclusion bodies  
-)   Not evaluable because of the severe autolytic changes  
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 PC 
184/
14 
PC 
185/
14 
PC 
186/
14 
PC 
191/
14 
PC 
192/
14 
PC 
193/
14 
PC 
226/
14 
PC 
227/
14 
PC 
112/
15 
PC 
113/
15 
PC 
114/
15 
PC 
127/
15 
PC 
134/
15 
PC 
135/
15 
PC 
136/
15 
PC 
197/
15 
PC 
198/
15 
PC 
199/
15 
EX 
116/
14 
EX 
90/
15 
EX 
114/
15 
EX 
126/
16 
A 
EX 
126/
16 
B 
EX 
126/
16 
C 
EX 
149/
16 
EX 
156/
16 
EX 
191/
16 
EX 
24/
17 
BRA
IN 
0 2 2 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
TON
GUE 
AND 
PHA
RIN
X 
0 2 0 0 2 2 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 2 
TRA
CHE
A 
2 2 2 0 1 1 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
ESO
PHA
GUS 
0 2 2 0 1 1 0 0 0 0 0 0 1 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 
LI-
VER 
0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 0 0 0 0 0 0 0 
LUN
GS 
0 2 2 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
STO
M-
ACH 
AND 
IN-
TE-
STI
NE 
0 2 2 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
GE-
NI-
TAL 
AP-
PA-
RA-
TUS 
1 1 2 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
KID-
NEY
S 
0 1 2 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
HEA
RT 
0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 
Table 10: Results of TeHV3 PCR screening on examined tortoises. PC = samples from Vanzago, EX = routine necropsy samples.   
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 PC 
184/
14 
PC 
185/
14 
PC 
186/
14 
PC 
191/
14 
PC 
192/
14 
PC 
193/
14 
PC 
226/
14 
PC 
227/
14 
PC 
112/
15 
PC 
113/
15 
PC 
114/
15 
PC 
127/
15 
PC 
134/
15 
PC 
135/
15 
PC 
136/
15 
PC 
197/
15 
PC 
198/
15 
PC 
199/
15 
EX 
116/
14 
EX 
90/
15 
EX 
114/
15 
EX 
126/
16 
A 
EX 
126/
16 
B 
EX 
126/
16 
C 
EX 
149/
16 
EX 
156/
16 
EX 
191/
16 
EX 
24/
17 
BRA
IN 
- 0 0 - 0 - 0 0 0 0 0 0 0 0 0 - - 0 0 0 0 0 0 0 0 0 0 0 
TON
GUE 
AND 
PHA
RIN
X 
- 0 0 - 2 - 0 0 0 0 1 1 1 0 0 - - 0 2 0 1 0 0 2 0 0 1 1 
TRA
CHE
A 
- 0 2 - 0 - 0 0 0 0 0 0 0 0 0 - - 0 0 1 0 1 0 1 0 0 2 0 
ESO
PHA
GUS 
- 0 0 - 0 - 0 0 0 0 0 0 0 0 0 - - 0 0 0 0 0 0 0 0 0 0 0 
LI-
VER 
- 0 0 - 0 - 0 0 0 0 0 0 0 0 0 - - 0 0 0 0 0 0 0 0 0 0 0 
LUN
GS 
- 0 1 - 0 - 0 0 0 0 0 0 0 0 0 - - 0 1 0 0 0 0 0 0 0 0 0 
STO
MA
CH 
AND 
IN-
TE-
STI
NE 
- 0 0 - 0 - 0 1 0 0 0 0 0 0 0 - - 0 1 0 0 1 1 1 1 0 0 0 
GE-
NI-
TAL 
AP-
PA-
RA-
TUS 
- 0 0 - 0 - 0 0 0 0 0 0 0 0 0 - - 0 0 0 0 0 0 0 0 0 0 0 
KID-
NEY
S 
- 0 0 - 0 - 0 0 0 0 0 0 0 0 0 - - 0 0 0 0 0 0 0 0 0 0 0 
HEA
RT 
- 0 0 - 0 - 0 0 0 0 0 0 0 0 0 - - 0 0 0 0 0 0 0 0 0 0 0 
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Table 11: Results of TeHV3 histology screening on examined tortoises. PC = samples from Vanzago, EX = routine necropsy samples., - = samples 
excluded from the histological evaluation because of the poor conservation status. 
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Summarizing, there were eight PCR positive animals from Vanzago (PC 184/14, PC 185/14, 
PC 186/14, PC 191/14, PC 192/14, PC 193/14, PC 134/15, and PC 135/15) and four positive 
routine PCR samples (EX 116/14, EX 90/15, EX 114/15, EX 24/17), for a total of 12 positive 
animals from the 28 examined. 
Retrospective samples: 
To increase the sample size, retrospective cases ranging from 1999 to 2012 were selected 
from the veterinary anatomical pathology section digital archive. Digital archive screening us-
ing the keywords reported in the material and methods section returned 60 tortoise samples, 
subdivided into 23 necropsies and 37 surgical specimens.  
Selection criteria were then refined considering the presence of: 
-  Lesions supportive for immunosuppression (e.g. bacterial overgrowth, spleen white pulp in-
volution) 
-  Lesions supportive of a TeHV3 infection 
-  Intranuclear inclusion bodies in key organs like tongue or the respiratory tract epithelium.  
This further selection reduced the case load to 27 samples, classified as follows: 
-  Two animals with intranuclear inclusion bodies (EX 6/12 and EX 66/10) 
-  Ten animals with lesions classically associated with TeHVs infections 
-  Fourteen animals with lesions occasionally associated with TeHVs infections  
-  Two animals with neoplastic lesions.  
No literature is available about the possible role of TeHVs in inducing neoplastic disease in 
tortoises, contrary to other herpesviruses in reptiles (e.g. Chelonian herpesvirus 5), birds (Ma-
rek’s disease, Gallid herpesvirus 2) and mammals (Samiri herpesvirus 1). These two samples 
were included to check if the animals were also TeHVs positive. 
The gross inclusion criteria included: diphtheronecrotic glossitis and gingivitis, nasal dis-
charge, and liver granulomas. 
The histological inclusion criteria included: liver and kidney granulomatous lesion, hetero-
philic inflammation of the tongue, trachea, lungs, and liver, septicemic diseases, severe intes-
tinal oxyurid proliferation, ulcerative skin diseases, abscesses, and degenerative liver diseases.  
The necropsies of four surgical specimens fitted the macroscopic and microscopic inclusion 
criteria, namely EX 34/12, EX 33/12, EX 6/12 and EX 66/10.  
Based on the selection criteria, twenty-three surgical cases were included in the study.  
Most common organs submitted as surgical samples were (in descending order): digestive 
tract (63%), lungs (60%), liver (57%), trachea and larynx (53%), genital tract (10%), skin 
(10%), fat-bodies (7%). 
pag. 85 
 
The total case load of 27 cases was subdivided into 52% female, 24% male, and 14% un-
known. 
The selected cases covered a period of 13 years and were all submitted from Northern Italy. 
Table 12 shows all the main histological lesions detected in the selected retrospective sam-
ples. Lesion severity is ranged from 0 to 5, the table legend is reported below: 
LESION SEVERITY: LESION DISTRIBUTION: 
0. No lesion 
1. Mild 
2. Moderate 
3. Moderate to Severe 
4. Severe 
5. Most severe 
0. No lesion 
1. Focal 
2. Multifocal (<5 lesions) 
3. Multifocal (5 lesions) 
4. Scattered 
5. Diffuse 
ORGAN SYSTEM 
MEAN SEVE-
RITY 
MEAN DISTRIBUTION 
MEAN 
PREVALENCE 
GENITAL SYSTEM 0 0 0% 
HEART 0 0 0% 
SKIN 2 1 8% 
ESOPHAGUS 3 2 8% 
LIVER 1 5 20% 
TONGUE AND PHARINX 2.5 2 12% 
SPLEEN 1 1 8% 
KIDNEYS 4 5 8% 
STOMACH AND INTE-
STINE 
2 5 48% 
TRACHEA AND LUNGS 3 2.4 25% 
URINARY BLADDER 1 1 12% 
 
Table 12: Severity and distribution of histological lesions in retrospective tortoise samples.  
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Selected digital archive samples and the related causes of death are reported in Table 13. 
Amongst the 28 cases selected from the digital archive, histology blocks were only available 
for 22 samples (Table 13). The six missing cases were all surgical samples, ranging between 
2mm and 3mm, which were completely consumed during the diagnostic process.  
PCR results on the final 22 samples are recorded in Table 14.  
 
CASE 
# 
CAUSE OF 
DEATH 
TOR-
TOISE 
SPECIES 
CASE 
# 
CAUSE OF DEATH 
TOR-
TOISE 
SPECIES 
EX 
34/12 
SUSPECT HER-
PESVIRUS 
T. her-
manni 
EX 
13/08 
HERPESVIRUS AS-
SOCIATED INTRNU-
CLEAR INCLUSIONS 
T. hor-
sfieldi 
EX 
33/12 
SUSPECT HER-
PESVIRUS 
T. hor-
sfieldi 
EX 
67/05 
NECROTIZING EPA-
TITIS 
Kinixys 
spp. 
EX 
23/12 
SUSPECT HER-
PESVIRUS 
T. her-
manni 
EX 
221/04 
HETEROPHILIC 
TRACHEITIS AND 
PNEUMONIA 
Gerochel 
one radiata 
EX 
6/12 
SUSPECT HER-
PESVIRUS 
T. her-
manni 
EX 
17/04 
GRANULOMATOUS 
HEPATITIS 
Trachemis 
scripta 
EX 
179/10 
SEPTICEMIA 
AND FUNGAL 
IPHAE 
Trachemys 
scripta 
EX 
184/02 
GRANULOMATOUS 
HEPATITIS 
Trachemis 
scripta 
EX 
169/10 
BACTERIAL 
SEPTICEMIA 
T. hor-
sfieldi 
EX 
137/02 
HEPATIC DEGENE-
RATION 
Trachemis 
scripta 
EX 
156/10 
HETROPHILIC 
TRACHEITIS 
AND NE-
CROTIZING 
ENTERITIS 
(AMOEBA) 
T. graeca 
EX 
27/02 
HEPATIC DEGENE-
RATION 
Geoche-
lone enlon-
gata 
EX 
66/10 
HERPESVIRUS 
ASSOCIATED 
INTRNU-
CLEAR IN-
CLUSIONS 
T. her-
manni 
EX 
12/00 
LYMPHOMATOUS 
LEUKEMIA 
Geoche-
lone par-
dalis 
EX 
137/08 
SUSPECT HER-
PESVIRUS 
T. her-
manni 
EX 
32/00 
HETEROPHILIC RI-
NITIS 
T. her-
manni 
EX 
122/08 
SUSPECT HER-
PESVIRUS 
T. her-
manni 
EX 
43/00 
ULCERATIVE DER-
MATIS 
Tryaxis 
spp. 
EX 
96/08 
SUSPECT HER-
PESVIRUS 
T. her-
manni 
EX 
45/00 
HETEROPHILIC 
HEPATIITS 
T. elegans 
 
Table 13: Retrospective cases selected from the archive of the section of Veterinary Pathol-
ogy of the University of Milan.  
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 CASE# TeHV3 PCR results Tortoise species 
01 EX 6/12 Negative T. hermanni 
02 EX 33/12 Negative T. horsfieldi 
03 EX 34/12 Positive T. hermanni 
04 EX 23/12 Negative T. hermanni 
05 EX 179/10 Negative 
Trachemys 
scripta  
06 EX 169/10 Negative T. horsfieldi 
07 EX 156/10 Negative T. graeca 
08 EX 66/10 Negative T. hermanni 
09 EX 137/08 Positive T. hermanni 
10 EX 122/08 Negative T. hermanni 
11 EX 96/08 Negative T. hermanni 
12 EX 13/08 Positive T. horsfieldi 
13 EX 67/05 Negative Kinixys spp. 
14 EX 221/04 Negative 
Geocheolone sul-
cata 
15 EX 17/04 Negative 
Trachemys 
scripta 
16 EX 27/02 Negative 
Geocheolone en-
longata 
17 EX 137/02 Negative 
Trachemys 
scripta 
18 EX 184/02 Positive 
Trachemys 
scripta 
19 EX 12/00 Negative 
Geochelone par-
dalis 
20 EX 32/00 Negative 
Testudo her-
manni 
21 EX 43/00 Positive Tryaxis spp. 
22 EX 45/00 Negative 
Geochelone ele-
gans 
 
Table 14: TeHV3 PCR results for the 22 selected retrospective samples.  
 
Comparative evaluation of TeHV3 anatomical pathology and histopathological lesion profiles: 
This work aimed to investigate the lesion profile induced by TeHV3 in three distinct popula-
tions: 
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- A retrospective population from the anatomic pathology archive of the University of Mi-
lan  
- The population from Vanzago’s Oasis 
- A population from diagnostic routine necropsies 
To better complement the lesion profile with PCR positivity, only PCR positive cases were 
included in the evaluation.  
Macroscopic lesions: 
Macroscopic evaluation was carried out on one retrospective animal (only one animal with 
full necropsy was PCR positive), on all Vanzago’s but two autolytic animals, and on all rou-
tine cases. All the lesions were evaluated only on PCR positive cases. 
Table 15 summarizes classically TeHV3 associated gross lesions’ distribution in PCR positive 
animals of the three examined populations. Fig. 1 to 3 show diphero-necrotic stomatitis and 
glossitis, nasal discharge and liver granulomas. In addition, granulomatous hepatitis (Fig. 4), 
massive accumulation of urates (Fig. 5) in the urinary bladder (compatible with dehydration) 
and suppurative and fibrinous arthritis (Fig. 6) were detected in some PCR animals. Accumu-
lations of urates were mostly detected in very young tortoises, most of which still retained the 
vitelline sac residue (Fig. 5). 
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LESION 
Vanzago 
Oasi 
 
Routine cases 
Retrospective 
samples 
ULCERATIVE STOMATI-
TIS/GLOSSITIS 
13% 50% 75% 
DIPHTHERIC PLAQUES 7% 0% 30% 
OCULAR LESIONS 13% 0% 0% 
LIVER FATTY DEGENERA-
TION 
13% 0% 100% 
SEROUS ATROPHY OF THE 
FAT-BODIES 
13% 0% 0% 
 
Table 15: Prevalence of gross TeHV3 associated lesions in PCR positive samples.  
 
Microscopic lesions: 
The histological lesions in our case load were distributed as follows: 
1) TeHVs associated inclusion bodies: Intranuclear inclusions (Figure 7) were detected in two 
retrospective samples and two Vanzago samples; no inclusion bodies were detected in the rou-
tine diagnostic service samples.  
In Vanzago's samples, inclusion bodies were found most frequently in the tongue and trachea. 
In the two retrospective samples, inclusion bodies were most commonly detected in the lungs. 
Occasionally, cytopathic effects (e.g. Syncytia – Figure 8) were also detected in PCR positive 
animals.  
2) Neoplasms: Only one retrospective sample was diagnosed with a tumor. The subject was 
affected by a lymphomatous leukemia (Figure 9-11) 
3) Necrotic lesions: were found to be dispersed, but the most affected organs were the liver 
(44% of animals), large intestine (31% of animals), tongue (25% of animals) and esophagus 
(25% of animals). 
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4) Bacteria: The most affected organs were the small and large intestine (31% of subjects) and 
liver (31% of subjects). In 57% of these subjects there were also bacterial embolisms of vari-
ous organs (especially lungs and kidneys) associated with host inflammatory responses, which 
suggests ante-mortem bacterial proliferation. In most cases the bacteria population consisted 
of bacilli, and where a mixed bacteria population was present, bacilli were frequently the most 
relevant component (Figure 12-14). 
5) Mycosis: Fungal hyphae were only detected in two subjects. One subject was characterized 
by the presence of an ulcerative dermatitis, the other by an extensive ulcerative glossitis. 
6) Inflammation: Seventy percent of the animals showed randomly distributed inflammatory 
processes. The most common inflammatory process type was heterophilic (88% of subjects) 
(Fig. 11-12) while granulomatous (Figure 15-16) and lymphocytic inflammation were de-
tected in a smaller number of cases (46% of the animals). Among the examined cases, a very 
low percentage of mixed inflammatory processes were detected (13%). Rhinitis was only de-
tected in one retrospective case (EX 32/00). 
Heterophilic inflammation was mainly detected in the large intestine (41% of the subjects), 
small intestine (33% of the subjects), liver, kidneys and lungs (31% of the subjects). 
Granulomatous lesions were mainly found in the liver (Fig. 3), less frequently in the lungs and 
kidneys.  
7) Extramedullary hematopoiesis: was detected in the spleen (50% of animals), liver (40% of 
animals), and kidneys (about 10% of animals) of five tortoises (Figure 17). 
Regarding the severity of this finding, most of the cases were mild forms and more rarely in-
termediate forms. Mild cases were characterized by erythropoiesis only. Moderate cases might 
be marked by either erythropoiesis and leukopoiesis, or by the presence of erythropoiesis in 
multiple organs.  
7) Edema: the most affected organs were the lungs (56% of subjects), small and large intestine 
(33% of subjects respectively), liver, urinary bladder and trachea (11% of subjects respec-
tively). Most of the cases were post mortal changes, with no other associated lesions.  
8) Ulcerative and erosive lesions: the most affected organ was the tongue (50% of subjects) 
followed by the small and large intestine (33% of subjects), esophagus and trachea (25% of 
subjects). 
Ulcers and erosions were also detected in the trachea and esophagus of one subject.  
In two of the tortoises mentioned above, intestinal ulcerations involved the serosa inducing a 
severe coelomitis. 
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9) Thrombosis: only one tortoise was found to have intra vitam thrombosis, with thrombi for-
mation at the level of the liver, heart, lungs, and pancreas. Some of the examined thrombi 
were also associated with intravascular bacteria, suggesting a disseminated intravascular coag-
ulation (D.I.C.) secondary to a septicemic disease. 
10) Hemorrhages: the largest number was detected in the lungs (33% of subjects) (Figure 18), 
while the stomach, small and large intestine, urinary bladder and trachea were less affected 
(17% of subjects each). Fifty percent of the detected hemorrhages were localized, followed by 
multifocal (35% of subjects) and diffuse forms (15% of subjects). 
11) Fibrin: approximately 30% of animals had fibrin deposits. The tongue was the most com-
mon site of deposition (44% of subjects), followed by the liver (33% of subjects), small and 
large intestine and urinary bladder (11%). 
12) Abscesses: multifocal abscesses were observed at the level of the liver, spleen, kidneys, 
and lungs of one subject. No other abscesses were identified.  
13) Mineralization: was detected in two subjects. The most affected organ was the kidney 
(50% of subjects), followed by the small and big intestine, skin, and pancreas (25% each). 
Mineralization was always multifocal. 
14) Metabolic diseases: the most common metabolic change was the presence of a "fatty 
liver," histologically cases associated with both lipidosis and glycogenosis (Figure 19) were 
detected. Fat-body atrophy was the second most common finding. 
15) Gout: visceral gout was detected in the 30% of the examined tortoises. Articular gout was 
only detected in one subject. 
TeHV3 related histological lesions were evaluated on five retrospective samples (EX 34/12, 
EX 13/08, EX 137/08, EX 184/02, EX 43/00), five Vanzago samples (PC 184/14, PC 191/14 
and PC 193/14 were excluded because of the presence of severe autolytic changes), and four 
routine diagnostic samples (EX 116/14, EX 90/15, EX 114/15, EX 24/17). All lesions were 
only evaluated on PCR positive cases. 
16) Parasites: they were found mainly at the gastric (33% of the animals) and the large intes-
tine (67% of the animals) level. 
Most subjects were infested by Ossiurid spp. (Figure 20) in adults having been exposed to cil-
iated protozoa such as Balandium spp. and Nyctotherus spp., only one subject had a serious 
form of infestation by amoeba (probably Entamoeba histolitica) and a subject featured a sin-
gle myocardial parasitic cyst from Sarcocystis spp. 
 
Table 16 reports the prevalence of classically associated TeHV3 lesions in our caseload.  
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LESION 
Vanzago 
Oasi 
 
Routine cases 
Retrospective 
samples 
NECROTIZING GLOSSITIS 14.3% 50% 33.3% 
NECROTIZING TRACHEO-
BRONCHITIS 
25% 25% 0% 
PNEUMONIA 43% 25% 0% 
HEPATITIS 0% 0% 44.4% 
GRANULOMATOUS HEPATI-
TIS 
28.6% 0% 
 
22.2% 
GRANULOMATOUS PNEUMO-
NIA 
14.3% 0% 11.1% 
INTRANUCLEAR INCLUSION 
BODIES 
28.6% 0% 33.3% 
HETEROPHILIC RHINITIS 0% 0% 11.1% 
 
Table 16: Prevalence of classically TeHV3 microscopic lesions in our PCR positive caseload.  
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Figure 1: Diphtero-necrotic glossitis and stomatitis (TeHV3 associated) 
  
Figure 2: Mucopurulent rhinitis Figure 3: Granulomatous hepatitis 
 
 
Figure 5: Urate aggregates in the urinary 
bladder (arrow) in a very young tortoise (T. 
hermanni) still presentig residual yolk site (ar-
row head).  
Figure 6: Bacterial osteoartritis, T. graeca. 
GROSS AND HISTOLOGICAL LESIONS IDENTIFIED IN RETROSPECTIVE 
AND PROSPECTIVE TURTLES INCLUDED IN THIS STUDY 
Fig.  
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Figure 7: TeHV1 associated inclusion bodies and heterophilic pneumonia in a T. horsfieldi -
H&E – 20 x  
Inset: Detail of the amphophilic intranuclear inclusion bodies – H&E - 40 x 
 
 
Figure 8: Trachea –Multinucleated epithelial cell (syncytia) in a TeHV3 PRC positive tor-
toise (arrow). No inclusions were detected in this animal – H&E – 40x 
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Figure 9: Kidney – Medium cell lymphoma, 
H&E – 1.6x 
Figure 10: Small intestine – Medium cell lym-
phoma – H&E - 5x 
  
Figure 11: Imprint cytology from the spleen – 
Medium cell lymphoma – May-Grünwald-
Giemsa - 10x  
Insert: Same cell population - May-grünwald-
Giemsa - 40x 
Figure 12: Trachea – Necrotizing and hetero-
philic tracheatis with intralesional bacterial ag-
gregates (arrow) – H&E - 5x  
Insert: High power of the bacterial aggregates 
also present in the lungs– H&E - 10x 
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Figure 13: Small intestine – Heterophilic and 
catarrhal enteritis, with abundant intraluminal 
mucous admixed with bacteria – H&E - 5x 
Figure 14: Large intestine – Heterophilic 
granulomas in the submucosa – H&M – 1.6x 
Insert: High power of the granulomas– H&E - 
10x 
  
Figure 15: Kidney – Heterophilic granulomas 
in the renal interstium, centers on optically 
cleat needle-shaped crystals compatible with 
urate crystals (gout) – H&E – 10x 
Figure 16: Fat bodies – Histiocytic granuloma 
(arrow) – H&E – 5x 
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Figure 17: Kidney – EMH (arrow) – H&E – 
10x 
Figure 18: Lung – Extensive faveolar and 
aeducular hemorrhages with bacteria (arrow) – 
H&E – 10x 
  
Figure 19: Liver – Extensive hepatocytes gly-
cogenosis with heterophilic hepatitis (arrow) – 
H&E – 5x 
Figure 20: Large intestine –Adult oxyurid ad-
herent to intestinal mucosa (arrow) – H&E – 
5x 
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PCR on retrospective samples: 
Five samples returned as PCR positive, among these four were TeHV3 positive and one 
TeHV1 positive (EX 13/08). 
 
Viral isolation: 
Among all Vanzago and routine cases, viral isolation was only successful from one tortoise 
(PC 192/14).  
Early cytopathic effects, including syncytia formation and single cell necrosis were detectable 
30 days after the infection.  
 
Discussion: 
The aims of this work were to: 
- Identify the presence of TeHVs in Italy.  
- Compare TeHVs’ lesion profile documented in literature with the one identified in our case-
load. 
Identification of TeHVs in Italy: 
Although tested for the presence of TeHV1, TeHV2, and TeHV4, all our samples were only 
TeHV3 positive, but one retrospective case was positive for TeHV1 (EX 13/08). 
TeHV3 prevalence: 
The prevalence in our study was: 
- Retrospective samples: 25% (five PCR positive case out of 20 selected) 
- Vanzago's Oasis: in this case two different considerations have to be made. ELISA test posi-
tive animals were 16 out of 17, for a total seroprevalence of 94.12%. PCR positive tortoises 
were 8 out of 18 for an overall prevalence of 44.4%.  
- Routine diagnostic cases: four out of ten were PCR positive, for a prevalence of 40%. 
Molecular evaluation of our case load demonstrates that TeHV3 is diffusely present in North-
ern Italy, and the first cases can be dated back to 2000 (retrospective case EX 43/00). This re-
sult traces the presence of this virus on Italian soil before the very first report of it by Origgi 
FC [8] in 2003. 
Only few published works worldwide report the presence of TeHVs. The prevalence of 
TeHV2 has been investigated in desert tortoises (Gopherus agassizii) by Jacobson et al. in 
2012 [5] and later by Braun et al. in 2014 [9], who reported a prevalence of 31% and 48%, re-
spectively.  
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The only study investigating TeHV3 prevalence in Europe was performed by Soares et al. 
(2004) [10], and reported a seroprevalence for TeHV3 and Mycoplasma agassizii of 8.2% in 
the UK.  
Results obtained from our case load have to considered group by group. 
Retrospective samples: 
This group contained samples from 1999 to 2012. The overall prevalence of TeHV3 in these 
samples is 25%, which is very close to the data (31%) obtained by Jacobson, although it is 
higher than the previously reported prevalence of TeHV3 evaluated by Soares.[10] 
The gap between our and Soares’ results might be explained in different ways. Soares investi-
gated the presence of TeHV3 between 1999 and 2002. Among our retrospective cases, only 
seven fit in that time range. If only those samples are considered, two positive cases out of 
seven, the overall prevalence remain 25%. During the 90s, the most common pet tortoise in 
United Kingdom (UK) was Terrapene spp., which is susceptible to different herpesviruses 
that might not be amplified by Soares probes. Furthermore, it is also possible that the overall 
prevalence of TeHV3 in UK was lower in that specific time range.  
The Vanzago Oasis samples: 
Two different prevalences were calculated for this population: 
- Seroprevalence: 94.12% 
- PCR: 44.4% 
Vanzago's population was living in a small enclosure, where animals were introduced without 
testing and quarantine, but only after clinical examination. Animals in close contact might 
have come in contact with the virus, developing antibodies and resulting seropositive. How-
ever, the PCR based prevalence was much lower, suggesting that the virus was present in less 
than half of the animals. Unfortunately, no introduction records were available, and we could 
not establish when the animals were introduced to the Oasis. Our positive sample prevalence 
was calculated by dividing the number of positive animals by the total number of examined 
tortoises (18) and multiplying that number by 100. 
Prevalence grouped by tortoise species was: 
- Four Testudo hermanni (out of seven) for a prevalence of 57.14%  
- One Testudo graeca (out of two) for a prevalence of 5.8% 
- Two Testudo marginata (out of nine) for a prevalence of 22%. 
Although the distribution of our population was not homogeneous, our data support literature, 
that states that T. hermanni and T. marginata seem more susceptible to TeHV3 infections 
compared to T. graeca.  
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The different susceptibility of tortoises to TeHV3 has not yet been explained, although two 
distinct theories can support this difference: 
- Coevolution with the virus: the most diffuse explanation suggests that the virus evolved with 
T. graeca. 
- Tortoises’ evolution: Van der Kuyl et al. (2002) [11] demonstrated that, based on the 12S 
rRNA mitochondrial subunit gene sequence, two different taxa are present in the clade Tes-
tudo spp. 
One taxon includes T. margianta, T. graeca e T. kleinmanni. The other taxon includes T. her-
manni and T. horsfieldi. 
Probably both theories are correct. It is indeed possible that the virus started evolving in an 
ancestor of T. marginata and T. graeca, causing the immune system of these tortoises to be 
more efficient against this virus; this is further supported by the presence of a single report de-
scribing a herpesvirus infection in T. kleinmanni. 
Prospective cases: 
PCR-based prevalence in our routine samples was 40% (four positives out of ten). Despite the 
limited number of cases, the PCR-based prevalence in the routine cases was close to the one 
calculated via PCR in Vanzago's Oasis and to the prevalence estimated for TeHV2 in the Cal-
ifornia desert, suggesting that TeHVs prevalence is increasing worldwide. 
Macroscopic and microscopic lesion profiles: 
Stomatitis and glossitis associated with the presence of diphtheronecrotic plaques are reported 
in the literature as "pathognomonic" lesions. Stomatitis and glossitis were macroscopically 
detected in 13%, 50%, and 75% of Vanzago, routine, and retrospective cases respectively. 
Among these cases, diphtheric plaques were detected in 7%, 0%, and 30% respectively of the 
Vanzago, routine, and retrospective cases. Although the mean incidence of stomatitis and 
glossitis is 46%, which is in agreement with literature, the variability among the samples is 
high. Furthermore, the diphtheric plaques’ mean value is 12.3%, which is lower than the inci-
dence reported in literature. As mentioned in the "Results section" some of the examined 
cases, especially those from Vanzago's Oasis, were characterized by post mortal changes not 
allowing to properly evaluate lesions from both a macroscopic and microscopic point of view. 
Furthermore, two tortoises with lesion profiles strongly suggestive of a herpesvirus infection 
(EX 66/10 and EX 34/12) were PCR negative. Although the case EX 66/10 showed the pres-
ence of intranuclear amphophilic inclusion bodies, the case was repeatedly negative for differ-
ent herpesvirus PCR, including Pan herpes, TeHV1, TeHV2, TeHV3, and TeHV4. These two 
examples demonstrate that overinterpretation might occur when only based on microscopic 
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and gross findings. According to literature, one of the most important lesions induced by 
TeHV3 is heterophilic hepatitis, but in our study only nine animals showed this injury (44%, 
four out of 20) and only among the retrospective samples. [4, 12] The presence of heterophilic 
hepatitis in only four animals out of 50 (22 retrospective, 18 from Vanzago and 10 from rou-
tine cases) does not suggest this might be a true significant lesion.  
According to Mader et al. (2006) [13], granulomatous lesions of the liver are associated with 
TeHVs infection, and this is coherent with what we found (28.6% Vanzago's Oasis, 22.2% 
retrospective samples), although no granulomatous hepatitis was detected in the routine diag-
nostic specimens.  
Heterophilic rhinitis has been reported by Mader (2006) [13], as one of the most common 
TeHVs lesions. Heterophilic rhinitis was detected in two retrospective samples (one T. here-
manni and one T. horsfieldi), from a PCR negative tortoise. PCR negativity suggests that 
these lesions might be correlating with other pathologic processes than TeHVs.  
Intranuclear inclusion bodies were detected in 28.6% of Vanzago's and 33.3% of the retro-
spective samples, while no inclusions were detected in the routine cases. Origgi et al. [14] re-
ported that inclusion bodies are viable for four weeks after infection, which might justify why 
only a few cases were identified. The distribution identified in this study is lower than what is 
reported in literature. 
The abovementioned findings suggest that histopathology should be limited to post-mortem 
examinations. [14] Although some lesion profiles are reported as "pathognomonic" [14], the 
concept of "pathognomonic" should be deprecated in modern pathology, because many lesion 
profiles of different diseases may overlap and atypical presentations of typical conditions are 
not infrequent, leading to misdiagnoses. Despite the presence of "pathognomonic" lesions in 
our caseload, our findings suggest that viral identification should always be carried out to 
confirm the actual presence of the virus and exclude other possible causes. The latter support 
the use of more precise terms such as "extremely relevant" or "commonly associated with" 
that are progressively replacing the word "pathognomonic" in pathology.  
According to our findings, there are two main limiting factors in TeHVs’ anatomical pathol-
ogy interpretation: 
 Conservation status of the entire body or body parts 
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 Confounding factors  
 Pathologist experience 
One of the most relevant aspects we identified in our samples is that the cause of death of 
most of the animals was related to secondary infection more than to the TeHVs lesions them-
selves. Prevention of these secondary injuries might have a pivotal role in preventing subject 
death, reducing the mortality associated with TeHVs.  
Genomic data (see chapter TeHV3 genome), suggest that TeHV3 might be responsible for 
host immune system modulation; this finding in combination with the seasonal immune sup-
pression tortoises physiologically experience during the winter might be responsible for the 
onset of the secondary infections we observed.  
We also detected the very first case of TeHV1 reported in Italy (EX 13/08); this was detected 
in a T. horsfieldi. Most of the cases of TeHV1 are reported in T. horsfieldi, which suggests 
that this tortoise species might be the target of the virus.  
The neoplastic lesions we selected from the archive were negative for TeHVs, suggesting that 
TeHV3 is not involved in neoplastic disease of tortoises. However, this hypothesis needs to 
be confirmed by using a higher case load.  
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Scientific communications related to the research argument: 
SisVet 2015 
XII congress of Italian association of Veterinary Pathologists (A.I.P. Vet) 
Page: 296 
TeHV3 outbreak characterization in captive Testudo spp. 
Marco Tecilla 1, Francesco Carlo Origgi 2, Guido Grilli 1, Annalisa Forlani 1, and Paola 
Roccabianca 1 
1 Facoltà di Medicina Veterinaria, Università degli Studi di Milano 
2 Vetsuisse Faculty, University of Bern. 
Tortoises represent a popular non-conventional pet in Italy. Of these, several species are ei-
ther considered endangered (Testudo hermanni) or near threatened (T. marginata and T. 
graeca) according to the Italian com- mission of the International Union for Conservation of 
Nature. When pet tortoises are abandoned or found injured or seized following illegal deten-
tion, they are sent to wildlife rehabilitation centers. Starting from 2008, the Testudo spp. pop-
ulation housed in the WWF Vanzago’s oasis exhibited clinical signs of variably severe leth-
argy, nasal discharge, conjunctivitis and diphtheronecrotic glossitis. During that period of 
time 50 tortoises died with reported mortality peaks during March and October. In Spring 
2012, the Vanzago center population was composed of 9 T. marginata, 7 T. hermanni and 2 
T. graeca, still variably exhibiting the same abovementioned clinical signs. By the end of 
2012 all Testudo species had died. Based on these findings, Testudinid herpesvirus 3 
(TeHV3) infection was suspected. The presence of TeHV3 was investigated by molecular bi-
ology and anatomical pathology. All the tortoises housed in Vanzago were tested for the pres-
ence of anti-TeHV3 antibodies by ELISA and they all resulted positive but one T. hermanni. 
Of these, 3 T. marginata, 2 T. graeca and 12 T. hermanni died and were all necropsied. Le-
sion frequency distribution was lingual and oral diphtheric plaques (15.4%), serous atrophy of 
the fat (23.1%), hepatic lipidosis (15.4%) ulcerative stomatitis and/or glossitis (7.7%), pneu-
monia with emphysema (43%), focal intralesional bacterial aggregates (17%), intravascular 
bacterial thrombi (25%), hepatic granulomas (28.6%), necrotizing tracheobronchitis (25%) 
and intranuclear amphophilic/eosinophilic inclusion bodies (8.33%). PCR con- firmed the 
presence of the virus in 8/12 tortoises. To better complement the epidemiological evaluation 
of TeHV3 distribution in northern Italy tortoises, 20 retrospective cases were selected from 
pag. 113 
 
the archive of the University of Milan. Selection criteria were the presence of inclusion bodies 
or necrotizing lesions of the respiratory or gastrointestinal tract. Of the 20 cases, 5 were 
TeHV3 PCR positive tortoises. Lesions closely resembled those of the Vanzago’s population 
but there were more cases with diphtero-necrotic glossitis and stomatitis and inclusions bod-
ies. These results are consistent with a high prevalence of TeHV3 in northern Italy tortoises 
household population. The finding of intranuclear inclusion bodies was specific but did not 
represent a sensitive diagnostic tool. TeHV3 diagnostic gross and microscopic lesions have 
been reported to vary according with the host immune response and by the viral replicative 
status, and can be obscured by autolytic changes, thus gross and microscopic findings are not 
always diagnostic and the support of additional techniques is often necessary to confirm viral 
infection. In the current caseload, TeHV3 infection was often associated with secondary le-
sions suggestive of immunodepression that can be attributed to virus itself associated with ab-
normal hibernation. According to the literature and to our findings, T. hermanni spp. seems 
the species with higher mortality and lower antibody concentrations when infected with 
TeHV3  
Francesco C. Origgi (2012) Testudinid herpesvirus es: A Review. Journal of Herpetological 
Medicine and Surgery (2012), Vol. 22 (1-2), pp. 42-54  
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Chapter 6: The genome of Testudinid herpesvirus 3. 
Original Title: A Genomic Approach to Unravel Host-Pathogen Interaction in Chelonians: 
The Example of Testudinid herpesvirus 3 
 
Authors: Francesco C. Origgi, Marco Tecilla, Paola Pilo, Fabio Aloisio, Patricia Otten, Li-
sandra Aguilar-Bultet, Ursula Sattler, Paola Roccabianca, Carlos H. Romero, David C. 
Bloom, Elliott R. Jacobson. 
Published on: Plos One 10(8): e0134897 
Date: August 5, 2015 
DOI: https://doi.org/10.1371/journal.pone.0134897 
Introduction: 
Herpesviruses have been reported as significant pathogens of snakes [1, 2], lizards [3–10] and 
alligators [11, 12], however, more herpesviruses have been detected in chelonians than in any 
other reptilian taxa [13]. Presently, chelonian herpesviruses have been detected and/or iso-
lated from both turtles and tortoises [14]. The first detection of a chelonian herpesvirus dates 
back to the mid 70’s with the discovery of Chelonid herpesvirus 1 (ChHV1), known as “Gray 
patch disease-associated herpesvirus”. The disease consisted in a multifocal to coalescent ne-
crotizing and ulcerative dermatitis observed mainly in young green turtles (Chelonia mydas) 
[15]. Chelonid herpesvirus 2 and 3 (ChHV2, 3) were detected in fresh water turtles and more 
specifically in Pacific pond turtles (Clemmys marmorata-ChHV2) [16] and in painted turtles 
(Chrysemis picta-ChHV3) [17] with necrotizing hepatitis. Chelonid herpesvirus 4 (ChHV4) 
was detected in Argentine tortoises (Geochelone chilensis-ChHV4) with glossitis, rhinitis and 
pharyngitis [18]. Additional four herpesviruses were either detected or isolated from tortoises 
and were named Testudinid herpesviruses (TeHV1, 2, 3 and 4). TeHV1, 2 and 3 were associ-
ated with pathology mainly in tortoises of the genus Testudo (TeHV1 and 3) and in desert tor-
toises (Gopherus agassizii) (TeHV2) [14], whereas TeHV4 was detected in a clinically 
healthy bowsprit tortoise (Chersina angulata) [14, 19–21]. Chelonid herpesvirus 
5 and 6 (ChHV5, 6) are two other sea turtle herpesviruses associated with a debilitating neo-
plastic disease called fibropapillomatosis (mainly in green and loggerhead-Caretta caretta-sea 
turtles) and with a multisystemic disease (in green turtles), respectively [22–25]. Two addi-
tional herpesviruses have been discovered in sea turtles and have been named loggerhead gen-
ital herpesvirus and the loggerhead cutaneous herpesvirus and they are responsible for multi-
systemic lesions in loggerhead sea turtles [13]. In the last few years an increasing number of 
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novel herpesviruses have been detected in fresh water turtles. These include a herpesvirus in-
fecting the Australian Krefft’s river turtles (Emydura macquarii kreftii) associated with pro-
liferative and ulcerative tegument lesions [26] and Pelomedusid herpesvirus 1 in a clinically 
healthy West African mud turtle (Pelusios castaneous) [27]. Emydid herpesvirus 1 is a novel 
chelonian herpesvirus detected in an eastern river cooter (Pseudemys concinna concinna) with 
viral inclusions in the hepatocytes [28] and in both diseased (with pneumonia, hepatitis and 
splenitis) and clinically healthy northern map turtles (Graptmeys geographica) along with 
asymptomatic painted turtles [29]. Glyptemis herpesvirus 1 and Glyptemys herpesvirus 2 were 
recently detected in asymptomatic bog (Glyptemis muhlenbergii) and wood turtles (Glyptemis 
insculpta), respectively, whereas Emydid herpesvirus 2 was found in bog turtles and in a spot-
ted turtle [30]. At least two herpesviruses have been detected in box turtles. Terrapene herpes-
virus 1was detected in captive eastern box turtles (Terrapene carolina carolina) with stomati-
tis and glossitis [31], whereas Terrapene herpesvirus 2 was recently identified in an eastern 
box turtle coinfected with a spirorchid trematode and with papillomatous growths [32]. 
Despite the existence of all the chelonian herpesviruses described above, to date the only ge-
nome sequenced is that of ChHV5, a Scutavirus [22]. Only a few hundred nucleotides (nt) of 
DNA sequence belonging to the DNA polymerase (DNApol) gene have been determined for 
other herpesviruses infecting reptiles [33], accounting for less than 0.01% of their entire pre-
dicted genomes. These short sequences have been used to unravel the phylogenetic related-
ness of reptilian herpesviruses. However, the relatively high conservation of the DNApol gene 
among herpesviruses, and more specifically of the selected PCR-amplified-region, has ham-
pered any higher resolution regarding diversity of these viruses beyond the genotype. 
Testudinid herpesvirus es are important pathogens that have been detected in the chelonian 
family Testudinidae (tortoises) [14, 19–21]. Of the three genotypes, associated with obvious 
pathology, TeHV1 has been detected most frequently in Horsfield’s tortoises (Testudo [Agyo-
nemis] horsfieldii) having stomatitis and glossitis [14]. TeHV2 has been identified in North 
American desert tortoises [20, 21]. Severe stomatitis, glossitis and pneumonia have been ob-
served in a TeHV2-infected captive desert tortoise along with pneumonia [21]. TeHV2 has 
been shown to serologically cross-react by ELISA with TeHV3 suggesting the existence of 
similar antigenic epitopes in the two distinct genotypes [20, 21]. Consistently, the partial se-
quence of the TeHV2 ribonucleotide reductase gene (large subunit), a conserved gene in her-
pesviruses, shared 79% identity with the homologous TeHV3 gene [21]. TeHV3 is considered 
the most pathogenic of the known TeHVs and it has been detected in several species of tor-
toises associated with stomatitis and glossitis although it appears to be overrepresented in 
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Greek tortoises (Testudo graeca) [14]. The pathology of TeHV3 has been thoroughly charac-
terized in a transmission study in Greek tortoises infected with the type-strain 1976/98 with 
the virus inducing a disease whose severity was viral-load-dependent [34]. The classic clinical 
signs associated with the disease including stomatitis, mono- and bilateral recurrent conjuncti-
vitis and oral discharge were reproduced in the experimentally infected tortoises [34]. In this 
study, the virus showed prominent neurotropism and indirect evidence of latency. Further-
more, the severity of the disease appears to vary with the species of tortoise infected. For in-
stance, TeHV3 infection in the Greek tortoise is generally characterized by low mortality, 
whereas a severe, acute to sub-acute disease with high mortality has been observed in Her-
mann’s tortoises (Testudo hermanni) [14]. 
Although numerous serological and molecular tests have been developed to diagnose expo-
sure and infection with TeHV3 [33, 34–38], none of these tests can predict the virulence of 
the strain or whether one or several strains are involved within a single outbreak. To better 
understand the biology of this virus, we decided to sequence the complete genome of the 
TeHV3 type-strain 1976/96 [34, 36], the best characterized TeHV3 strain to date, to provide a 
complete reference genome sequence for TeHV3. Knowledge of this complete sequence in 
synthesis with further phylogenetic and experimental data would facilitate a better under-
standing of the host-pathogen relationship in chelonians and the development of more refined 
diagnostic tests contributing to predict the outcome of an outbreak. In addition, in this study 
we selected the sequence of the glycoprotein B (gB), gene as a tool to perform a higher reso-
lution phylogenetic analysis on TeHV3 strains. The choice of the gB gene over other TeHV3 
genes was based on its key features as an ideal phylogenetic marker including conservation 
among herpesviruses and sequence variability secondary to its antigenicity [39, 40]. These 
characteristics are expected to refine the resolution power of the viral DNApol sequence since 
the protein encoded by this gene is expected to be under a negative evolutionary pressure be-
cause of strong functional constraint. As we will show, the gB sequence allowed us to sepa-
rate TeHV3 strains into at least two distinct genogroups. Moreover, we present preliminary 
data consistent with distinct genogroup-associated pathology in naturally and experimentally 
infected tortoises. We provide the first evidence of homologous recombination in a reptilian 
herpesvirus with indirect proof of a single tortoise infected with multiple strains of TeHV3. 
These new data will be fundamental for further investigations on host-pathogen interactions in 
chelonians and for tortoise conservation around the world. 
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In this manuscript we also propose to uniform the nomenclature of the TeHVs strains by pre-
senting in the following order: the abbreviation of the country where the strain originated, fol-
lowed by the original number assigned to the strain and the last two digits corresponding to 
the year of isolation. According to this procedure, the type strain 1976/96 will be renamed as 
(TeHV3)-US1976/98. All the other TeHVs strains investigated in this study will be named ac-
cordingly. 
Material and Methods: 
Genome sequencing 
The TeHV3 strain US1976/98 was grown on Terrapene heart cells (TH-1;ATCC-CCL 50 
Sub-line B1; American Type Culture Collection, Rockville, MD, USA), harvested and pel-
leted as previously described [36]. Total DNA was extracted using the DNAeasy kit (Qiagen 
Hombrechtikon, Switzerland). A total of 3.5μg of viral DNA was delivered to a biotechnol-
ogy company (Fasteris SA, Geneva, Switzerland) for next generation sequencing (NGS). The 
viral DNA was processed using the Illumina technology for NGS. Briefly, the DNA was frag-
mented to produce short DNA inserts to build a DNA template library with each of the inserts 
carrying universal adaptors. Following quality control, the library was sequenced with the Il-
lumina HiSeq 2000 to obtain 50 bases long single-end reads. De novo genome assembly was 
performed using the VELVET software (http://www.ebi.ac.uk/~zerbino/velvet/). To optimize 
the assembly, several values of k-mers were tested. To evaluate the quality of the assemblies, 
the following indicators were computed: sum of the contigs (DNA consensus sequences ob-
tained by overlapping shorter DNA sequences) lengths, number of contigs, N50 (the length of 
the smallest contig in the set that contains the fewest (largest) contigs whose combined length 
represents at least 50% of the assembly) [41], number of contigs to reach the N50, average 
and maximum lengths of the contigs, and the number of reads from the library that can be 
mapped on the contigs. The assembly with the highest N50 and percentage of mapped reads 
was then chosen. 
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Bridging of the contigs was performed using viral sequences obtained from two previously 
generated sub-genomic DNA libraries (HindIII and EcoRI) [10] [34]. Following the assem-
bly, multiple PCRs spanning 1–7.5Kb were performed to assess the junctions between contigs 
and the overall correctness of the assembly of the whole genome. Sequencing of the PCR 
products was carried out when the amplicon obtained was not consistent with the expected 
size derived from the sequenced genome. Finally, the single-end Illumina reads were mapped 
to the obtained genome sequence using BWA (Burrows-Wheeler aligner (http://bio-
bwa.sourceforge.net)) [42]; the remapping was visualized with IGV (Integrative Genomic 
Viewer 2.3.34) [43]. For open reading frame (ORF) identification the program “ORF finder” 
(http://www.ncbi.nlm.nih.gov/projects/gorf/) was used and each putative ORF was manually 
assessed using the program “BLAST” (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The gene iden-
tity was attributed according to the best hit provided by BLAST. An arbitrary cutoff corre-
sponding to predicted genes encoding for at least 90 amino acids (aa) was selected when no 
homology could be found with any other known herpesviral genes using BLAST. Detection 
of the tandem repeats was carried out using the software “Tandem repeat finder” [44], using 
standard settings. 
Genome comparison. 
The TeHV3 genome was compared with that of Chelonid herpesvirus 5 (ChHV5), the only 
other available genome of a chelonian herpesvirus [22] using the program EasyFig v2.1 [45] 
with standard settings. Briefly the annotation files of the two genomes (HQ878327-ChHV5 
and KT008627-TeHV3) were converted by the software into the corresponding tBLASTX 
files [45]. The graphic output of the comparison was then generated. Color tones from light 
gray to black were selected for the direct matches spanning from low to high, respectively, 
and orange to red for the inverted matches spanning from low to high, respectively. 
Animals and pathology 
A retrospective investigation was carried out on selected formalin-fixed, paraffin embedded 
(FFPE) tissues obtained from ten tortoises necropsied from 1999 to 2009 and stored in the ar-
chive of the Centre for Fish and Wildlife Health (FIWI) of the University of Bern, Switzer-
land.  
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All the tortoises selected for the study were captive animals and were either diagnosed as pre-
sumptively infected with TeHV or carrying compatible lesions based on having at least one of 
the following criteria: 1) eosinophilic to amphophilic intranuclear inclusions in at least one of 
the examined tissues (= presumptively infected); 2) presence of diphtheronecrotic stomatitis 
and/or glossitis (= compatible lesion); and 3) pneumonia (= compatible lesion). All these tor-
toises died of natural causes, with the exception of Z02/1970 that was humanely euthanized 
by the attending clinician because of very poor prognosis with an overdose of sodium pento-
barbital performed by intra vascular injection. None of these tortoises was included in experi-
mental studies. Two additional tortoises (PN186/12, PN13/08), selected using the above crite-
ria, were provided by the University of Milan (Italy) along with a third tortoise (PN191/12) 
that despite absence of consistent lesions was also included in the study because it came from 
the same die off as PN186/12. A tortoise with a diphtheronecrotic stomatitis (S12/1458) sub-
mitted for necropsy to the Institute of Animal Pathology (ITPA) of the University of Bern was 
also included in the study. The three tortoises provided from the University of Milan and the 
tortoises submitted to the ITPA also died of natural causes and were not part of any transmis-
sion study. Finally, a tortoise (TG4/1998) experimentally infected with the TeHV3 type-strain 
US1976/98 with well-characterized associated pathology [34] was also considered for this 
study. This tortoise was part of a transmission study carried out previously. The study was ap-
proved by the Institutional Animal Care and Use Committee (IACUC) of the University of 
Florida and the tortoise was humanely euthanized with an overdose of sodium pentobarbital 
performed by intracoelomatic injection [34]. All the tissues available from all the tortoises 
were reviewed by two of us (FCO and MT). The following data was obtained for each tor-
toise: 1) time of death; 2) sex; 3) species; 4) age; 5) geographical origin 6) presence of any in-
flammatory, necrotic or degenerative lesions in any of the sections observed using light mi-
croscopy, and presence and location of the intranuclear inclusions. No live animals were in-
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cluded in this study. A detailed list of the tortoises included in this study including the identi-
fication numbers of each animal is provided in Table 1.
 
Table 1: Tortoise and TeHV strains.  
Virus isolation 
Virus isolation was attempted from fresh tissues obtained from tortoises PN186/12 and 
PN191/12 (from the University of Milan, Italy) and from an oral swab from tortoise S12/1458 
(from the ITPA of the University of Bern, Switzerland). Tissues and swabs were processed 
for viral isolation by inoculation onto TH-1 cells at 28°C as previously described [34]. Cell 
cultures were monitored daily for the detection of cytopathic effects (CPE). The type-train 
1976/96 was already available from previous studies [34, 36]. 
TeHV3 strain detection and partial characterization of the gB gene 
Total DNA was extracted either from infected cell cultures (strains 1976/96, CH1458/12 and 
IT191/12) or from FFPE tissue blocks containing at least a section of the tongue and/or oral 
mucosa or lung from all the remaining tortoises in the study. Three 20 μm sections were ob-
tained from each of the selected paraffin blocks and placed into an RNAse/DNAse-free 1.5 ml 
Eppendorf tube. Total DNA was extracted from each set of paraffin slices with the FFPE 
DNA extraction kit (Qiagen Hombrechtikon, Switzerland). 
Total DNA was also extracted from infected cell cultures as previously described [34] and 
quantified with a Nanodrop spectrophotometer (Thermo Scientific, Wilmington, DE, USA). 
pag. 122 
 
The complete gB gene of strains US1976/98, CH1458/12 and IT191/12 was amplified by 
PCR with a forward (gBTeHV3FW) and a reverse (gBTeHV3RV) primers (Table 2) which 
were designed on the basis of the sequence available from the US1976/98 genome 
(KT008627). The PCR reaction-mix contained 5 μl of 2 μM forward and reverse primers, 
1.25 μl of each 10 mM dNTPs (Promega, Madison, WI, USA), 5 μl of 10x PCR buffer, 1 μl 
of PFU II Ultra DNA polymerase (Agilent Technologies, Santa Clara, CA, USA) 250 ng of 
total DNA template and double distilled water (Promega, Madison, WI, USA) up to 50 μl. 
PCR reactions were carried out in a DNA engine thermal cycler (MJ Research, Waltham, 
MA, USA) and comprised an initial denaturation step at 95°C for 2 minutes, followed by 40 
cycles comprising a denaturation step at 95°C for 30 seconds, an annealing step at 50°C for 
30 seconds and an elongation step at 68°C for 1 minute followed by a final elongation step at 
68°C for 10 minutes. Given that FFPE tissues undergo DNA fragmentation, no full amplifica-
tion would have been possible with a single PCR reaction. Consequently, either full or partial 
gB gene amplification from the paraffin blocks-derived DNA was carried out with a series of 
sequential and overlapping PCR reactions, which were set up with each of the subgroup of 
primer sets listed in Tables 2 and 3, respectively. More specifically, the pairs FWA and RVA, 
FW1 and RVB, FW2 and RVC, FW3 and RVD, FW4 and RVE, FW5 and RVF, FW6 and 
gBTeHV3RV were used to amplify several DNA fragments covering the full length gB of 
strain CH6883/03, while the primer pairs FW4 and RVE, FW5 and RVF, FW6 and 
gBTeHV3RV were used to amplify the 3’ half portion of the gB gene of all the other paraffin-
blocks-derived strains in the study. Each of the PCR reaction mixes contained 0.25 μl of 10 
μM forward and reverse primers, 12.5 μl of hot-start master mix (Qiagen AG, Hom-
brechtikon, Switzerland), 250 ng of total DNA template and double distilled water (Promega, 
Madison, WI, USA) up to 25 μl. The reaction mixes were placed in a DNA engine thermal 
cycler (MJ Research, Waltham, MA, USA) and after an initial denaturation at 95°C for 15 
minutes (hot start), 45 cycles comprising denaturation at 95°C for 1 minute, annealing at 50°C 
(FWA and RVA, FW4 and RVE, FW5 and RVF) or 52°C (FW1 and RVB, FW2 and RVC, 
FW3 and RVD, FW6 and gBTeHV3RV) for 30 seconds, an elongation at 72°C for 30 sec-
onds, followed. A final step comprising 10 minutes extension at 72°C was added. A summary 
of the primer pairs used for the gB gene amplification and cycling conditions is listed in Ta-
bles 2 and 3. 
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Table 2: PCR and sequencing primers 
 
Table 3: Glycoprotein B gene PCR amplification conditions 
Phylogenetic analyses 
Multiple phylogenetic analyses were carried out. The first analysis (1) was based on the par-
tial aa sequence of the DNApol and gB proteins, respectively, encoded in the genome of the 
TeHVs strains included in this study (N = 15). 
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These sequences were compared to homologous sequences available from other herpesviruses 
(TeHV1-AB047545.1, TeHV2-AY916792.1, TeHV4-GQ222415.1, ChHV5-AF239684.2, 
ChHV6-EU006876.1 and GaHV1- AF168792.1 for the DNApol; and ChHV5-AAU93326, 
ChHV6-AAM95776 and GaHV1-YP_182356 for the gB sequences). The second analysis (2) 
was based on the partial nt sequences of the gB gene of all the TeHV3 strains included in this 
study (n = 15), which were compared to the homologous gene of other herpesviruses 
(ChHV5-AAU93326, ChHV6-AAM95776 and GaHV1- YP_182356).  
The third analysis (3) was carried out using the complete aa sequence of the gB protein of the 
reference strain (US1976/98), which was compared to homologous sequences of 36 other her-
pesviruses. Sequence alignment was carried out using multiple software packages (ClustalW, 
ClustalW2, TCoffee, Mafft L and Muscle) [46–49] for phylogenetic analysis 1, whereas Clus-
talW was used for analysis 2 and 3. Maximum likelihood phylogenetic trees were obtained 
using MEGA6.0–6 [50] software package with 500 bootstrap replications, Jones Taylor Thor-
ton replication method, uniform rates among sites and very strong branch swap filter. 
Recombination analysis 
Assessment of recombination events of the gB gene was carried out with the Recombination 
Detection Program (RDP4) (Version 4.46) [51] using standard settings and feeding the soft-
ware with two of the predicted parent strains (US1976/98 and CH6883/03) together with the 
predicted recombinant strain (CH3429/01). The methods used for the recombination assess-
ment were those included in the software package and included RDP, GENECONV, 
BootScan, MaxChi, Chimera, SiScan, PhylPro, LARD and 3Seq, all operating under standard 
settings. 
 
Results: 
Sequence analysis of the TeHV3 genome 
Next generation sequencing (NGS): A total yield of 1.598 mega bases (Mb) was obtained 
with 31,959,585 clusters. 95.8% of the bases had a Q-score (measure of base-calling accu-
racy) larger than 30. The de novo assembly of the reads led to a total of 24 contigs spanning 
from 107 to 64,501 nt long and accounting for 140,195 nt (N50 of 23,603 nt). The average 
base coverage (depth) was 8,984. Bridging of the contigs was carried out by PCR and with the 
aid of the sequencing information derived from the HindIII and EcoRI subgenomic libraries 
as previously mentioned. The final sequence of the genome comprised 150,080 nt (Fig 1). 
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The TeHV3 genome is composed of a unique long (UL) and a unique short (US) region, with 
the US flanked by inverted repeats consistent with a type D arrangement similar to that of Hu-
man herpesvirus 3 (HHV3-VZV) and the recently described genome of ChHV5 [22]. The GC 
content was 45.8%. 
 
 
Figure 1: TeHV3 genome map. The TeHv3 genome is composed of a unique longue region 
(UL) (blue bar) and a unique short region (green bar) flanked by two inverted repeats (red 
bars). The progressive numbers and homologous herpesvirus genes of the identified sense (or-
ange) and antisense (green) open reading frames (ORFs) are shown in the map (SnapGene 
Viewer-V2.7; www.snapgene.com). 
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Analysis of the sequence of the unique long (UL) region. 
The length of the available UL region was determined to be 112,838 nt (position 37,243 to 
150.080 of the genome). The putative 5’ and 3’ ends of the UL region were identified as those 
regions immediately contiguous to the inverted and terminal repeats, respectively. The puta-
tive 5’ end of the UL region was obtained by NGS complemented with the sub-genomic li-
brary approach, whereas the sequence of the putative 3’ end was obtained by sequencing a 
PCR amplicon bridging the 5’ end region of the terminal repeat and the 3’ end of the UL re-
gion. This approach was attempted given that herpesvirus genomes are known to adopt a 
closed circle configuration within a few hours after the start of replication [52]. By harvesting 
the total DNA of early-infected TH-1 cells, we could successfully amplify the bridging re-
gions between the terminal repeat and the 3’ end of the UL region. The actual putative 3’ end 
of the UL region was considered to be the last nucleotide prior to the beginning of the se-
quence corresponding to the reverse and complement of the 3’ end of the internal inverted re-
peat. Multiple PCRs confirmed the assembly obtained. 
The predicted UL region comprises at least 79 ORFs; 37FW, 42RV, with 35 partially overlap-
ping. Sixty-two of them showed variable degrees of similarity with known herpesvirus genes, 
ranging from 38 to 79% for the UL47 (Psittacid herpesvirus 1) and UL 45 (Ateline herpesvi-
rus 3) homologues, respectively. The remaining ORFs could not be associated unambiguously 
to a known herpesvirus gene (Table 4 and Figs 1 and 2). 
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Figure 2: TeHV3 and ChHV5 genome comparison. The graphical comparison between 
TeHV3 and ChHV5 genomes obtained with the EasyFig1 software is shown in the figure. The 
genomes of TeHV3 and ChHV5 are depicted in red, with a black backbone. Similar regions 
are connected with grey (low) to black (high) (direct sequences) and orange (low) to red 
(high) (inverted sequences) bars. Green, blue and red bars highlighting the US and UL regions 
and of the inverted repeats (terminal and internal) of each genome, respectively are also 
shown. Letters A, B, C, D, E and F correspond to regions of the genomes that show no simi-
larities within the conserved UL block. 
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Table 4: TeVH3 Open reading fragments features. 
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Table 4 (continue): TeVH3 Open reading fragments features 
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The UL ORFs are largely co-linear to the homologous genes of Human herpesvirus 
1 (HSV1), in particular from UL1 to UL43, while the segment spanning from UL53 to UL44 
has an inverted orientation compared to HSV1. Two genes share homology with HSV1 UL55 
(UL55a and UL55b), with 74% nt identities between each other, suggesting gene duplication. 
TeHV3 encodes for the thymidylate synthetase (UL45), whose homologue is found only 
in Varicella zoster virus (VZV) of all the Alphaherpesvirinae, whereas is common in Gam-
maherpesvirinae. The longest gene identified in the UL region was the homologous of HSV1 
UL36, encoding for the large tegument protein. This gene is 7,725 nt long and encodes for a 
protein 2,574 aa long. In contrast, the shortest gene identified within the UL region is the ho-
mologous gene of HSV1 UL11. The gene is 240 nt long and encodes for a 79aa long protein. 
Finally, upstream of the homologous gene of HSV1 UL1 is a 333nt ORF (ORF24b) encoding 
for a predicted 110 aa long protein that shares 51% similarity with a motif of a predicted pro-
tein with unknown functions encoded by Bovine herpesvirus 6 (Table 4). Interestingly, almost 
entirely overlapping with ORF24b is ORF24a, which is another predicted ORF whose en-
coded predicted protein shares very limited similarities with a protein encoded by the retro-
peritoneal fibromatosis-associated herpesvirus (Genbank AGY30683) (Table 4). 
Interestingly, the UL region of ChHV5, the closest related herpesviral genome to TeHV3, 
lacked several genes compared to TeHV3. More specifically, the HSV1’s UL13, UL40, UL44 
through 51 and UL54 through UL56 homologous genes could not be detected in the ChHV5 
genome [22]. In contrast, homologues of all these genes except for UL56 were identified in 
the TeHV3 genome. UL13 encodes for a serine-threonine protein kinase, whereas UL40 en-
codes for the small subunit of the ribonucleotide reductase. UL44 encodes for the glycopro-
tein C, a surface membrane protein which mediates immune evasion in vivo [53], while UL45 
encoded for thymidylate synthetase. UL46, UL47, UL48 UL49.2, UL49.5 and UL51 encode 
for tegument proteins. UL50 encodes for a metabolic enzyme (dUTP diphosphatase). 
UL54 encodes for a transcriptional regulator (similar to ICP27), while UL55 encodes a pro-
tein with unknown functions. Ackermann and colleagues [22] reported that all the homo-
logues genes from HSV-1 that are missing in ChHV5 in comparison with TeHV3 are known 
to be non-essential for herpesvirus replication in vitro. The biological meaning of these differ-
ent sets of genes in TeHV3 is currently unknown. Table 4 provides a summary of all the com-
parison data. 
Analysis of the sequence of the unique short (US) region. 
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The US region was identified as the portion of genome between the terminal and inverted re-
peats. It is predicted to be 20,374 nt long (position 8,435 to 28,808 of the genome) and com-
prises at least 19 ORFs (11 FW, eight RV, two overlapping). Only five of the detected ORFs 
shared a relatively significant similarity with other known herpesviral genes (ORF8 and 9 
with US3; ORF10 with gD; ORF14 with gE; ORF16 with US10) (Table 4). There are two 
genes that share high similarity with HSV1 US3, US3a (ORF8) and US3b (ORF9) (see be-
low). ORF8 and 9 do not share any significant similarity between each other (only 10 positive 
aa between the two sequences), suggesting that an origin by gene duplication is unlikely. 
Fifty-four per cent sequence similarity was observed between the TeHV3 ORF8 encoded pro-
tein and ChHV5 US3 protein homologue, whereas 50% sequence similarity was observed be-
tween the TeHV3 ORF9 encoded protein and the putative cyclin-dependent kinase 2 of 
ChHV5. The predicted protein encoded by the ORF 10 of TeHV3 shared 48% sequence simi-
larity with a 175 aa long motif of ChHV5 glycoprotein D (gD), a molecule that is known to 
serve as the major receptor-binding protein in a number of Alphaherpesvirinae [22] (Table 4). 
The longest predicted gene detected in the US region encoded for a protein of 545 aa, identi-
fied as TeHV3 ORF17, that did not share any similarity with any gene of known herpesvi-
ruses. The shortest ORF detected in the US region was instead identified as TeHV3 ORF15 
and encoded for a 91 aa long protein and did not show any similarity with other known her-
pesvirus genes. The highest similarity between the identified proteins encoded by the TeHV3 
US region and those of other herpesviruses was observed for the homologue of HSV1 US3 
(see above) and of US10, both with 54% similarity with the correspondent protein encoded by 
ChHV5 (Table 4). Otherwise, the lowest similarity was observed for the glycoprotein E (gE) 
(ORF14) and of a gE-like protein (ORF11), with 41% similarity for the homologous proteins 
encoded by ChHV5 and Cercopithecine herpesvirus 6, respectively. No similarities could be 
found between the other TeHV3 US encoded predicted proteins and those of other known her-
pesviruses. Overall, findings were similar to those described for the US region of ChHV5, ex-
cept for the number of ORFs identified, which in ChHV5 were 11 versus the 19 identified in 
TeHV3. Table 4 provides a summary of all the comparison data. 
Analysis of the sequence of the inverted repeats (Internal and terminal repeats). 
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The regions identified as putative inverted repeats are both 8,434 long (position 1 to 8,434 
and position 28,809 to 37,242 of the genome). The beginnings and the ends of the inverted re-
peats were identified as those regions immediately contiguous to unique sequences of either 
the UL or US regions. The inverted repeats encode for at least two predicted proteins with 
motifs sharing 58 and 40% similarity with two known transactivators, ICP4 (ORF2 and 22) 
and IE-2 (ORF1 and 23),(Table 4). 
No detectable latency associated transcript (LAT) encoding gene was detected, in contrast 
with ChHV5. Strikingly, a major difference in the number of the predicted ORFs was ob-
served between the inverted repeat regions of TeHV3 and that of ChHV5, where 12 ORFs 
were identified. However, while in ChHV5, the cutoff selected for the detection of the ORFs 
was 40 aa, we considered only the ORFs predicted to encode at least 90 aa as mentioned 
above (Table 4). Finally, five additional putative ORFs encoding more than 90 aa were actu-
ally identified in the TeHV3 inverted repeats, however, they were almost entirely clustered 
within the ICP4 homologous coding sequence and all of them showed very low similarities 
only with very short motifs of known herpesvirus genes and consequently were not consid-
ered in the final list of TeHV3 putative genes. 
Tandem repeats. 
A total of 17 tandem-repeat regions were identified and the length of the repeat motifs ranged 
from 13 to 73 nt (Table 5). Four of them mapped within the UL region, eight in the inverted 
repeats, three in the US region, one bridging between UL region and the inverted repeat and 
one bridging between US and inverted repeat. In four of the repeated motifs up to 4 mis-
matches were observed. Two indels were also observed (Table 5). 
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Table 5: Tandem repeats features.  
Ambiguous sequencing results. 
In the region comprised between the homologous genes to UL44 and UL55 we identified a 
tandem repeat region. The PCR bridging this repeated sequence yielded a product that ap-
peared to be approximately 50 nt longer than the original predicted sequence. Several at-
tempts to sequence that region failed. Similarly, the region across UL15b and UL18, which 
also contains repeated sequences, might be approximately 200 nt shorter than predicted by the 
original sequence. 
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The putative 3’ end of the UL region comprises a 5.4 Kb contig that was originally assembled 
in the opposite orientation of the one then determined to be the correct one. The ambiguity 
was determined by the conflicting results of a short bridging PCR over the sequence gap, 
which could not be confirmed with a long bridging PCR. The orientation of the contig pre-
sented in the final sequence here was selected on the basis of PCR and sequencing results. 
Similarly, between the IE-2 and ICP4 homologues we identified a GC rich region 1,015 nt 
long with repeated motifs (tandem repeats). Interestingly, the PCR product spanning between 
the two genes over the GC rich region showed multiple bands ranging from approximately 
900 to 700 nt, but all smaller than the expected product. However, when running a PCR posi-
tioning the primers distally from the GC rich region, an amplicon of the expected size was ob-
tained. The pattern of the short bridging PCR results was very similar to that described by 
Hommelsheim and colleagues [54] when sequencing repetitive DNA sequences. In the con-
text of a different research project, while screening subgenomic clones of TeHV3 strain 
US1976/98 obtained by partial digestion of the genomic DNA with Sau3AI we detected a re-
peated motif comprising alternating long series of single A, T, C or G (up to 22 nt long) that 
we could not find in the assembled genome. This repeated motif was contiguous with a se-
quence that was only partially matching that bordering a similar, but different repeated motifs 
at the beginning of the putative UL region. Blasting the novel identified nt motif (with the op-
tion “somewhat similar sequences” of BLAST) no match with any of the known herpesvi-
ruses was observed. Contrastingly, when the search was not restricted to herpesviruses only, 
identities up to 84% of portions of the sequence (up to 33%) with eukaryotic organisms 
(Oryzias latipes-HG313981.1) were observed. Finally, the original sequence of the TeHV3 
genome was determined to be 170 nt longer than the one presented in this article. This addi-
tional sequence was located at the 5’ end of the terminal repeat and it was one of the two mo-
tifs of a tandem repeat originally identified in that region. When assessing the assembled ge-
nome by the software IGV, a total of 12 ambiguous nt were observed across the entire ge-
nome. Of these, six clustered in the first 222 nt of the genome and two were in the last 20 nt 
of the genome. In particular in association with four of the nt ambiguities at the 5’ end of the 
genome (in correspondence of the 5’ end of the terminal repeat), we also observed an abrupt 
drop of the coverage. Interestingly this drop in coverage corresponds to the joining of the two 
tandem repeats described above (region between original nt 166 to 172). Multiple attempts of 
sequencing these regions were carried out, but the presence of repeated motifs did not allow 
us to conclusively resolve these ambiguities. Given the clustering of several sequence and as-
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sembly ambiguities in the region across these two tandem repeats and that once the two tan-
dem repeats were collapsed into just one, the assembly of that region appeared to be more ro-
bust, we considered that this 170 nt fragment might have represented a sequencing artifact 
and then it was removed. Following the editing of the sequence according to what described 
above, the inverted and tandem repeats, which originally differed in size for exactly 170 nt in 
length, were then both measuring exactly 8,434 nt, further supporting the editing described 
above. A possible insertion of a nt was instead detected at position 127,377, whereas a possi-
ble deletion of a nt was observed at position 131,553 of the genome. A drop of coverage of 
30% between contiguous nt was seen at positions 37,191 and 37,242 but the assembly in that 
region appears solid and no further assessment was considered necessary. 
Genome Comparison. 
The graphic outcome of the software EasyFig1 (Fig 2), highlighted a prominent conservation 
of the arrangement of the genes clustering into the central portion of the UL region of the ge-
nome, although showing overall low similarity as suggested by the predominant light gray of 
the connecting lines. However, within this highly conserved portion of the genome, few re-
gions showed absence of virtually any similarity. More specifically, the regions correspond-
ing to the homologue of UL4 (A), UL12-13 (B), UL16 (C), in that between the UL15b and 
UL18 homologues (D) and in that corresponding to the UL22 (E) and UL36 (F) homologues, 
none or very limited numbers of connecting lines were observed. The extremities of the ge-
nomes showed a relative low or absence of similarities, with the most relevant clustering 
within the US regions of the genomes where low similarity-labeling color (orange) high-
lighted corresponding inverted matches (ORF 8-US3a, 9-US3b, 14-gE and 16-US10). No 
matches could be observed in the terminal portion of the putative UL regions of the two ge-
nomes. 
Animals 
A total of 15 tortoises were included in this study. Ten of them were diagnosed as presump-
tively infected by herpesvirus and five as carrying consistent lesions (or history = IT191/12) 
based on the criteria described above. The only exception was tortoise TG4/1998, which alt-
hough did not show any intranuclear inclusions in the examined tissues was also considered 
conclusively infected by TeHV given that it was part of a previous challenge study carried out 
with the TeHV3 strain US1976/98. Ten out of 15 were T. hermanni, one T. horsfieldii, two T. 
graeca, one Testudo sp, one Stigmochelys (formerly Geochelone) pardalis. The tortoises died 
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either during the spring (April-June: n = 8) or the fall (October-December: n = 4) including 
also Z02/1970 that was euthanized because of very poor prognosis. One animal was part of a 
terminal transmission study and was euthanized in August. No information was available for 
two individuals. Seven were male and six female. No sex information was available for two 
tortoises. Most of the tortoises were from Switzerland (n = 11), fewer from Italy (n = 3) and 
one from the US, accounting for three countries and two continents. The selected cases 
spanned between 1998 and 2012. A complete summary concerning the tortoises’ information 
is provided in Table 1. 
 
 Virus isolation 
Cell cultures inoculated with tissue extracts from tortoise PN191/12 and swab washes from 
tortoise S12/1458 showed CPE consistent with cell rounding, detachment and cell lysis after 7 
to 21 days and up to two blind passages performed. The presence of the virus in the superna-
tants of the cell cultures showing CPE was confirmed by PCR using the protocol described by 
Vandevanter and colleagues [33]. No virus could be isolated from the cell culture infected 
with the tissue extracts from tortoise PN186/12. Characterization of the TeHVs strains se-
quences DNA polymerase (DNApol). Partial amplification of the DNApol gene from all the 
tortoises included in the study (N = 15) was carried out with consensus primers according to 
an established protocol [33]. The PCR products were consistent with the expected size (181nt) 
and the DNA sequences were translated into the predicted 60 aa long sequence (58 aa reada-
ble for strain CH5132/08). Fourteen out of the fifteen sequences shared 100% identity with 
the homologous sequence of other TeHV3 strains (DQ343881; TeHV3 1976/96 = 
US1976/98). The remaining strain (IT13/08) showed 100% identity with the homologous se-
quence of TeHV1 strains (AB047545.1). The aligned sequences along with those of TeHVs 
reference strains are shown in Fig 3.DNApol aa sequence generated for the novel detected 
TeHV3 strains could not be deposited in the NCBI/Genbank database because their length 
was shorter than the minimum accepted. 
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Figure 3: Alignment and comparison of the partial amino acid sequence of the DNA poly-
merase protein of the TeHVs strains. The alignment of the partial amino acid sequences of the 
DNA polymerase protein shows unique differences between the 4 recognized TeHVs geno-
types. All but one of the detected TeHVs strains had sequences identical to TeHV3, whereas 
one strain belonged to genotype 1. (The Genbank accession numbers for TeHVs reference 
strains were: TeHV1-AB047545.1, TeHV2-AY916792.1, TeHV3 (1976/96 = US1976/98)-
DQ343881, TeHV4-GQ222415.1. The partial DNA polymerase amino acid sequences of the 
TeHVs strains detected in this study could not be deposited in Genbank because their length 
was below the minimum required to be accepted). 
Glycoprotein B (gB). 
Within the portion of the genome identified as the UL region a 2,484 nt long ORF was deter-
mined to be the homologue of the HSV1 gB gene (UL27 = ORF52). The nucleotide sequence 
encoded for a protein 827 aa long. The protein was 25 aa shorter than the homologue of 
ChHV5 (852aa; Genbank AAU93326) and 38 aa shorter than that of ChHV6 viruses (865aa; 
Genbank AAM95776), the only reptilian herpesviruses with a complete available gB se-
quence. 
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Either complete or partial amplification of the gB gene was successfully obtained for all tor-
toises in the study (N = 15). In particular, the full amplification of the gB gene was obtained 
for strains US1976/98, IT191/12 and CH1458/12, and CH6883/03 (Table 1). The sequences 
obtained showed the highest variability in the 3’half of the gene. The 3’ half partial sequence 
of the gB gene was then selected for phylogenetic analysis. The amplified portion of the gB 
gene was 1084 nt long (1069–1084 nt readable according to the amplicons, including the pri-
mers) and was obtained from all the remaining tortoises in the study (Table 1). The alignment 
of the complete and partial sequences of the gB genes of the different TeHVs strains revealed 
the existence of a total of 66 single nt polymorphisms (SNP) between two groups 
(genogroups) of strains (n = 11 and n = 3) named A and B, respectively. Two SNPs were lo-
cated within the first 102 nt of the gB sequence, while the remaining 64 clustered in the 3’half 
of the gene. Furthermore, the strain CH3429/01 showed intermediate features between 
genogroup A and B and was identified as an additional putative group C. Of the 66 SNPs 33 
were uniquely differentiating genogroup A from B (Fig 4). Five of the SNPs were missense, 
resulting in aa changes (Fig 5). All the missense SNPs clustered in the 3’ half of the gene. 
Within a 250 nt-long region of the highly variable portion of the gB gene were clustered most 
of the SNPs (22 SNPs; 1,521–1,779 nt) differentiating genogroup A and B; similarly for the 
additional putative recombinant strain (genogroup C) (Fig 6). This region of the gB gene was 
then selected as target region for TeHV3 genotyping. 
 
Figure 4: Hypervariable region of the gB gene of TeHV3. The unique nucleotide changes un-
ambiguously differentiating the genogroup A, B and C are shown in the figure (* = not availa-
ble nucleotide for the putative group C TeHV strain). 
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Figure 5: Hypervariable region of the TeHV3 gB protein. Three unambiguous amino acid 
changes differentiate the A and B genogroups within TeHV3 (colored blocks). The putative 
genogroup C shows an intermediate sequence between genogroup A and B. 
 
Figure 6: Selection of hypervariable nucleotide changes for phylogenetic analysis. In a hy-
pervariable region of the glycoprotein B gene spanning across approximately 250 nt, are clus-
tered 22 of the 33 unambiguous nucleotide changes differentiating the A and B genogroups 
within TeHV3. This region was selected for a high-resolution phylogenetic analysis of 
TeHV3 strains. The light blue block highlights the selected region of the gene. (* = not avail-
able nucleotide for the putative group C TeHV strain).  
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The TeHV strain with intermediate SNPs between genogroup A and B (putative genogroup 
C) revealed a sharp regional demarcation of the SNPs arrangement. Briefly, the SNPs over-
lapping with those of genogroup A were located in the 3’ end of the hypervariable region of 
the gB gene, whereas the SNPs overlapping with those of the genogroup B were located in the 
5’ end of the hypervariable region suggesting the occurrence of homologous recombination 
(Fig 7). The recombination event was confirmed by the software GENECONV, BootSCAN, 
MaxChi, Chimaera and 3Seq of the RDP4 package [51]. In particular, the MaxChi software 
identified the TeHV3 genogroup A as the most likely major parent and genogroup B as the 
most likely minor parent. 
 
 
Figure 7: Glycoprotein B homologous recombination. 
 
The putative C genogroup shows full identity with either genogroup A or B partial gB nt se-
quence according to the portion of the hypervariable region considered. This arrangement is 
consistent with the outcome of homologous recombination. The highlighted sequence blocks 
show the homologous regions between the gB sequences of B and C and A and B 
genogroups, respectively (* = not available nucleotide for the putative group C TeHV strain). 
 
TeHV DNApol- and gB-based phylogenetic analyses (1, 2 and 3) 
The phylogenetic analysis carried out on the partial aa sequences of the DNA pol (Type 1 
analysis) revealed the presence of 14 strains clustering within TeHV3 and one within TeHV1 
genotypes, respectively (Fig 8). In contrast, the phylogenetic analysis based on the partial aa 
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sequence of the gB protein (Type 1 analysis) revealed the existence of two distinct TeHV3 
genogroups supported by significant bootstrap values (Fig 9). Additionally, the strain 
CH3429/01 clustered alone in an intermediate position between the two main TeHV3 
genogroups paralleling the findings of the gB sequencing described above. The partial gB aa 
sequence of the single TeHV1 strain, IT13/08, clustered together with the TeHV3 genogroup 
A strains (Fig 9). Overlapping results were obtained independently from the alignment soft-
ware used.
 
 
Figure 8: DNA polymerase-based phylogenetic analysis. Maximum likelihood tree inferred 
from the partial amino acid sequence of the DNA polymerase of the 15 investigated TeHVs 
strains and of the reference strains TeHV2, TeHV4, ChHV5, ChHV6 and Gallid herpesvirus 1 
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(GaHV1) that served as the outgroup. (Genbank accession numbers: TeHV1-AB047545.1, 
TeHV2-AY916792.1, TeHV3 (1976/96 = US1976/98) DQ343881, TeHV4-GQ222415.1, 
ChHV5-AF239684.2, ChHV6-EU006876.1, GaHV1- AF168792.1. No accession numbers 
could be obtained for the partial DNA polymerase protein sequences generated for the novel 
detected herpesvirus strains because their length was shorter than the minimum accepted by 
Genbank).
 
 
Figure 9: Glycoprotein B-based phylogenetic analysis. Maximum likelihood tree inferred 
from the partial aa sequence of the gB of the 15 TeHVs strains investigated in this study and 
of reference strains of other ChHV (ChHV5, -6). Gallid herpesvirus 1 (GaHV1) was included 
as outgroup. Bootstrap values from 500 iterations are shown. This analysis reveals the exist-
ence of at least two distinct genogroups within the TeHV3 genotype (A-green boxed and B-
red boxed). A third putative genogroup (C-blue boxed) composed of a single strain is also ob-
served. A TeHV1 strain (IT13/08) clusters within the A genogroup of the TeHV3 genotype. 
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Clear separation of the TeHV3 genogroups from the sequences of other two chelonian herpes-
viruses (ChHV5 and ChHV6) is observed. (Genbank accession numbers: CH1970/02-
KP979727, CH1690/03-KP979726, CH1611/07-KP979721, CH2360/06-KP979725, 
CH2053/01-KP979723, CH5132/08-KP979729, CH7204/00-KP979719, CH6883/03-
KP979730, CH2313/07-KP979722, CH3429/01-KP979720, CH1458/12-KP979718, 
US1976/98-KP979717, IT186/12-KP979728, IT191/12-KP979716, IT13/08-KP979724, 
ChHV5-AAU93326, ChHV6-AAM95776, GaHV1-YP_182356). 
The separation between the genogroups A and B was even more robust when the phylogenetic 
analysis was carried out using the 250 nt of the hypervariable region of the gene described 
above (Type 2 analysis) (Fig 10). 
 
 
Fig 10: Glycoprotein B hypervariable region-based phylogenetic tree. 
 
The phylogenetic analysis (Maximum likelihood tree) based on the hypervariable region of 
the glycoprotein B gene unambiguously identifies two main genogroups (A-green boxed and 
B-red boxed) and a third minor one (C) (blue boxed) within the TeHV3 genotype (Genbank 
accession numbers: CH1970/02-KP979727, CH1690/03-KP979726, CH1611/07-KP979721, 
CH2360/06-KP979725, CH2053/01-KP979723, CH5132/08-KP979729, CH7204/00-
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KP979719, CH6883/03-KP979730, CH2313/07-KP979722, CH3429/01-KP979720, 
CH1458/12-KP979718, US1976/98-KP979717, IT186/12-KP979728, IT191/12-KP979716, 
IT13/08-KP979724). 
 
Finally, when the full gB aa sequence was compared with the homologous sequence of other 
well-characterized herpesviruses, TeHV3 clustered unambiguously among the Alphaherpes-
virinae in close association with ChHV5, the only recognized herpesviral species of the ge-
nus Scutavirus (Type 3 analysis) (Fig 11). 
 
 
 
Fig 11: Glycoprotein B (full sequence)/based phylogenetic analysis. Maximum likelihood 
tree inferred from the full-length aa sequence of the gB of 2 strains of the TeHV3 and of 35 
additional herpesviruses. Bootstrap values from 500 iterations are shown. This analysis shows 
unambiguous clustering of the TeHV3 main genogroups (A and B) within the Alphaherpes-
virinae subfamily in close association with ChHV5 member of the novel identified genus of 
the Scutavirus. (Genbank accession numbers: Chelonian HV5-ChHV5-AAU93326, Chelo-
nian HV6-ChHV5-AAM95776, Bovine HV5-BoHV5-YP_003662497.1, Bovine HV1-
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BoHV1-NP_045331.1, Suid HV1-SuHV1-YP_068330.1, Feline HV1-FeHV1-
YP_003331552.2, Equine HV4-EqHV4-NP_045250.1, Equine HV9-EqHV9-
YP_002333514.1, Equine HV1-EqHV1-YP_053078.1, Cercopithecine HV9-CeHV9-
NP_077446.1, Human HV3-HHV3-NP_040154.2, Saimirine HV1-SaHV1-YP_003933812.1, 
Cercopithecine HV2-CeHV2-YP_164470.1, Macacine HV1-McHV1-NP_851887.1, Human 
HV1-HHV1-NP_044629.1, Human HV2-HHV2-NP_044497.1, Meleagrid HV1-MeHV1-
NP_073321.1, Gallid HV3-GaHV3-NP_066859.1, Gallid HV2-GaHV2-YP_001033956.1, 
Gallid HV1-GaHV1-YP_182356.1, Testudinid HV3-TeHV3-CH6883/03-KP979730, Testudi-
nid HV3-TeHV3-US1976/98-KP979717; Cercopithecine HV5-CeHV5-YP_004936031.1, 
Macacine HV3-McHV3-YP_068182.1, Human HV5-HHV5-YP_081514.1, Saimirine HV3-
SaHV3-YP_004940228.1, Human HV7-HHV7-YP_073779.1, Human HV6A-HHV6A-
NP_042932.1, Human HV6B-HHV6B-NP_050220.1, Human HV4-HHV4-YP_001129508.1, 
Macacine HV4-McHV4-YP_068009.1, Equine HV2-EqHV2-NP_042604.1, Ovine HV2-
OvHV2-YP_438135.1, Saimirine HV2-SaHV2-NP_040210.1, Bovine HV4-BoHV4-
NP_076500.1, Human HV8-HHV8-YP_00119354.1, Macacine HV5-McHV5-NP_570749.1). 
 
TeHV3 genogroups A and B appear to be associated with distinct lesional patterns 
Pathological examination was performed on all the 15 tortoises in the study. A summary of 
the pathological findings is available in Table 1. Briefly, of all the tortoises infected with 
TeHV3 genogroup A strains (n = 10), four had inclusions limited to one tissue and no inclu-
sions were detected in any tissue from the remaining tortoises infected with this TeHV3 
genogroup. Differently, all the tortoises infected with TeHV3 genogroup B (n = 3) showed 
inclusions in at least one tissue and two tortoises had inclusions in more than one tissue. 
Pneumonia was observed both in tortoises infected with TeHV3 genogroups A and B, but it 
was overrepresented in the tortoises infected with TeHV3 genogroup B (two out of three). In 
contrast, in tortoises infected with TeHV3 genogroup A, pneumonia was seen in a minority of 
individuals (two out of eight with available lung tissue). Furthermore, inclusions were seen in 
the lung of both TeHV3-genogroup-B-infected tortoises with pneumonia, while no inclusions 
were seen in the affected lungs of tortoises infected with TeHV3 genogroup A. Of the tor-
toises infected with TeHV3 genogroup A for which brain tissue was available (n = 6) only 
one showed tissue changes consistent with meningitis. In contrast, meningitis was seen in two 
out of the three tortoises infected with TeHV3 genogroup B. Vasculitis and/or perivasculitis 
were observed in two out of three individuals infected with the TeHV3 genogroup B. The tor-
toise infected with the bona fide recombinant TeHV3 strain had inclusions in the tongue and 
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developed pneumonia. The only tortoise infected with a TeHV1 strain had pneumonia, trache-
itis and hepatic lipidosis. Inclusions were seen only in the lung (Table 1). 
 
Phylogeography of TeHV3 genogroups in Switzerland 
The distribution of the infected tortoises from Switzerland was closely examined given that 
they were the most numerous and representative group. Fig 12 summarizes the locations of 
the tortoises infected with different TeHV3 strains. Tortoises infected with either genogroups 
A or B or the recombinant strain (C) were already present on the Swiss territory in 2000/2001 
and additional cases of tortoises infected with either A or B genogroups were observed during 
the following years, at least up to 2008. In contrast, no additional infections with the recombi-
nant TeHV3 strain were recorded (Fig 12).
 
 
Fig 12: TeHV3 phylogeography (Switzerland). Green dots show the geographic origin of the 
tortoises infected with TeHV3 genogroup A, whereas red dots correspond to the geographic 
origin of the tortoises infected with TeHV3 genogroup B. The blue dot shows the location of 
the only tortoise infected with the recombinant strain originated from putative homologous 
recombination between a strain from the genogroup A and one from the genogroup B. The 
year next to the respective color dot correspond to the time when the specific tortoise died of 
TeHV3 infection. Main borders of Switzerland and of the Swiss cantons are also shown in the 
figure along with the main lakes (http://d-maps.com/carte.php?num_car=24787&lang=de). 
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Discussion: 
The main goal of this research project was to fill a major gap concerning the biology of one of 
the most relevant viruses of reptiles, thereby providing new data to further investigate and 
better understand host-pathogen interactions in chelonians. This first example of a de novoas-
sembly of a chelonian herpesvirus revealed that the TeHV3 genome shares several common 
features with other known Alphaherpesvirinae including length, gene-content and overall ar-
rangement. The only other chelonian herpesvirus genome available to date is that of ChHV5. 
The two genomes share the overall arrangement and show the most similarities within the UL 
region. This is consistent with the findings of Alba et al. (2001) [55], with the most conserved 
gene blocks in the Herpesviridae spanning from the UL5 to the UL39 homologues. Despite 
the similarities between the two chelonian virus genomes, interesting differences were identi-
fied. For example, the two genomes appear to differ by approximately 18 Kb in length, with 
ChHV5 lacking several genes that were identified in TeHV3 [22]. The missing genes encode 
for proteins that apparently are dispensable for viral growth in vitro [22]. Among these are UL 
46, 47, 48, 49.2, 49.5 and 51, which encode for structural elements such as tegument proteins. 
The absence of these genes might be compensated by other genes with similar functions that 
are present in the ChHV5 genome. However, other genes present in TeHV3 and absent in 
ChHV5 might have more critical roles for TeHV3. These include genes encoding for enzymes 
such as seronine-threonine kinase (UL13) that is likely relevant for intracellular signaling and 
cell cycling, and a dUTP diphosphatase (UL50), which together with the small subunit of the 
ribonucleotide reductase (UL40) and the thymidylate synthetase (UL45) are important for de 
novo synthesis of DNA. UL 54 encodes for the homologous gene of HSV1 ICP27 a potent 
gene transactivator.  
Additionally, the lack of UL44 homologous gene encoding for the glycoprotein C (gC) in 
ChHV5 in comparison to TeHV3 might be critical for immune evasion. Glycoprotein C is 
known to bind to C3 and to inhibit virus neutralization [53]. 
The overall functional implications associated with the presence or absence of these genes in 
TeHV3 and ChHV5, respectively, are difficult to predict without the appropriate investiga-
tions. However, the lack of genes encoding for proteins relevant for the de novo synthesis of 
viral DNA and subsequently for viral replication, together with that of a major immediate 
early gene such as the homologue of ICP27 might help to explain some of the different fea-
tures of TeHV3 and ChHV5, including for example the failure to grow ChHV5 in cell culture 
or the distinct pathological changes caused by these two viruses: necrotizing lesions in tor-
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toises infected with TeHV3 and proliferative lesions of neoplastic nature in sea turtles in-
fected with ChHV5. Further in vitro and in vivo studies are necessary to explore the functional 
bases for these differences. The differences in gene content of TeHV3 and ChHV5 may be 
secondary to differences in co-evolution that might have occurred with their respective hosts. 
Chelonians are a group of vertebrates that has evolved into multiple families that have di-
verged over millions of years [56], with adaptations to very different environments such as 
dry land and oceans. The genus Testudo comprises several species commonly infected by 
TeHV3. This genus is part of the family Testudinidae, which includes tortoises, dry land che-
lonians whose appearance in the fossil record dates back to the late Cretaceous [57]. Tortoises 
of the genus Testudo are considered to have originated in the African continent and later 
spread into Europe [56]. Cheloniidae is one of the two families of sea turtles having members 
susceptible to infection with ChHV5. Of the Cheloniidae, Chelonia mydas and Caretta 
caretta are two species of sea turtles most commonly infected by ChHV5. The presumptive 
long-standing independent co-evolution of the two viruses with hosts with distinct anatomical 
and physiological adaptations to their native habitats, may partially account for the different 
content in genes between TeHV3 and ChHV5. More sequencing data including that of 
TeHV2, the only North American TeHV genotype known to date are needed to contribute to 
better understand the actual correlation and evolutionary relationships between Testudinid 
herpesviruses and ChHV5. Finally, the presence in TeHV3 (and the absence in ChHV5) of 
the homologous gene of UL45, which encodes for the thymdylate synthetase gene present 
only in HHV3-VZV among the Alphaherpesvirinae but common in Gammaherpesvirinae was 
an interesting finding. However, despite this common feature with a Varicellovirus, TeHV3 
does not appear to cluster in this genus. Furthermore, TeHV3 clusters closely to ChHV5, 
a Scutavirus. Their ancestors, the Americhelydae are believed to have originated in the North 
American continent during the Cretaceous [58], whereas their presence in the Mediterranean 
is considered to be more recent and occurred probably no more than 12,000 years ago [59]. 
No detection of ChHV5 has been yet reported in Mediterranean sea turtles. This suggests that 
it is unlikely that TeHV3 and ChHV5 might have diverged recently from a hypothetical com-
mon ancestor consistently with the results of the genome comparison (Fig 2). The novel ge-
nomic information described in this report is considered an important step to further illumi-
nate the host-pathogen interactions in chelonians. The sequencing of the TeHV3 genome has 
allowed for the identification of several homologous genes to those of well-characterized her-
pesviruses. 
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Among these, the gB gene is one of the most critical genes for herpesvirus infectivity given 
the role of its encoded protein in cell entry [39, 40]. Furthermore, gB is both relatively well 
conserved among herpesviruses and at the same time it is under a likely higher evolutionary 
pressure than the DNApol because of the direct pressure exerted by the host immune system 
eliciting the production of neutralizing antibodies [40]. These features convinced us to select 
the gB gene sequence (and translated aa sequence) as an ideal phylogenetic marker to attempt 
to increase the phylogenetic resolution power among the TeHV3 strains and potentially trace 
correlations between distinct TeHV3 genogroups and pathology phenotypes in tortoises. The 
phylogenetic analysis performed with the partial sequence of gB, showed unambiguously the 
existence of at least two distinct genogroups of TeHV3 strains, named A and B, respectively, 
which could not be detected when using the partial DNA pol sequence. The phylogenetic 
analysis performed on a highly variable region of the gB gene further highlighted this distinc-
tion. The localization of four of the five missense substitutions spanning across a relatively 
central portion of the gene (1521-1845nt; Figs 5 and 6) is of interest given that it does not 
have a correspondence in the homologue gene of the type species of Alphaherpesvirinae, 
HSV1. Comparing different HSV1 gB aa sequences (data not shown), aa changes occur either 
within the very proximal N- and C-portion of the protein. The crystal structure of HSV1 gB 
has recently become available and antigenic and mutational analysis suggests that several do-
mains spanning for most of the length of the protein ectodomain are required for virus entry 
[39]. The different clustering of aa changes occurring in TeHV3 gB might suggest a different 
arrangement of the most functionally relevant domains of TeHV3 gB than the HSV1’s homo-
logue. Similar distribution of the missense mutations is observed in ChHV5 strains. However, 
the specific functions of the different HSV1’s gB domains are not yet fully understood and 
more investigations are needed to understand potential functional differences between 
HSV1’s and TeHV3 gB. 
Most of the identified strains in the fatally infected tortoises investigated in this study be-
longed to group A and a smaller number clustered within group B, possibly suggesting that 
subgroup A is the most common of the two genogroups. However, a large sample size is nec-
essary to clarify this point. 
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A distinct third group (C), which was identified in a single tortoise, was shown to be the result 
of homologous recombination between members of the A and B genogroups consistent with 
co-infection of tortoises with both TeHV3 genogroups. To the best of our knowledge this is 
the first example of homologous recombination demonstrated in a chelonian herpesvirus and 
the first indirect example of multiple TeHV3 strain infection in tortoises. The gB-based phy-
logenetic analysis (either with aa or nt sequences) clustered the only detected TeHV1 strain 
together with TeHV3 genogroup A, suggesting that the phylogenetic relationships between 
distinct TeHVs might be more complex than previously considered and might be influenced 
also by homoplasy. Consequently, our novel genotyping method is complementary to the one 
based on the DNA pol, and we recommend for a more thorough and precise TeHVs character-
ization the following hierarchical approach: 1) identification of the TeHV genotype by se-
quencing of the partial DNA pol gene [33] and 2) identification of the TeHV3 genogroups 
based on the gB gene sequence. 
Within the limitations associated with the small sample size, we observed differences between 
the pathology phenotype associated with TeHV3 genogroups A and B infection. 
Specifically, TeHV3 genogroup B infection was associated with more frequent occurrence of 
intranuclear inclusions, viral pneumonia, vasculitis or perivasculitis and changes in the CNS 
than with TeHV3 genogroup A infection. These findings are suggesting of the existence of at 
least two subgroups of Testudinid herpesvirus responsible for different pathology. 
The putative recombinant strain between A and B subgroups showed intermediate patho-
genicity between the two. However, since this is based on a single isolate, further isolates 
need to be studied to confirm this observation. A transmission study carried out with both 
TeHV3 genogroups will be necessary to confirm the observations described above. 
An important contribution of this investigation is the indirect assessment of some anecdotal 
observations reported by veterinarians and tortoise breeders; which include tortoises develop-
ing clinical signs of herpesvirus infection primarily in the spring or late fall. These observa-
tions support circumstantial reports from veterinarians and tortoise breeders that die-offs of 
tortoises secondary to TeHVs infection mostly occur after the end or just prior to hibernation. 
Furthermore, a presumptive different sensitivity of different species of tortoises to TeHV in-
fection and/or disease has been suggested for the Mediterranean Hermann’s and Greek tor-
toise [14]. 
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Consistently, Hermann’s tortoises were overrepresented in our study group suggesting that 
this species is more sensitive to TeHV3. Further work is needed to substantiate these findings. 
In conclusion, we have successfully performed the first complete de novo assembly of a che-
lonian herpesvirus, providing fundamental genetic information to obtain greater insight into 
the biology of this virus and the host-pathogen interaction in an early diverging vertebrate lin-
eage. This enabled us to identify at least two distinct subgroups of the TeHV3 genotype and 
the distinct lesional profiles caused by these viruses in the tortoises examined in this study. 
This unearths new foundations for future studies on host-parasite resistance and infection. 
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Chapter 7: Testudo graeca immune response against Testudinid herpesvirus 3 
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Numerous infectious diseases have been documented in reptiles, however scant information is 
available concerning their associated immunological response. One of the most diffuse and 
lethal reptile pathogens is Testudinid herpesvirus 3 (TeHV3), a member of the subfamily Al-
pha-herpesvirinae. All species of tortoises (Testudinide) are considered susceptible to TeHV3, 
however the virus is overrepresented in the genus Testudo, which includes, among others, T. 
graeca, T. hermanni, T. marginata, and T. horsfieldii, which are popular pets in Europe. The 
occurrence of TeHV3-associated diseases is highest right after hibernation. 
The aim of this work is to partially characterize the immunological response to T. graeca 
against TeHV3. A bacteriophage library composed of about 5,000 clones containing genomic 
DNA fragments of TeHV3 was produced. Bacteriophages were amplified and were screened 
with TeHV3-seropositive sera from T. graeca. Phagemids were excised from the positive bac-
teriophages, sequenced, and compared with the TeHV3 genome to identify the encoding 
genes. Six different structural and non-structural proteins were initially identified as immune 
relevant. Phagemids of the positive clones were transfected into Vero cells, and the expres-
sion of the encoded polypeptides was assessed by FACS using T. graeca seropositive sera. 
From all six selected clones, only that expressing a partial sequence of the glycoprotein B 
(gB) showed an unambiguous positive signal in the FACS analysis. This result is consistent 
with the well-known immunogenicity of gB of other herpesviruses, including those infecting 
humans, and with the remarkable highly conserved role of gB in host-pathogen interaction 
across species and evolution. 
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Introduction: 
More than 130 herpesvirales have been documented to infect animals [1,2], and from them, at 
least 30 (̴ 39%) have been detected in reptiles. At least one herpesvirus has been detected in 
each of the reptilian orders, with the only exception of Ryncocephalia [3]. Herpesvirus infec-
tions in reptiles may be associated with either clinically undetectable forms [4,5] or with obvi-
ous diseases including neoplasia [6–8]. However, the most frequently associated findings with 
herpesvirus infections in reptiles are necrotizing [3,9,10] lesions. 
The classification of chelonian herpesvirus comprises different groups, including that of Che-
lonid herpesviruses [11–15] (ChHVs), [6,16–19] Testudinid herpesvirus (TeHVs), 
[3,4,9,10,15,20–26] Emydid herpesvirus (EmyHVs), [12,27] and Terrapene herpesvirus (Ter-
HVs) [8,28]. It is likely that the current taxonomy of chelonian herpesvirus will undergo ex-
tensive revision in light of the new genetic information currently accumulating in the availa-
ble databases [3,4,6,11,14,29–32].  
Testudind herpesviruses (TeHVs) include four distinct genotypes detected only in tortoises. 
Two of them, genotype 1 and 3, are considered of Eurasian origin and are currently the most 
diffuse and overrepresented in the genus Testudo spp. [3,9,10,21,23,24,30,31,42–45]. From 
the other two genotypes, TeHV2 has been detected only in the US, whereas TeHV4 is the first 
detected African genotype [3] and has been reported in an asymptomatic bowsprit tortoise 
(Chersina angulata) [4] and just recently in a leopard tortoise (Stigmochelys pardalis) with 
respiratory signs. [46]  
Of all TeHVs genotypes, TeHV3 has been associated with high mortality and morbidity in 
several species of tortoises, with Testudo hermanni being the most sensitive and T. graeca the 
most resistant to the viral disease [3,47–49]. Infected animals usually develop nasal discharge, 
mono or bilateral conjunctivitis, pneumonia and diphteronecrotic stomatitis and/or glossitis 
that, in most severe cases, can extend aborally involving esophagus and trachea. The histolog-
ical hallmark of herpesvirus infection is the presence of intranuclear eosinophilic/amphophilic 
inclusion bodies in epithelial cells of various organ systems and/or in neurons [3,46–48]. Re-
cently the entire TeHV3 genome has been sequenced, revealing the existence of at least two 
genogroups of this virus presumably associated with distinct pathology [14]. Furthermore, 
Gandar et al. [53] demonstrate the presence of three continuous genomic unique regions (UT, 
UL and US), two of which (UT and US) are flanked by inverted repeats. [53] The presence of 
inverted repeats near the two unique sequences suggests that TeHV3 may have four genome 
isomers differing by the orientation of UT and UL. 
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Despite the extensive work carried out on TeHV3 in the last 20 years, the limited knowledge 
available on reptiles’ immune system has restricted the possibilities to understand the dy-
namic of the infection and the mechanisms behind the host-pathogen interaction in this animal 
group [54–62]. For better understating of reptiles’ immune system, it is not only necessary to 
fill the gap in comparative immunology but also to implement immunological therapies in-
cluding vaccinations.  
The aim of our work was to investigate the tortoises’ antiviral immune response by evaluating 
the antigenicity of the whole viral proteome, using TeHV3 as model. 
To investigate the TeHV3 antigenic proteins we built a phage expression library starting from 
the whole genome of the TeHV3 type strain US1978/98. 
Phage display libraries have been widely used to investigate the host-pathogen interaction in 
human medicine. This technique allows to insert fragments of genomic DNA into bacterio-
phages that express the encoded proteins. [63] 
The library was screened with hyper-immune sera obtained from Greek tortoises infected with 
TeHV3 during a transmission study. [64] Here we show how this approach allowed the detec-
tion of a highly immunogenic viral protein, which could be considered for the development of 
future antiviral treatments in Chelonians including that of a vaccine. 
 
Materials and methods: 
Virus and genomic DNA: The TeHV3 strain US1978/98 [9] was grown on Terrapene Heart 
Cells (TH-1; ATCC-CCL 50 Sub-line B1; American Type Culture Collection, Rockville, MD, 
USA) according to an established protocol [14,25,65]. The TeHV3 genomic DNA was ob-
tained from the same strain similarly to what was previously described [14,25].  
Phage Library and DNA sequencing: 
Library preparation: The DNA fragments to insert into the bacteriophage were obtained ac-
cording to the manufacturer’s instructions. Briefly, distinct batches of US1978/98 genomic 
DNA were fragmented by restriction digestion with Sao3AI for different lengths of time. The 
digested DNA batches were then resolved in a 1% DNA agarose gel. The digested batch 
whose TeHV3 genomic DNA fragments ranged between 0.2 to 2 Kb was selected and the 
fragments were ligated into the bacteriophage genome using an auto-assembly bacteriophage 
kit (ZAP Express EcoR I/Xho I Library, Agilent Technologie, US).  
Phage amplification: The library was amplified according to the manufacturer’s instructions 
(ZAP Express EcoR I/Xho I Library, Agilent Technologie, US). Briefly, lambda bacterio-
phages containing TeHV3 genomic fragments were initially expanded infecting the E. coli 
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bacterial strain XL1- MRF (ZAP Express EcoR I/Xho I Library, Agilent Technologie, US). 
Bacteria were incubated with the bacteriophage suspension for six hours at 37°C while shak-
ing. Subsequently the suspension containing both bacteria and bacteriophages was mixed with 
LB-top-agar and overlaid on LB-agar in Petri dishes and incubated overnight at 37°C. The 
plates showing plaques of lysis were then overlaid with 8ml of SM buffer to harvest the bacte-
riophages. The buffer was subsequently recovered and stored at +4C. After that, the bacterio-
phage suspension was titrated by ten-fold dilutions, using the same procedure as described 
above to determine the optimal concentration of the phages to infect the bacteria.  
Sera collection: TeHV3 seropositive and seronegative sera samples were obtained from Greek 
tortoises (Testudo graeca) that were experimentally infected with either one of two strains of 
TeHV3 (US1978/98 and D4295/75) [65] or from spontaneously infected T. graeca.  
Library screening: Two consecutive screenings were performed on the bacteriophage library. 
In both XL1-MRF E. coli were infected with the selected suspension of bacteriophage as de-
scribed above and incubated at 37°C overnight. An estimate of the number of clones carrying 
a fragment of the TeHV3 genome was made by white/blue selection (Figure 1) carried out ac-
cording to the standard protocol. [65] 
Plates were then cooled for 1hr at +4° and drawn to properly orientate the membrane for the 
selection of the positive clones. 
Membranes were then immersed in blocking solution (TBS-T with 5% skimmed milk pow-
der) for 1hr at room temperature on a rocker. After that they were washed twice with blocking 
solution for 5 minutes each, and twice with PBS for 30 seconds each. In the first screening the 
membranes were incubated with hyper-immune tortoise sera from the first transmission study 
performed on TeHV3 by Origgi et al. [65]. During the second screening, the membranes were 
incubated in a mix of tortoise sera, composed of 50% hyper-immune serum from the trans-
mission study and 50% serum from ELISA positive, spontaneously infected tortoises. Sera 
were diluted 1:20 in the blocking solution for 1hr and washed as described above. A biotinyl-
ated mouse monoclonal antibody (HL1546) directed against the heavy chain of Testudo spp. 
IgY was used as secondary antibody [25] at the concentration of 1µg/ml in PBS. Membranes 
were incubated with the primary antibody for 1hr on a rocker at room temperature and then 
washed as described above. A mixture of 2 µl AP-Streptavidin (Zymed, 43-4322) and 2 µl of 
polyclonal antibody rabbit anti-mouse (Jackson ImmunoResearch, 315-005-003) diluted in 
1ml of PBS was then applied to membranes for 1 hour at room temperature. Following five 
washes of 10 seconds each with distilled water, membranes were finally stained with the 
chromogen substrate composed of 45 µl NBT (18.5 mg/ml nitro blue tetrazolium chloride) 
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with 35 µl BCIP (9.4 mg/ml 5-bromo-4-chloro-3-indolyl-phosphate) diluted in 10ml of SM-
Buffer (10ml 1M carbonate buffer + 10 ml 100mM MgCl2 + 980ml H2O). The chromogenic 
reaction was closely monitored for three minutes and then the membranes were rinsed 4-5 
times with distilled water and immediately dried with Whatman 3M paper (Sigma-Aldrich, 
US).  
Positive bacteriophages were punched out from the plate using a 20µl tip. These phages were 
amplified and stored at 4°C according to the manufacturer’s instructions (ZAP Express Predi-
gested Vector Kit and ZAP Express Gigapack Cloning Kits, Agilent Technologies). 
The positive clones from the primary screening were then expanded and tested again with hy-
per-immune tortoise sera similarly to what is described above. Following this, the selected 
clones were amplified in E. coli strain XLOLR to obtain the phagemids as described by the 
manufacturer (ZAP Express Predigested Vector Kit and ZAP Express Gigapack Cloning Kits, 
Agilent Technologies). Phagemids were then digested with SAO3AI to obtain the correspond-
ent TeHV3 genomic inserts and resolved in a 2% agarose gel. 
Sequencing: Each of the positive clones was then partially sequenced in order to determine 
the identity of the genomic insert. A mastermix was composed of 3µl of 10x PCR Buffer (Qi-
agen, Silicon Valley, USA), 0.4µl of dMTs, 2µl each of FW and RW Turboprimers (TriLink, 
San Diego, USA), 0.1µl of Taq (Qiagen, Silicon Valley, USA), and 21.5µl of DNA-RAN free 
water. Samples were then placed in a thermocycler (Thermofisher Inc., US) and amplified for 
the first time. The amplification program consisted of 3 minutes’ denaturation at 94°C, then 
35x amplification cycles subdivided in 30 sec. at 94°C denaturation, 30 sec. at 65°C annealing 
and 2 minutes at 72°C elongation, with a final extension of 10 minutes 72°C to exhaust the 
polymerase. Each PCR amplicon was submitted for automated Sanger sequencing (ABI Prism 
3700, Applied Biosystems) using the Big-dye terminator technology. Briefly, a master-mix 
containing 2l of Sequencing Buffer 5x (Thermofisher Inc., US), 0.5μl of either FW or RV 
Primer (10μM), 2μl of BigDye (Thermofisher Inc., US), 2 μl of DNA and ddH2O up to 10 μl 
was prepared. Sequencing was carried out using the same primers used for PCR amplification 
as described above. 
 
Fluorescence Activated Cells Sorting (FACS) Validation in VERO cells: 
Eukaryotic cell transformation: Extracted phagemid clones were used to transfect VERO 
cells. Briefly, 105 Vero cells were seeded in each well of a 6-well plate (TPP, Trasadingen, 
Switzerland) on the day prior to transfection. 
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The following day, one microgram of phagemid was mixed with 135μl of OptiMEM (Ther-
moscientifc, US) and 3μl of TransIT-LT1 (Mirus Bio LLC, Medison WI, US) in Eppendorf 
tubes. A single well was used for each of the tested phagemids. Tubes were incubated for 15 
minutes at room temperature. The suspension was then added to each well. Plates were gently 
mixed and incubated overnight at 37°C. Each phagemid was transfected in duplicate. 
Cell membrane fixation and permeabilization: One of the duplicates underwent permeabiliza-
tion, while the other did not. Initially, the cell monolayers of each well were fixed with cold 
(4°C) 10% buffered formalin for 5 minutes, directly into the well. Later, cells were chemically 
and mechanically detached by using PBS 0.5 mM EDTA incubated for 30 minutes at 37°C and 
sterile cells scrapers (TPP, Switzerland), respectively. Detached cells were collected in 10 ml 
Falcon tubes (TPP, Switzerland) and centrifuged at 300g for 15 minutes. After two PBS washes, 
cells were resuspended in 10ml PBS. The cells that underwent permeabilization were instead 
resuspended into a 0.2% Tween 20 PBS solution, and incubated at 37°C for 15 minutes. After 
permeabilization cells were pelleted at 300g for 5 minutes, and finally resuspended in PBS. 
 
Cellular staining: The same staining procedure was performed for both permeabilized and not 
permeabilized cells to evaluate the expression of intracellular and superficial proteins. Cell 
tubes were centrifuged at 300g for 15 minutes and resuspended in to 300l of DPBS with 15l 
of seropositive T. graeca serum (1/20). Tubes were incubated at +4C° for one and a half hours. 
After incubation, cells were centrifuged (300g x 15min), washed two times with DPBS, and 
then resuspended in 1ml DPBS with 0.1μl of primary antibody (HL1546 mouse anti turtle-IgY), 
and incubated for 1 hour at room temperature. The primary antibody was washed away as de-
scribed above. 
Later, a solution of 1ml DPBS with 0.5μl of secondary antibody (rabbit anti mouse, Jackson 
ImmunoResearch, 315-005-003) was incubated for 1 hour at 4°C with the cells. Following an 
additional wash, cells were resuspended in a solution of 1ml DPBS with 1μl of a green fluoro-
chrome anti rabbit (Alexia fluor 488, Thermofisher, US). Cells were incubated with a green 
fluorochrome anti rabbit (Alexia fluor 488, Thermofisher, US) for 1.30 hours and then centrif-
ugated (300g x 15 min), washed three times with DPBS, and resuspended in PBS.  
 
Results: 
Bacteriophage library screening and clone sequencing: 
The optimal working dilution for the bacteriophage suspension was determined to be 10-3. 
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The initial screening of the phage library carried out with hyperimmune sera obtained by ex-
perimentally infected Greek tortoises [64] revealed 16 positive out of approximately 5,000 
clones, accounting for 0.32%. 
A second screening carried out on each of the amplified clones confirmed the positivity 
of clone 1 and 6 (12.5%), whereas all the other clones were negative and were considered as 
false positives.  
Clone 1 contained a 1.8 Kb long DNA fragment corresponding to the entire gene of the ribo-
nucleotide reductase and to a partial sequence of the major capsid protein encoding gene of 
TeHV3. Clone 6 contained a 2.3 Kb long DNA fragment corresponding to the partial se-
quence of the glycoprotein B encoding gene.  
The initially positive 16 clones were screened a second time by using a mix of both experi-
mentally and spontaneously infected Greek tortoise sera. Among the 16 tortoises, 6 tested 
positive (37.5%), but only 5 carried a DNA insert (Figure 2).  
Clone 1a contained 2 Kb of DNA containing part of the large sub-unit of ribonucleotide re-
ductase and a fragment of the tegument protein genes. Clone 1b contained 2 Kb of DNA en-
coding for a partial sequence of the glycoprotein B gene. Clone 3 contained 500 bp of DNA 
encoding for part of the envelope protein gene. Clone 6 contained 300 bp of DNA encoding 
for a fragment of the immediate early 2 gene. Clone 7 contained 600 bp of DNA encoding for 
a part of the uracil DNA glycosylase gene (Figure 1). 
  
 
Figure 1: Immunoblot nitrocellulose membranes of the six selected clones. For each clone, 
positive sample and negative controls are shown. The criteria used to determine if the reaction 
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was a true or a false positive was the presence of a marked difference between the reaction in-
tensity, and stain size and definition compared with the negative control. Clone 2, which 
shown a strong immunoblot positivity, was then empty at sequencing.  
 
Eukaryotic cell transformation and FACS: 
The clones that were confirmed positive during the second screening were then selected for 
expression in Vero cells. Expression of the partial sequences of the genes carried by the posi-
tive phagemids was assessed by FACS analysis (Figure 2).  
 
 
 
Figure 2: Fluorescence level detected via FASC in gB sample (left) and in gB negative con-
trol (right). Although the difference is minimal, all the other positive samples showed a fluo-
rescence pattern similar to the detected for negative control, making this a significant differ-
ence.  
 
We considered that in order to validate the selected clones, it was necessary to test them in a 
different setting to that used initially, in order to provide an independent second line of evi-
dence for our results. 
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Discussion: 
This work aimed to start evaluating the host-pathogen interaction between Testudo graeca 
and TeHV3 by investigating the most relevant immunogenic proteins of this virus. 
The viral proteins were expressed in bacteria using a bacteriophage display library, and sero-
logically screened using hyperimmune Testudo graeca sera obtained from a transmission 
study [64]. Phage library is a molecular technique widely used to investigate infectious dis-
eases in human beings [66] and occasionally in veterinary medicine [67,68]. Phage displays 
have been used with pathogens of different mammals [67], birds [68] and fish [69] species, 
but this was the very first time they were applied to reptiles. The most relevant result obtained 
was the identification of the glycoprotein B as an immunogenic protein in TeHV3. 
Among the herpesviruses, the most antigenic proteins identified both in human beings and an-
imals [29,70,71] are the major tegument protein (UL37) and the family of the glycoproteins 
[72]. Glycoproteins are a class of capsidic proteins involved in the attachment and entry of vi-
ral particles into the host cell [73]. Three major classes of glycoproteins have been identified 
(B, D and G) and all of them seem to have a crucial role in the infection of the host cell by the 
virus [74–76]. Among the glycoproteins, gB is considered a relevant and highly conserved 
immunogenic molecule in herpesvirales [77,78]. Our results also confirm the role of this pro-
tein in a very ancient herpesvirus like TeHV3, as previously suggested by Origgi et al. [14]  
Furthermore, the identification of gB can be considered an internal control, demonstrating the 
effectiveness of the phage display library in reptiles. The immunological role of gB, along 
with its genetic structure, shed light on the phylogenetical origin of the herpesviruses and 
their evolution. The key role of gB in the immune response of Testudo graeca against TeHV3 
can have both diagnostic and clinical implications. The discovery of the immunological role 
of gB, in association with knowledge of the gB sequence, open the door to develop new and 
more specific tests, and potentially to vaccination. Different diagnostic tests have been devel-
oped to detect TeHV3 in living tortoises [3], among which ELISA is the most commonly 
used. The actual ELISA protocol to detect TeHV3 [25] has been demonstrated to cross react 
with TeHV2 [21], thus not providing a sufficient specificity level. Furthermore, recent studies 
on the TeHV3 genome have demonstrated the presence of at least two subtypes of gB corre-
lating with different level of lesion severity [14]. New diagnostic tests based on the recogni-
tion of gB isotypes will more specific and will provide more clinical information. The chance 
to clone gB might also be used to develop a vaccination, protecting the animal from the infec-
tion or reducing the clinical signs of the disease. Even if the use of gB based vaccinations 
have failed to protect human beings, they might protect against more ancient herpesviruses 
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with a potentially lower recombination rate compared to the human herpes simplex or cyto-
megalovirus, against which gB based vaccinations have been tested [77–79]. However, there 
is no information available about the possible response of reptiles to vaccination. 
During this experiment, other five proteins were serologically detected as immunorelevant, 
but were negative to the FACS.  
The expression of the selected clones in a eukaryotic system implies the glycosylation of the 
residues to the candidate immunogenic peptides, which differs to what occurs in prokaryotic 
systems. Glycosylation was expected to closely reproduce the native state of the viral peptide, 
providing more informative data concerning the actual antigenicity of the candidate peptides. 
Transfected cells were tested either with or without cell membrane permeabilization. Unam-
biguous positivity was confirmed by FASCS analysis only for the surface expression of clone 
1b, encoding for the partial sequence of the gB gene (Figure 3). No other clones showed con-
vincing positive signals, despite cell permeabilization, increased amounts of transfected DNA 
phagemids, prolonged expression time of the transfected cells, or the use of other fluorescent 
dyes. 
The expression of the proteins in eukaryotic cells may have led to conformation changes not 
allowing allostery binding of the antibody to the protein, with consequent misdetection. How-
ever, the possibility of false positives has to be considered, and the proteins should be retested 
using a different technique. 
This is the very first study evaluating the immunological response of reptiles against viruses 
and the host-pathogen interaction. As previously demonstrated in other herpesviruses, the gB 
represents an immunologically important antigen, based on which new diagnostic tools and 
vaccinations can be developed. 
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New insights 
Introduction: 
The final objective of this work was to develop a possible oral vaccination against TeHV3. 
Although different attempts have been made to produce herpesvirus vaccines using gB in hu-
mans, better results were obtained with animals. Although complete viral neutralization was 
never obtained, a sensible reduction in the viral load was evident [1,2] 
Basing on our previous results (see section "initial assessment") and literature, gB was the 
ideal target for this purpose. We would like to generate this vaccination by knocking out all 
other sequences in the original phagemid we created with the phage display library (see mate-
rial and methods of initial assessment), leaving only the phagemid and gB sequences. Trans-
formed bacteria cells should be able to express gB on the surface, for this reason the gB se-
quence has to be glycosylate. Engineered phagemid will be used to transform bacterial cells 
that could be orally administered to tortoises. 
Material and methods: 
Sequencing: 
Standard Sanger sequencing was used to sequence FMP1 (the phagemid containing the gB se-
quence). Briefly, two sequencing tubes, containing 0.5 ml of turbo primers (TriLink biotech-
nologies, Sandiego, CA), one tube reverse and one tube forward, and 1l of DNA at 70ng/l, 
each Mastermix (Thermo Fisher, Switzerland) solution was added to each of the tubes to 
achieve a total volume of 50l. 
Samples were first amplified with a standard thermocycler according to the following pro-
gram: 
 
Denaturation 96°C 10 seconds 
25x Anealling 55°C 5 seconds 
Extensions 60°C 1 minute 
Elongation hold 8°C Infinite  
 
The PCR product was then centrifuged at 4500 RPM for 40 minutes at +4°C. At the end of 
centrifugation, the tubes were poured over a blot sheet to be emptied. A second centrifugation 
was performed at 1000 RPM for 1 minute. The tubes were let to dry in the air for 30 minutes 
and sent for sequencing. The results of the sequencing were evaluated with SnapGene Viewer 
(V. 3.3.4). 
 
pag. 179 
 
 
Enzymatic restriction of FMP1: 
5l of FMP1 was mixed with 1l DnpI (Promega, Madison, US) and 6l of enzyme buffer. 
The reaction mix was incubated at 37°C for two hours, not shaking. The incubation product 
was loaded on 2% agarose gel to check for the presence of restriction fragments.  
 
PCR knock-out of FMP1 (direct site mutagenesis PCR): 
A reaction mix composed of 3l of 10x Buffer, 0.4l dNTPs, 0.2l reverse primed, 0.2l for-
ward primer, DNA polymerase 1l, 0.2l of FMP1, and 25l of water was prepared.  
Primer sequences for gB knock-out were: 
- Reverse: AAA TTA ACC CTC ACT AAA GGT TAT AGT TCG GTG CGA ACGT 
- Forward: ACG TTC GCA CCG AACTAT AAC CTT TAG TGA GGG TTA ATTT 
The following cycling program was set on the thermocycler: 
 
Initial denaturation 94°C 3 minutes  
Denaturation 94°C 30 seconds 
18x Anealling 45°C 1 minute 
TestudoExtensions 68°C 9.30 minute 
Enlongation 68°C 10 minutes  
Elongation hold 8°C Infinite  
 
PCR products were run on a 1.5% agarose gel. 
 
Agarose gel extraction: 
Gel extraction was carried out according to the extraction kit guidelines (MinElute Gel Ex-
traction kit, Qiagen Hombrechtikon, Switzerland).  
 
Bacterial cell transformation: 
To perform bacterial cell transformation, XL-1 blue and DH5 E. coli cell strains were used. 
Both commercially available and home-made competent strains of XL-1 blue and DH5 were 
used during the transformations. Blue commercial (Chem-Aligent, Switzerland) and home-
made XL-1 carried Tetracycline resistance. Ampicillin resistance was carried by both com-
mercial (Thermo Fisher, Switzerland) and home-made DH5 strains.  
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The transformation procedure was as follows: 
- Take cells from -80°C and place them on ice for 5-10 minutes. 
- Add one microliter of FMP1 to each tube and incubate on ice for 30 minutes. 
- Immerse in warm bath at 42°C for 45 seconds. 
- Incubate on ice for 2 minutes. 
- Pour the tube content into a Falcon round bottom polypropylene tube (Fisher scientific, 
Reinach, Switzerland) containing sterile SOC medium. 
- Incubate Falcon tube at 37°C for 2 hours. 
- Mix 20l of appropriate antibiotics with 80l of incubation product. 
- Gently spread the content on an LB-agar plate. 
- Incubate overnight at 37°CAgarose gel extraction. 
- Collect and amplify single colonies.  
 
pET30C+ plasmid ligase reaction: 
Newly obtained DNA fragments from gel extraction were transferred to a cloning vector 
called pET30C+ (EDM Bioscience, USA). 
Two different protocols were used in this reaction: 
- 5 microliters solution with 1 microliter ligase mixed with 5 microliters fast ligase buffer. 
The reaction was incubated for 3 hours at room temperature. 
- 5 microlites solution with 1 microliter ligase with 3 microliters buffer. The reaction was car-
ried out overnight with +4C° (fridge) incubation.  
 
Mini- and Midi-preps: 
Procedures were carried out as described in the “initial assessment” material and methods sec-
tion of the previous work.  
 
Results:                                                          
Sequencing:  
Sequencing produced the following sequence:  
TAAAACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGAATTGGGTA 
CACTTACTGGTACCCCACCCGGGTGGAAAATCGATGGGCCCGCGGCCGCTCTAG 
AAGTACTCTCGAGAAGCTTTTTGAATTCTTTGGATCCACTAGTGTCGACCTGCAG 
GCGCGCGAGCTCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTTCGAGCTTGGCGT 
AATCAAGGTCATAGCTGTTTCCTGTGTGAAATGTTATCCGCTCACAATTCCACAC
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AATATACGAGCCGGAAGTATAAAGTGTAAGCCTGGGGTGCCTAATGATGAGCTA 
ACTCAC AGTAATTGCGGCTAGCGGATCTGACGGTTCACTAAACAGCTCTGCTTA-
TATAGACCTCCCACCGTACACGCCTACCGCCCATTTGCGTCAATGGGGCGGAGT 
TGTTACGACATTTTGGAAAGTCCCGTTGATTTTGGTGCCAAAACAAACTCCCATT-
GACGTCAATGGGGTGGAGACTTGGAAATCCCCGTGAGTCAAACCGCTATCCACG 
CCCATTGATGTACTGCCAAAACCGCATCACCATGGTAATAGCGATGACTAATACG 
TAGATGTACTGCCAAGTAGGAAAGTCCCATAAGGTCATGTACTGGGCATAATGC 
CAGGCGGGCCATTTACCGTCATTGACGTCAATAGGGGGCGTACTTGGCATATGAT 
ACACTTGATGTACTGCCAAGTGGGCAGTTTACCGTAAATACTCCACCCATTGACG 
TCAATGGAAAGTCCCTATTGGCGTTACTATGGGAACATACGTCATTATTGACGTC 
AATGGGCGGGGGTCGTTGGGCGGTCAGCCAGGCGGGCCATTTACCG-
TAAGTTATGTAACGCGGAACTCCATATATGGGCTATGAACTAATGACCCCGTAAT 
TGATTACTATTAATAACTAATGCATGGCTTATCTTCAGCGTGTTCCTGATCGAG-
TAGCCACCGAACAAAAACACATGCTGGAGGAGACTAGAAAATGGGTCGGCTCTC 
AGTTTATCGAGGAACTCTTGGTTCTGGACGATCAGTGCCGTGAGCCTATTTTTAA 
ACCGTATGCGGCTACAAAATTTTCCACGGTGTTTGAACAATCAGAGGAGATTAA 
AGATCCTGTGATCAAGGGAAGAACGTTTTTCGGTAGCTTTAAGATGGGTGGAAG 
TAAAGGAAAAAGGCGGAGCGTTTGTAAATAAAAACACCGTGTGTTTCTGTAGGA 
CTCATTCTCTTAGAGATGGCGAGGGTACGCGAACGCATAGACGTCTTGTATCGGA 
CGCCCAGGAATTTGACAGGACATGGTGTCATGGAAGGCAATTATGCCATCGCAT 
GCAAAACCATAATGTCTAACTACGGAGAAAATAACCCTCAGGATGTTACCTT-
GGTTCTGAGTGCGTAGGAGGCGATCGATTGGCGGTTATCAATATACCATCCCGTC 
ATCGCCTGGACTTTACCAACCCCAAGGTAGGACTTTTGAAGGCCGTGCCTCGCT 
TTCCCGACTACTGCGGACTGCTCTGCGAACATCTGGTATCCCACGCAGTCAATGG 
ACATTGCCGGGACGACGCATGTGTGGTGTGTCTGGAAGTCGACTATCCTTTCTG-
GAACCACCATTACGCCGTGAAGGATCTGGTCAGGGAAAACTACGGACGACTCTG 
GGCCATACCACAGCTGCATTCTCATAGGACCGTCGCCTTAGAGGTAAATGAC-
CTCTGTAAGGCGATGGATGGTGCAGAACATTGGTTTCTCACCGGAATTCCCCTGC 
TGGAATATCACCGCTCGGTGAGAGCCTATTTGCAGATACAGGAGATGTGTGAG-
GAACTGAAGAGGTATTATTATGGGATGATTCATTTAACCCATTGGTTCTACGAAC 
TGACCATCGAAACGATAATGTTCGTGGACAAGAAGCGCGGTCCTCCGACCAGCA 
CCCTGTTAGATCGAATGCCACACACTTGGACCCAGAGGATTATTTCTCTTTTGG-
TAGACATTATCTGTCCGGGATATTTCGTCTACGTATTTTACTCCAACGTGTTCATC 
AACGGAGACTTCTTTGTTCACTTATTTGATGAAAAGGAGGTCGGTGTTTAATGGT 
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CTCGTATATCTTTTTTGTATCGATGATGATGTACGTAGCGGGTATTATTTATGATA 
CCATCGATTTCGTAGCTCCTAGGCTGTGGACCTACGCAATTCTAAATATACCC 
ATCTGTTACTAAATAAAAAGACATATCAAAAAGCTGTGCTCAGTGTGGTGAT 
CTGGGTGGAAAACCTCTGGAAAATACCAAAAAATGCATCTATAAACCGACGAG-
TCATTTATCCGACGAGAATCTGGCCATGGAAGACTCTATTAACCAAATTACGGTG
ATTATGGACAACAGCAGTCATCTATTGATGTTCATCATTCTAGAGGGTTCTCTTCT 
GTTAACGTGCTTGGCAAGTTTAGAGTACGCAGATTCGCGCAACAGAAATTAC-
GTTGTGCCGGCGGTACTGGGCAACGCTTTGATTTTTTATTTTGGTTGTTGTGGGG 
CCATAGTTTATTATTACTGTTGGCAACACAGACAAGCTAATATCGTTAGATGGG-
TAGTGTTTATCATAAGCCTGATAGCTAACGTAGACATGTGTATCATGGCAGCA 
TATTTACCCCAGTACTATTTCATCGAATTGCCTATGTTATTGACCGCAATTTTTG 
GATTGTACACCACCCTGGTAATCAGAAAAACCGTGAAAGATCCGTTCGATGCT 
GCCGCCGAAAGCGGAATTGGTCCAGATCCGGAACCGTTCTTAGAATTAGTGTC 
AGAAACATTCGCGATAGATAGCGAATGCAGAATTTGTTCCATGCTGGAACTTTT 
TCGGAAAGCTCGAGTTCAGAAGGTCGAATGGTTTTTAGATTATATCGC GTTATG 
TAGGAAATGTCTAGCCGCCCCTTTGTGCGCCACTTCCACCTTCATAACCGCGTTCG 
AATTTGCCTACATCATGGAAAAACATTATAGCGAACAGGATGGTATTACCGTAA 
TTGGGGTATACAGTAATCGGATGATTTCTGTAAATGACATCCAAAAACATTTTTA 
CATACACTGTTGTTTTAAGACCAACGACGGGGTAGTGGGAAAGATCGGGCTAAC-
CAATCAACGCACACGGTAGTTCAGGTGGCCCAACCCACAACGTTCGCACCGAAC 
TATAATACTATATAACTTATTATAATATAATAAGAAGGTGCGAACGCTG-
GATCGAGTCAGTTCGTACAGCAGCTTTTCTCCAAATTCAATATACGTACGATA 
AACTGCAAGCTCATAACAACGCCATGTTCTCTCGTATCGTATACGCTTGGTGC 
GAGTTACAAAATCGAGACATAACCATGTGGGAACAATTAAATAAAATAAATC 
CCTCGGCGGTCATGTCCGCCATAATGAAGCGTCGCGTTTCGGCCAAAAAATTGG-
GAGACGTGGTGGCCGTTTCCGACTGTTTAACTATTCCCAGGAACAATGTCCGTCT 
CATCAATTCCATGTATATCACCAAGGGAAATTTG TAGGTAGCGGTGTGTGTTATA 
GCCGTCCGTTGGTAGTTTATACATTCGGAAACAGTACCGAAAGCCTCTATGG 
TCATCTGGGAGAAAATAATGAAATCATCCCTTACGTGGGATTGACGGAAAACT 
GCGAGCCAAAATCCAGGAAACTGTTTCTTTACGAGAACGCATATATGCTGTAT 
GAGAACTATAATTTTGTTAGGATGGTTCCATTAACCGACATCCCAGAAGTAAGCA 
CGTATATCAATCTCGATCCACTAGTGTCGACCTGCAGGCGCGCGAGCTCCAGCT 
TTTGTTCCCTTTAGTGAGGGTTAATTTCGAGCTTGGCGTAATCAAGGTCATAGCTG 
TTTCCTGTACGCCAGGGTTTTCCCAGTCACGA CGTTGTAAAA CGACGGCCAGTG 
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AATTGTAATACGACTCACTATAGGGCGAATTGGGTACACTTACCTGGTACCCCAC 
CCGGGTGGAAAATCGATGGGCCCGCGGCC GCTCTAGAAGTACTCTCGAGAAGCT 
TTTTGAATTCTTTGGATCCCAATAACGCATAATGCTACATTTCTCATCTCTTCTG-
CACCCCTGGTAAGAGCGGTGAC ATTCCCGGTGGGTGATACGGTAGTTAGCTCCC 
CTCTATATGTTTCATTCGTCAACCGGACCTGCATCCCTAGCCGACG ATTGATTGG-
GACTAATGAAATAAGAAGTAAT TTCGAACTTCGAACAGATCATTCAGTCTGTT 
CTGTATGTGGGGTAGTGATCTTGAGACCCTTGAAGCTACTCAACAACATGGCTAT 
CAGAGGGACCAAAAACCAAGTTTTTCCATGTCTACGAGGCACCAAAAACACGGT 
CGTGCGTTGCTTAAAATGTTTTAAAATATTATTTGTGAAATAAAGATTGTTGAAC 
ATATTTTTGAGAAACGAGTCAGTTTTTTCAGCGTGTTCCCGCATGTAAATACTGGC 
CGTAAAATACGTGGCGTGCATCAATATCATCTTTTGAAAAAGTTCCAAATATGCC 
TTTTTACGATTCGAGACCCCGGTATGATCCTCTTCTAACCACGTGCATATAACAGG 
TTCTATACAGTCATATAGACTGACATTGTTTGTGGAGTGATGAGATATATCTTCT 
CGTAATACCCTTAGACAGTACCAATATTGCTTGATCGTATAATGTATTTATCAATC 
CGTTCTGGTTCGTCTCTAAGTTCGGACCTTCCGAAAAGTCCCTGGTGGTGGCGAT 
GAGGTATTATCTT TTGGACTGTACGTTTGACAAATTCGGTTCCGGATTCGTACGA 
TCCTGGCGTCGACACTGAGTGTTTGGTATCCTTTGAGCGGCTACGACAAATATA T 
GCCCCTCTGACACTGATACCCACGAAGAGAGCATGGGAGTGACTTTATTGAAGG 
ATAATCAATGTCGGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAA 
AGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCG 
TTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGAC-
GCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTC
CCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGA-
TACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTG 
TAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAA 
CCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA 
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTA 
GCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAAC-
TACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTA 
CCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTA 
GCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCT 
CAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAAC 
TCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCC 
TTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAACCTGA 
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GGCTATGGCAGGGCCTGCCGCCCCGACGTTGGCTGCGAGCCCTGGGCCTTCACC 
CGAACTTGGGGGGTGGGGTGGGGAAAAGGAAGAAACGCGGGCGTATTG 
GCCCCAATGGGGTCTCGGTGGGGTATCGACAGAGTGCCAGCCCTGGGACCGA 
ACCCCGCGTTTATGAACAAACGACCCAACACCGTGCGTTTTATTCTGTCTTTTTAT 
TGCCGTCATAGCGCGGGTTCCTTCCGGTATTGTCTCCTTCCGTGTTTCAGTTAGC 
CTCCCCCTAGGGTGGGCGAAGAACTCCAGCATGAGATCCCCGCGCTGGAGGAT 
CATCCAGCCGGCGTCCCGGAAAACGATTCCGAAGCCCAACCTTTCATAGAAGGC 
G GCGGTGGAATCGAAATCTCGTGATGGCAGGTTGGGCGTCGCTTGGTCGGTCAT 
TTCGAACCCCAGAGTCCCGCTCAGAAGAACTCGTCAAGAAGGCGATAGAAGG 
CGATGCGCTGCGAATCGGGAGCGGCGATACCGTAAAGCACGAGGAAGCGGTC 
AGCCCATTCGCCGCCAAGCTCTTCAGCAATATCACGGGTAGCCAACGCTATGTCC 
TGATAGCGGTCCGCCACACCCAGCCGGCCACAGTCGATGAATCCAGAAAAGCGG 
CCATTTTCCACCATGATATTCGGCAAGCAGGCATCGCCATGGGTCACGACGAGA 
TCCTCGCCGTCGGGCATGCTCGCCTTGAGCCTGGCGAACAGTTCGGCTGGCGCGA 
GCCCCTGATGCTCTTCGTCCAGATCATCCTGATCGACAAGACCGGCTTCCATCCG 
AGTACGTGCTCGCTCGATGCGATGTTTCGCTTGGTGGTCGAATGGGCAGGTAGCC 
GGATCAAGCGTATGCAGCCGCCGCATTGCATCAGCCATGATGGATACTTTCTCGG 
CAGGAGCAAGGTGAGATGACAGGAGATCCTGCCCCGGCACTTCGCCCAATAGCA 
GCCAGTCCCTTCCCGCTTCAGTGACAACGTCGAGCACAGCTGCGCAAGGAACGC 
CCGTCGTGGCCAGCCACGATAGCCGCGCTGCCTCGTCTTGCAGTTCATTCAGGG-
CACCGGACAGGTCGGTCTTGACAAAAAGAACCGGGCGCCCCTGCGCTGACAGC 
CGGAACACGGCGGCATCAGAGCAGCCGATTGTCTGTTGTGCCCAGTCATAGCC 
GAATAGCCTCTCCACCCAAGCGGCCGGAGAACCTGCGTGCAATCCATCTTGTTCA 
ATCATGCGAAACGATCCTCATCCTGTCTCTTGATCGATCTTTGCAAAAGCCTAGG 
CCTCCAAAAAAGCCTCCTCACTACTTCTGGAATAGCTCAGAGGCCGAGGCGGCC 
TCGGCCTCTGCATAAATAAAAAAAATTAGTCAGCCATGGGGCGGAGAATGGGCG-
GAACTGGGCGGAGTTAGGGGCGGGATGGGCGGAGTTAGGGGCGGGACTATGGTT
GCTGACTAATTGAGATGCATGCTTTGCATACTTCTGCCTGCTGGGGAGCCTGGG-
GACTTTCCACACCTGGTTGCTGACTAATTGAGATGCATGCTTTGCATACTTCTGCC
TGCTGGGGAGCCTGGGGACTTTCCACACCCTAACTGACACACATTCCACAGCTG 
GTTCTTTCCGCCTCAGGACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGG 
GTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAAT 
AGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGCGCCCTGTAGCG 
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GCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTT-
GCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTC
GCC GGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGAT-
TTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCAC 
GTAGT GGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCAC-
GTTCTT TAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTC 
GGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAA 
AATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCT 
TACAATTTAC GCGTTAAGATACATTGATGAGTTTGGACAAACCACAACTAGAA 
TGCAGTGAAAAAAATGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTA 
ACCATTATAAGCTGCAATAAACAAGTTAACAACAACAATTGCATTCATTTTATGT 
TTCAGGTTCA GG GGGAGGTGTGGGAGGTTTTTTAAAGCAAGTAAAACCTC-
TACAAATGTGGTATGGCTGATTATGATCATGAACAGACTGTGAGGACTGAGGG 
GCCTGAAATGA GCCTTGGGACTGTGAATCTAAAATACACAAACAATTAGAATC 
AGTAGTTTAACA CATTATACACTTAAAAATTGGATCTCCATTCGCCATTCAGGCT 
GCGCAACTGTT GGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCA 
GCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGG 
GTTTTCCCAGTCACGACGTT. 
Evaluation with SnapGene© demonstrated that the gB sequence was antisense compared to 
the plasmid ORI, as demonstrated in Figure 1.  
 
 
Figure 1: FMP1 sequencing results. gB (red) in antisense compared to the phagemid ORI. 
However, other two forward sequences are present in the scheme (green), TE17 and UL15. 
Legend: FW = forward and RV= reverse. 
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Enzymatic restriction of FMP1: 
DpnI enzymatic cutting produced different fragments among which gB, TE17 and UL15 were 
present as shown in Figure 2 (SnapGene Viewer). Fragments were run in a 2% agarose gel 
and extracted according to migration height, basing on the DNA sequence molecular weight. 
 
 
Figure 2: Fragments compatible with gB, TE17, and UL15 size were extracted from the origi-
nal phagemid and inserted in new plasmids, which were used to transform bacterial cells 
(SanpGene viewer V4.0.3). 
 
PCR knock-out of FMP1 (direct site mutagenesis PCR): 
Like the enzymatic restrictions products, PCR products resulting from direct site mutagenesis 
were also used to transform bacterial cells.  
 
Ligase: 
gB, TE17, and UL15 fragments obtained from FMP1 were inserted in the new cloning vector 
using a standard ligase procedure. Bacteria were than transformed using the procedure de-
scribed in material and methods.  
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Bacterial cell transformation 
Although numerus attempts were made to transform bacterial cells with FMP1 knock-out, no 
viable bacterial cells were obtained.  
To increase the transformation chance, fragments were transferred into a new cloning vector 
(pET30C+). Using this cloning vector, some viable colonies were obtained (Figure 2). Alt-
hough colonies were identified on LB-ampicillin plates, multiple attempts at mini- and midi- 
prep extraction of the plasmids were unsuccessful.  
 
 
Figure 2: LB-Ampicillin plate with multiple E. coli colonies transformed with pET30C+.  
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Discussion: 
The sequencing results demonstrate that gB was actually antisense and could not be expressed 
during eukaryotic cell transformation. However, two other sequences were consensus to the 
plasmid origin of replication (ORI) and might be responsible for the results obtained in the 
“initial assessment” part. Still, the immunogenic role of gB could not be excluded. To better 
complement the immunogenic nature of gB, TE 17 and UL15 we knocked out all the genes 
individually. No viable colonies were obtained with enzymatic restriction of PCR mutagene-
sis using FMP1 as template. Taking the overall size of the plasmid into account, we consid-
ered that this might be the cause of the unsuccessful bacterial transformation. To reduce the 
size of the plasmid we opted to use pET30C+ as cloning vector (Figure 3).  
 
 
Figure 3: Schematic representation of TE17 and UL15 extraction from FMP1 and insertion 
into the new cloning vector pET30C+.  
 
With pET30C+ we were able to obtain viable colonies. Although the presence of viable colo-
nies, both mini- and midi-prep techniques failed to retrieve transformed pET30C+ from the 
selected colonies.  
Despite numerous attempts we were never able to understand why colonies without the insert 
were able to grow on antibiotics with added LB. To increase selectivity, we also tried to in-
crease the amount of antibiotics, still having the same issue.  
We are still working on troubleshooting the problem.  
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Conclusions 
The present work aimed to: 
1) Identify the presence of Testudinid herpesvirus in Italy 
2) Genetically characterize Testudinid herpesvirus 3 
3) Start to describe the host immune response against Testudinid herpesvirus  
The chelonian herpesvirus represents a threat to captive bred and wildlife turtles and tortoises 
worldwide. 
Although many studies have attempted to develop detection methods and understand the path-
ogenesis of these viruses, important information such as the distribution, prevalence, inci-
dence, viral biology, and host-pathogen interaction is missing or incomplete. 
According to the literature, worldwide distributed chelonian herpes viruses are the Chelonian 
herpesvirus 5 in Caretta caretta and Chelonya mydas, Testudinid herpesvirus 2 in American 
desert tortoises, and Testudinid herpesvirus 3 in Mediterranean tortoises, but the specific host-
pathogen distribution is limited. 
In Europe, turtles and tortoises are common companion animals. As a consequence, tortoises 
of different breeds are extensively bred and traded within Italy or with other European coun-
tries and constitute a relevant economic income. 
Although chelonian herpesviruses are anecdotally reported as a common cause of death in 
chelonians, evidence of mortality related to herpesviral infections, correlated with disease 
prevalence and incidence, is only reported in a few studies, among which only two were per-
formed in Europe. 
In the present study, numerous terrestrial tortoises and freshwater turtles from northern Italy 
were examined to identify the presence of chelonian herpesviruses in Italy, in both a prospec-
tive and retrospective way. All of the evaluated TeHV-positive cases except one were positive 
for Testudinid herpesvirus 3, which is the most common chelonian herpesvirus in Italy. The 
only TeHV-positive animal that was negative for TeHV3 was a retrospective Testudo hors-
fieldii, which was positive for TeHV1. 
The identification of the TeHV3 genotype in Italy is in agreement with previous studies per-
formed in the United Kingdom and Spain; in addition, the prevalence of this virus as evalu-
ated via PCR was similar. This suggests that, throughout history, there might have been a ho-
mogenous distribution of the virus in Europe that was probably secondary to the reptile trade 
and the release of pet reptiles into the wild. 
The serological prevalence of TeHV3 in Vanzago's tortoises was extremely high and could 
not be compared to any other prevalence evaluated in other studies. According to our opinion, 
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the prevalence was so high because of the management of the animals. Turtles and tortoises 
were introduced into the Oasis without any previous clinical examination, quarantine, or 
TeHV testing. Furthermore, even though no clinical abnormalities were detected during the 
periodic check-ups, quarantine of the affected animals was not possible due to the limited 
space available; this promoted the spread of the virus. 
In Italy, wildlife rescue centers are nationally recognized and funded structures that are ac-
tively involved in wildlife conservation and reintroduction as well as in monitoring and con-
trolling exotic and allochthonous species. Despite the obvious social relevance of wildlife res-
cue centers, their low budgets, limited spaces, lack of quarantine areas, and overcrowding 
makes the management of these structures extremely complicated. In addition to all of these 
problems, wildlife rescue centers are officially appointed as keepers of exotic or wild animals 
seized due to being owned illegally, which cannot be rejected or euthanized even if diseased. 
The present study raises the question of whether the management of these structures might 
represent a threat for infectious diseases diffusing into wildlife populations after the reintro-
duction of rescued animals into the wild. 
In this study we also compared the effectiveness of anatomical pathology and histopathology 
in detecting the presence of the virus. In our caseload, and contrary to other studies, the effi-
cacy of gross and histopathology in detecting TeHVs associated lesions was low, particularly 
in samples from Vanzago's Oasis. In our opinion, the sensitivity and specificity of our results 
was influenced by the typology of the samples we included in the study. The presence of bi-
opsy, "necropsy in a bottle," and autolytic bodies from Vanzago represented a different case-
load compared to studies available in literature, where only necropsies of fresh or minimal au-
tolytic bodies were considered for the anatomopathological evaluation. 
The inclusion of different typology cases allowed us to arrive at two conclusions: 
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1) Biopsy and "necropsy in a bottle" are samples frequently submitted from veterinarians to 
pathology diagnostic services. Based on our findings, the diagnostic relevance of the 
samples mentioned above relies almost entirely on the ability of the referral veterinarian 
in detecting the right specimens to submit. Furthermore, gross observations of the referral 
veterinarian are frequently missing, which does not allow the pathologist to correlate 
gross and histological findings. 
2) Most of the bodies submitted from Vanzago's Oasis were characterized by the presence 
of mild to severe autolytic changes. TeHV3-associated mortality occurs mostly during hi-
bernation or, less frequently, estivation, while animals are dormant in underground bur-
rows and physiologically immunosuppressed. Hibernation length is variable among tor-
toises, even in the same enclosure, and correlates with environmental conditions, animal 
health status, age, and breed. Due to the variable length of hibernation, Vanzago's Oasis 
staff was instructed by the management to wait one to two weeks after the first turtle’s 
awakening to recover the bodies. Although autolysis was initially an unwanted circum-
stance, we believe that Vanzago's animals’ conditions might represent a more realistic 
model of how the disease occurs in nature, suggesting that the use of anatomical pathol-
ogy in wildlife outbreak screenings might be of limited help. 
In both the prospective and retrospective samples, both animals with no lesions that were 
PCR positive and animals with classically TeHV3-associated lesions that were repeatedly 
negative to the PCR were found. This finding suggests that molecular tests (e.g. ELISA, PCR, 
and viral isolation) should always be implemented to corroborate anatomopathological find-
ings. 
TeHV3 genomic sequencing and comparison among different strains collected in Italy, Swit-
zerland, and the USA allowed us for the first time to describe the viral genome and include 
this virus in the subfamily Alphaherpesvirinae proposed genus Scutavirus. Phylogenetic anal-
ysis of the viral genome based on the gB and DNA-polymerase sequences showed that the vi-
rus has many characteristics with the Chelonian herpesvirus 5 (ChHV5) and ChHV6 and, to a 
lesser extent, to the human simplex virus and the varicella-zoster virus. 
Genomic differences between TeHV3 and ChHV5 include genes encoding for enzymes 
(UL13, UL50, UL40, UL45, UL 54) or structural proteins (UL44, encoding for the gC), 
which are present in TeHV3 and may play a key role in host immune evasion. Furthermore, 
the presence and expression of different genes might explain the existence of diverse lesion 
patterns induced by the viruses: necrotizing lesions in tortoises infected with TeHV3 and pro-
liferative lesions of a neoplastic nature in sea turtles infected with ChHV5. 
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The comparison among TeHV3 strains from different parts of the world allows subdividing 
TeHV3 into two genogroups (A and B) that correlate with different lesional profiles in ani-
mals. A third genogroup (C), genetically inbetween the first two, was also detected in a single 
individual from Switzerland, but the bootstrap results obtained were not strong enough to con-
firm the presence. 
While genogroup A was detected in the USA, Italy, and Switzerland, genogroups B and C 
were detected only in very restricted areas of the northwestern part of Switzerland, suggesting 
that spontaneous mutations with genetic segregation might have played a role in the develop-
ment of these TeHV3 genogroups. Excluding genogroup C, which was detected in a single 
animal, genogroup B detection in Switzerland was identified during a timespan of eight years, 
always in the same area, preceded and followed by genogroup A outbreaks. It would be of in-
terest to conduct a retrospective survey of the respective countries surrounding the geograph-
ical regions of genogroups’ B and C outbreaks (France for genogroup B and Germany for 
genogroup C) to compare the genotype distribution in the same years. 
Viral genome sequencing allowed us to develop a phage display library to start detecting the 
host antigenic response against TeHV3. 
Due to the limited knowledge available on reptile immunology, strict standardization of the 
experimental condition was necessary to gain the most reliable information, so we decided to 
focus only on the American TeHV3 strain and to use hyper-immune Testudo graeca sera col-
lected during the first transmission study performed on TeHV3 by Origgi et al. in 2004. Five 
clones were selected via immunoblot, each of them containing genes or a part of gene encod-
ing for a range of 1-6 proteins. Among the initially identified clones, only the ones compris-
ing gB, TE17, and Ul15 sequences were also positive at F.A.C.S. analysis. Based on the in-
formation available in the literature on the relevant immunological proteins of Alphaherpesvi-
rus in other species, gB was the most promising antigenic protein targeted by the host (Tes-
tudo gaeca) immune response. 
Unfortunately, sequencing of the clone returned that the gB sequence was antisense compared 
to the ORI of the phagemid. 
Because two sequences other than gB were present in the phagemid, DNA was extracted and 
reduced to fragments corresponding to each of the coding DNA sequences present in the 
phagemid. New fragments were then included in plasmids and expressed in bacterial cloning 
vectors. 
Unfortunately, despite the numerous attempts and various molecular biology techniques used 
to express TE17, UL15, and gB, we did not succeed. 
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This is the first time that host-pathogen interaction is investigated in reptiles. Although unable 
to identify the most antigenic protein involved in host immune system activation, we demon-
strated that: 
1) Reptiles' immune system is capable of discerning specific proteins among all viral proteins 
contained in the virus. 
2) At least two proteins seem to be immunorelevant in the host immune response against 
TeHV3. Among those proteins, TE17 sencode for a tegument protein might play a rele-
vant role in early immune response against the virus. 
3) The other four clones we detected with the immunoblot technique might represent tortoise 
IgY antibodies cross-reacting with multiple epitopes, and still might represent a defense 
mechanism for the host. 
 
Future perspective 
Immunology in reptiles is an expanding field that interconnects with new disciplines such as 
eco-immunology and eco-toxicology, which are growing in importance. 
Knowledge of reptiles' immune system might open new research frontiers, including the use 
of reptiles as research animals or in ecological and pollution surveillance plans. 
Furthermore, from a biodiversity perspective, understanding reptiles' immunology will pro-
vide new therapeutical approaches to prevent the extinction of these animals, secondary to the 
diffusion of new and old diseases such as TeHV3. 
In the future, we will have to characterize the exact proteins involved in boosting the host im-
mune system against TeHV3 to try to develop a vaccine against the virus. Moreover, we will 
try to describe the immune response in other tortoises (Testudo hermanni and T. marginata) 
to see if there are differences, and then try to correlate those differences with a possible host-
pathogen co-evolution. 
Once this information is obtained, we would like to create a snap ELISA test able to identify 
TeHV3 genogroups efficiently and cost effectively. 
With this tool it will be possible to set up a network of veterinarians worldwide to establish 
viral genogroup distributions and try to create genogroup-specific therapeutical approaches. 
 
  
pag. 196 
 
Publications outside the PhD research project:  
Indexed publications: 
1: Avallone G, Forlani A, Tecilla M, Riccardi E, Belluco S, Santagostino SF, 
Grilli G, Khadivi K, Roccabianca P. Neoplastic diseases in the domestic ferret 
(Mustela putorius furo) in Italy: classification and tissue distribution of 856 
cases (2000-2010). BMC Vet Res. 2016 Dec 5;12(1):275. PubMed PMID: 27919252; 
PubMed Central PMCID: PMC5139086. 
 
2: Bel L, Tecilla M, Borza G, Pestean C, Purdoiu R, Ober C, Oana L, Taulescu M. 
Diagnosis and surgical management of malignant ovarian teratoma in a green iguana 
(Iguana iguana). BMC Vet Res. 2016 Jul 19;12(1):144. doi: 
10.1186/s12917-016-0773-x. PubMed PMID: 27435282; PubMed Central PMCID: 
PMC4952068. 
 
3: Gianella P, Tecilla M, Bellino C, Buracco R, Martano M, Zanatta R, Cagnasso A, 
D'angelo A. An unusual case of intestinal leiomyositis in a Bernese mountain dog. 
Schweiz Arch Tierheilkd. 2015 Oct;157(10):563-7. PubMed PMID: 26897772. 
 
4: Tecilla M, Bielli M, Roccabianca P. Mesenteric heterotopic ossificans in a Ferret (Mustela 
putorious furo): a rare cause of soft tissue ossification. Journal: Journal of Exotic Pet Medi-
cine. Under publication (See acceptance letter below). 
pag. 197 
 
 
Non-indexed publications: 
1: Claudia Manno, Damer Blake, Gabriele Ghisleni, Marco Tecilla, Giusi Macaluso, Roberto 
Puleio, Vinenzo Monteverde, Guido R. Loira. Cardiac filariosis in migratory Mute swans 
(Cygnus olor) in Sicily. International journal of Health, Animal science and Food Safety; 
DOI: https://doi.org/10.13130/2283-3927/6796 
